Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39854,0.0986408964730666,0.00264550262251526,0.0934557113329367,0.103826081613196,7.29138069131975e-292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39878,0.149406450643772,0.00460145905506532,0.140387590895844,0.1584253103917,4.93182546036141e-224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39909,0.0759179626275191,0.00283500201353133,0.0703613586809977,0.0814745665740405,1.39450411928284e-154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,39972,-0.0772709698931285,0.00319349727219567,-0.083530224546632,-0.071011715239625,4.45446612992905e-127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39839,0.0647657351151555,0.00279951006754976,0.059278695382758,0.070252774847553,1.69045916701819e-116
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37384,0.0721965729259834,0.00325777762391285,0.0658113287831143,0.0785818170688526,6.42650320897618e-107
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37329,0.0624839383683216,0.00310648250552072,0.056395232657501,0.0685726440791422,1.10931290593128e-88
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39745,-0.101797101225449,0.00528026627218609,-0.112146423118934,-0.0914477793319646,6.96622828681151e-82
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,39855,0.0531565713191342,0.00282218067082774,0.0476250972043118,0.0586880454339566,2.72616571204777e-78
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40048,0.0448780619337176,0.00259842305645875,0.0397851527430584,0.0499709711243768,3.03661617740354e-66
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39909,0.0592446453036614,0.00356528350271589,0.0522566896383383,0.0662326009689846,1.71048669335723e-61
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39854,0.0408728675208893,0.0024881404204434,0.0359961122968202,0.0457496227449583,3.80474091729634e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,36759,0.0336231644685393,0.00211223989812535,0.0294831742682136,0.037763154668865,1.63281838831825e-56
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,37449,0.032533696651139,0.0020757098943402,0.0284653052582322,0.0366020880440458,6.93537259578643e-55
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40054,0.0363718583432278,0.00233510247314072,0.031795057495872,0.0409486591905837,2.62015259059696e-54
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37145,0.0425359572681445,0.00275981438530021,0.0371267210729561,0.0479451934633329,3.87972463372253e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,37449,-0.0367673911915877,0.00245084602609344,-0.0415710494027308,-0.0319637329804446,1.80757678545282e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39945,0.0625139794669572,0.00424751340939679,0.0541888531845395,0.0708391057493749,1.02795351558634e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,39864,0.0443383842906255,0.00301784282999901,0.0384234123438274,0.0502533562374235,1.50061537237579e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40026,0.0745849555042881,0.00527666385045857,0.0642426943573894,0.0849272166511869,4.29769451585775e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,39864,0.0492176586129727,0.00349308439150447,0.0423712132056239,0.0560641040203215,8.10461692637782e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,39904,0.0296618277397677,0.0021294850725982,0.0254880369974753,0.0338356184820602,7.58927799162701e-44
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37120,0.0518289877684032,0.00373565193360532,0.0445071099785368,0.0591508655582696,1.82815822206149e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,39682,0.0623664947623847,0.00453438807965274,0.0534790941262653,0.0712538953985041,8.48163115505637e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37449,0.0320469606910226,0.00234617185686995,0.0274484638515575,0.0366454575304877,3.37656198606439e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39862,0.0406424333292239,0.00298781804461737,0.0347863099617738,0.0464985566966739,6.59828851148989e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37120,0.142091705008498,0.0104451897437526,0.121619133110743,0.162564276906253,7.28199584951297e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39581,0.066440288796543,0.00492237567209863,0.0567924324792297,0.0760881451138563,2.74314803440717e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39927,0.0514822353230545,0.00383199800247196,0.0439715192382095,0.0589929514078996,6.28580929244123e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,39927,0.0390065236877287,0.00293937627668111,0.0332453461854337,0.0447677011900236,5.58448624823429e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40048,0.0571816412583685,0.00437301551792208,0.0486105308432413,0.0657527516734958,7.10571392094624e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,39772,0.0456760532964297,0.0035101853900106,0.0387960899320089,0.0525560166608505,1.63487355662792e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37039,-0.0505836084280272,0.00391176324808331,-0.0582506643942705,-0.0429165524617839,5.11305941206101e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,39904,0.0297519143520499,0.00232351372495084,0.0251978274511463,0.0343060012529536,2.35113197145219e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39835,0.0331591852548046,0.00260055004227064,0.0280621071719542,0.0382562633376551,4.6750198864536e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,39854,0.0325301388063623,0.00256963259344003,0.0274936589232198,0.0375666186895047,1.48532995960067e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39842,0.129063325947084,0.0102277148360109,0.109017004868503,0.149109647025665,2.4732596944766e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,39822,0.0299192460952152,0.00237403371540949,0.0252661400130125,0.0345723521774178,3.03591024537953e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39889,0.0256293800502411,0.00203477598738038,0.0216412191149756,0.0296175409855066,3.31046676465707e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39813,0.0369595793909829,0.00293655129429346,0.0312039388541677,0.042715219927798,3.74240204688142e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37052,-0.136392030254607,0.0108738404475702,-0.157704757531844,-0.115079302977369,6.94515533337751e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40026,0.0368886793071697,0.00294592552432325,0.0311146652794961,0.0426626933348433,8.30369083104049e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39569,0.0370155618480858,0.00305783171647242,0.0310222116837999,0.0430089120123718,1.39917930071046e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39745,0.0391149742283183,0.00323261581655178,0.0327790472278768,0.0454509012287598,1.48180766559585e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40048,0.0290581360202557,0.00241696252792693,0.0243208894655189,0.0337953825749925,3.74280810754278e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37378,0.110793725940456,0.00922821499193528,0.0927064245562626,0.128881027324649,4.86658552714193e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39854,0.0263648073325898,0.00219730823595465,0.0220580831901187,0.0306715314750609,5.00378544026035e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37408,0.0981786742360378,0.00822110653772134,0.082065305422104,0.114292043049972,1.03975179177327e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,39975,0.0637740336177921,0.00534250613524257,0.0533027215927167,0.0742453456428676,1.04157476663378e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40005,0.0237999242599272,0.0019944324592305,0.0198908366398354,0.027709011880019,1.09071850818475e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,39862,0.0351230232848271,0.00295747638628887,0.0293263695677009,0.0409196770019533,2.15750878094848e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,39864,0.0481734219215598,0.00409452055542255,0.0401481616329316,0.056198682210188,7.96429195440668e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,39875,0.0206858040332738,0.00175883323156182,0.0172384908994126,0.024133117167135,8.36966020627885e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37039,0.0965772754967951,0.00822383761022722,0.0804585537807498,0.11269599721284,1.09591726807245e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,37449,0.0210360429847336,0.00179734920633276,0.0175132385403214,0.0245588474291458,1.72323693622438e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37433,-0.0522741520747209,0.00446736440939016,-0.0610301863171257,-0.0435181178323162,1.77675401765485e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37405,0.075600407347071,0.00648043907987419,0.0628987467505176,0.0883020679436244,2.68572431585394e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39854,0.0347236894699241,0.00298779620574449,0.0288676089066649,0.0405797700331833,4.25611630208386e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39782,-0.0663982537434497,0.0057151522647677,-0.0775999521823944,-0.0551965553045051,4.45934366954437e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,39864,0.0274557503840989,0.0023666733668244,0.0228170705851231,0.0320944301830747,5.41962588884161e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,36812,0.0482136410604016,0.00415767829826136,0.0400645915958094,0.0563626905249939,6.11769871212936e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39864,0.0308304606432752,0.00266261087418161,0.0256117433298793,0.0360491779566712,6.98816219083054e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,39893,0.0277629785178389,0.0023990796393452,0.0230607824247223,0.0324651746109555,7.54623958254773e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37378,0.0912054015668852,0.00789251852889752,0.075736065250246,0.106674737883524,9.6076540515969e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37216,0.0342479967863357,0.00296657738914124,0.0284335051036189,0.0400624884690525,1.09893276968346e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37364,-0.0577941251926777,0.00502051823227348,-0.0676343409279337,-0.0479539094574217,1.60087809128843e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39854,-0.0379284186552815,0.00330352319711559,-0.0444033241216281,-0.031453513188935,2.1571882711918e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39968,0.0705453785746646,0.00614594346862692,0.0584993293761558,0.0825914277731733,2.22428001102146e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39927,0.0682715447135217,0.00594790075449427,0.0566136592347129,0.0799294301923304,2.22851085634472e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37263,0.0426866668623058,0.00371929035905602,0.035396857758556,0.0499764759660556,2.38322623082551e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39784,0.0309676446782881,0.00272049814228035,0.0256354683194186,0.0362998210371575,6.62614346033715e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36589,-0.11100542449977,0.00976669756200696,-0.130148151721304,-0.0918626972782367,8.62345101428861e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,39854,0.0253579178862148,0.00223618492804682,0.020974995427243,0.0297408403451865,1.08180547749895e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39881,0.0300322887633194,0.00264850667702542,0.0248412156763496,0.0352233618502893,1.0872744040782e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39485,0.0520254602392796,0.00460951553112303,0.0429908097982785,0.0610601106802807,1.98814135614451e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40026,0.0745681946111152,0.00662182347825556,0.0615894205937343,0.0875469686284961,2.62895812361234e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,39813,-0.0645284310038773,0.00573487677730523,-0.0757687894873955,-0.053288072520359,2.9204408103095e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39854,0.048472366212204,0.00430885889220744,0.0400270027834774,0.0569177296409306,3.00053695305998e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37220,0.0136656551953624,0.00121657352164044,0.0112811710929471,0.0160501392977777,3.79701472905204e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39560,0.0414734624217293,0.00370034569927207,0.034220784851156,0.0487261399923026,4.80213115013124e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39812,0.0201516776968203,0.00179869947824146,0.0166262267194671,0.0236771286741736,5.03181233859915e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,39836,-0.0456022034755005,0.00408001122831386,-0.0535990254829957,-0.0376053814680053,6.7656437588493e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37384,0.0772088951807234,0.00691146475668317,0.0636624242576244,0.0907553661038224,7.55022850258096e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37120,-0.0302852216752018,0.00271368174520075,-0.0356040378957953,-0.0249664054546084,8.57855307804431e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39873,0.0395625672413991,0.00355132460466248,0.0326019710162606,0.0465231634665375,1.01903212569106e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40054,0.0403134757455572,0.00361907690062132,0.0332200850203394,0.047406866470775,1.02845523885738e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,37449,-0.0354756523108591,0.00318758832638574,-0.0417233254305752,-0.029227979191143,1.20130015629763e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,39551,0.0380903634223895,0.00343224612858749,0.031363161010358,0.044817565834421,1.64160291364335e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39805,0.0193164851570668,0.00174161720566505,0.0159029154339633,0.0227300548801703,1.76099155536028e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39583,0.072335605131063,0.00653330709133683,0.0595303232320429,0.0851408870300832,2.18835917036062e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39854,0.0265558689214682,0.0023993174530027,0.0218532067135829,0.0312585311293535,2.27131729796177e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,39854,0.0768041603051336,0.0069702165382921,0.0631425358900811,0.0904657847201862,3.91101813483928e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,39854,0.0235326503335298,0.00214030778470416,0.0193376470755097,0.02772765359155,5.08983563134973e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39909,0.0337169972886353,0.00307147341481613,0.0276969093955957,0.0397370851816749,6.16587038677665e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39854,0.0357334500714095,0.00325674181693661,0.0293502361102138,0.0421166640326053,6.54192880989269e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39858,0.0277626670812161,0.00253151528153653,0.0228008971294045,0.0327244370330277,6.93562388256279e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37441,0.0250200000015719,0.00228259559700087,0.0205461126314502,0.0294938873716937,7.67997963446476e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40005,0.0295733403603872,0.00269965573412189,0.0242820151215083,0.0348646655992662,7.92377541541397e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,39904,0.0508244118295657,0.00464387137920668,0.0417224239263206,0.0599263997328108,8.86165754143475e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37433,0.0271712317881802,0.00248349753741736,0.0223035766148421,0.0320388869615182,9.61243873470371e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39169,0.0207390891737592,0.0019027964022879,0.017009608225275,0.0244685701222435,1.46690047752271e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39863,-0.0935153731748035,0.00859144006402554,-0.110354595700294,-0.0766761506493135,1.70191197737897e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39998,0.0207155878186368,0.00191040638387474,0.0169711913062423,0.0244599843310313,2.6579945341298e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39818,0.0277774450787533,0.00256523745113302,0.0227495796745326,0.032805310482974,3.13999764352162e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37017,-0.0902890196357135,0.00833629712918748,-0.106628162008921,-0.073949877262506,3.20325715961102e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37362,0.0861001539853115,0.00796218728130766,0.0704942669139485,0.101706041056675,3.83257771660313e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37428,0.0187141115768436,0.00173248856114659,0.0153184339969963,0.0221097891566909,4.34668102501827e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,39783,0.0240288030291538,0.00222706176901588,0.0196637619618827,0.0283938440964249,4.78805024204542e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39745,0.0374725821420186,0.00347406276570638,0.0306634191212341,0.0442817451628031,4.95243289522619e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,39864,0.0232423351846991,0.00215703163686462,0.0190145531764444,0.0274701171929537,5.58219406359608e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39881,0.0309223324665927,0.00287184797852008,0.0252935104286933,0.0365511545044921,6.06738751982981e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,37449,-0.0641016284186746,0.00595481358614396,-0.0757730630475167,-0.0524301937898324,6.48859534426319e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39784,0.0393643267713402,0.0036729464231414,0.0321653517819831,0.0465633017606974,1.04053552989307e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,39784,0.0705718328185194,0.00659422724603946,0.057647147416282,0.0834965182207567,1.22617429725829e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,39784,0.0541352619108032,0.00505909685871307,0.0442194320677256,0.0640510917538808,1.24583416442462e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37433,0.0423117984436502,0.00396172418909321,0.0345468190330275,0.0500767778542729,1.6066604660517e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37378,0.0995124649134472,0.00931828268729144,0.081248630846356,0.117776298980538,1.62336631492534e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39801,0.0257657484881314,0.00241722855076004,0.0210279805286417,0.0305035164476211,1.9387185511075e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,39806,0.0389772319074008,0.0036588722520846,0.031805842293315,0.0461486215214866,2.0758841636743e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,39987,0.0368300559169514,0.00347063469944892,0.0300276119060315,0.0436324999278713,3.20144473067186e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,39991,0.0358592703561243,0.00338119383830006,0.0292321304330562,0.0424864102791924,3.42667867208585e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,39909,0.0272054924680773,0.00256716696327638,0.0221738452200556,0.032237139716099,3.73544162300356e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40048,0.0149072479043077,0.00141449282194221,0.012134841973301,0.0176796538353145,6.93107140337873e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39759,0.0994606371441073,0.00943978307135584,0.0809586623242499,0.117962611963965,7.14951859791597e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37182,0.16653985194769,0.0158432032248505,0.135487173626983,0.197592530268397,9.61733154583641e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37039,0.0244750206556095,0.00233653328088137,0.019895415425082,0.029054625886137,1.4192319758496e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39784,0.0816516012480811,0.00780579956350157,0.066352234103618,0.0969509683925442,1.58896558823819e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,39711,0.0665154852444033,0.00636930751600108,0.0540316425130412,0.0789993279757654,1.90526722118329e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40026,0.0599224043350835,0.00574493745399539,0.0486623269252526,0.0711824817449145,2.16694021390913e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39485,0.0274873534859097,0.00263567497661433,0.0223214305317456,0.0326532764400738,2.21551885283896e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,37449,0.0250165852836217,0.00239991956021905,0.0203127429455924,0.029720427621651,2.40279379768361e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39862,-0.0326547820356771,0.00313533312352759,-0.0388000349577911,-0.026509529113563,2.54941665846237e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40054,0.0270669201856127,0.00260232829584686,0.0219663567257529,0.0321674836454725,2.94545520578664e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,39927,0.0385874008145084,0.00371524520433548,0.0313055202140108,0.0458692814150059,3.4417076973025e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37433,0.0664595908500492,0.00640115133277363,0.0539133342378128,0.0790058474622855,3.7021726075004e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40048,0.0266556821183151,0.00258260370422314,0.0215937788580377,0.0317175853785924,6.74753181057936e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37039,0.0492909237922038,0.0047778566568955,0.0399263247446886,0.0586555228397189,7.37571110065008e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,36540,0.022710155584005,0.00220227018538974,0.0183937060206411,0.0270266051473688,7.78271462794755e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39482,0.0266862929131157,0.00258959463119705,0.0216106874359695,0.0317618983902619,8.01599516089195e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40054,0.0422437121830104,0.00410479417683712,0.0341983155964097,0.0502891087696112,9.19290135723241e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37081,0.0358581275557699,0.00348429892972049,0.0290289016535177,0.0426873534580221,9.5577765671613e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,37441,0.049119828314617,0.00478171366722905,0.039747669526848,0.0584919871023859,1.15473207113882e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39640,0.0498663484854462,0.00485634115594859,0.0403479198197869,0.0593847771511054,1.17073383506739e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37039,0.0805327670914129,0.00785659957519273,0.0651338319240352,0.0959317022587907,1.45824219851386e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40054,0.0299814984035887,0.00293844500749186,0.0242221461889047,0.0357408506182728,2.2738196255323e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40048,0.0197620407365155,0.00193955673304158,0.015960509539754,0.023563571933277,2.63039035959893e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39864,0.0403238949655678,0.00396526130876101,0.0325519828003962,0.0480958071307393,3.22117316383165e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37441,0.0200074107423302,0.00197168245468007,0.0161429131311573,0.0238719083535032,4.14890260273511e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37403,0.0131884992431992,0.00130289381964632,0.0106348273566924,0.015742171129706,5.34618295112924e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39860,0.0366528204816941,0.00362540338565231,0.0295470298458156,0.0437586111175726,5.88766383281673e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39915,0.0301522094270976,0.00299327884309636,0.0242853828946287,0.0360190359595664,8.53180404677651e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37420,0.0203874655524279,0.00203521220218255,0.0163984496361501,0.0243764814687057,1.54375000488235e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39745,0.037500604824597,0.00374602803935297,0.0301583898674652,0.0448428197817288,1.60494295257707e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,39862,0.0526359401696701,0.00526017813825989,0.0423259910186807,0.0629458893206595,1.67332654552056e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39999,0.0296163878094086,0.00296694413001368,0.0238011773145818,0.0354315983042354,2.13392383422697e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39862,0.0748550350133478,0.00750564326475435,0.0601439742144293,0.0895660958122663,2.33714389395544e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40026,0.0286156067868005,0.00287009023872103,0.0229902299189073,0.0342409836546937,2.40182162066364e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40054,0.0304815516059272,0.00306695432022685,0.0244703211382826,0.0364927820735718,3.29192981111209e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,39896,0.0450128519051234,0.00453336014113005,0.0361274660285085,0.0538982377817383,3.62290955168771e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,39864,-0.0423350384645535,0.0042700462970141,-0.0507043292067011,-0.0339657477224058,4.20063804087224e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,39862,0.0409939804369543,0.00414192170619892,0.0328758138928044,0.0491121469811041,4.97873455972847e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37039,0.0861404720191511,0.00874653690752237,0.0689972596804073,0.103283684357895,8.33797936799827e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40048,0.028432070283841,0.00288936451671779,0.0227689158310741,0.0340952247366078,8.7498909811508e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,39909,-0.0358703928600037,0.00365576036782719,-0.043035683180945,-0.0287051025390624,1.15750218686684e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37047,0.0229871006574386,0.00234505118517124,0.0183908003345029,0.0275834009803742,1.31351200277968e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40005,0.0392550483220999,0.00401635112410071,0.0313830001188625,0.0471270965253373,1.684017546125e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40036,0.0440754565962472,0.00453076207107608,0.0351951629369381,0.0529557502555563,2.63560902546217e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,39994,0.0358998543248051,0.00369792944924851,0.028651912604278,0.0431477960453321,3.20340489279082e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,39864,0.0347257693388495,0.00359003425567787,0.0276893021977209,0.0417622364799781,4.52085504010075e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39679,0.0404721723603079,0.00419186289304457,0.0322561210899406,0.0486882236306753,5.38688073182202e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39854,0.0303353511508705,0.00314315109256721,0.0241747750094388,0.0364959272923022,5.57424693189679e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39583,0.0364917260415777,0.00378146663867043,0.0290800514297836,0.0439034006533717,5.64753617895712e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37120,0.0430639211572691,0.00446823733245159,0.034306175985664,0.0518216663288742,6.53265294841225e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39784,0.0391373803026326,0.00406435440491238,0.0311712456690044,0.0471035149362609,6.89106998107599e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39745,0.0252234470967732,0.00262459098452428,0.0200792487671057,0.0303676454264408,8.28231837183668e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40026,0.0967364374490294,0.0100720806297684,0.0769951594146832,0.116477715483376,8.75678560021643e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,39638,0.0237145902222424,0.00247108681634606,0.0188712600622042,0.0285579203822807,9.45279382708508e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39909,0.0221453591307624,0.00230826375945703,0.0176211621622266,0.0266695560992982,9.69658363662187e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,39615,0.0366459302405834,0.00382428920930782,0.02915032339034,0.0441415370908267,1.08629337007272e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39485,0.0409442275640947,0.004274286213224,0.0325666265861757,0.0493218285420137,1.12175278650569e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39758,0.0244747872671751,0.00256115731857116,0.0194549189227756,0.0294946556115745,1.39681130912e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39927,0.0499800498632848,0.00523265397860311,0.0397240480652227,0.0602360516613469,1.45750852628658e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37378,0.0982727101538835,0.0103071510199606,0.0780706941547607,0.118474726153006,1.76080231187842e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37378,0.0829522563508434,0.00870129465459703,0.0658977188278332,0.100006793873854,1.77938726022397e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37039,0.0667369065853857,0.00700172072164342,0.0530135339709646,0.0804602791998068,1.81791407192772e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40005,0.0505627851428477,0.00530753980479567,0.0401600071254481,0.0609655631602472,1.85062021453895e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,39792,0.0392126942118323,0.00411666609488191,0.0311440286658638,0.0472813597578008,1.87602487288801e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39816,0.0458311782270403,0.00483338566403815,0.0363577423255255,0.0553046141285551,2.83227846622866e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,37449,0.0178809481301695,0.00188791576769658,0.0141806332254842,0.0215812630348548,3.21436067852029e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37052,0.0789823689364554,0.00834528887481321,0.0626256027418215,0.0953391351310893,3.44969146236151e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39904,0.0385893681738853,0.00408652294381325,0.0305797832040113,0.0465989531437592,4.10665339668777e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37204,0.023494974019212,0.00249209309002851,0.0186104715627561,0.0283794764756679,4.86839460210407e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37433,0.0211642976901768,0.00225418415718066,0.0167460967421027,0.0255824986382509,7.01455625036448e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37283,0.0845451051221342,0.00901254731578519,0.0668805123831953,0.102209697861073,7.58148551103625e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40036,0.030439258011214,0.00324704937636635,0.0240750412335359,0.036803474788892,7.85405000671492e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40026,0.0381522059292123,0.00407667344083018,0.0301619259851852,0.0461424858732395,9.11302051475393e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39583,0.03523750151949,0.00376550026062073,0.0278571210086734,0.0426178820303066,9.2022278001734e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,39784,0.0239546700808777,0.0025628873409155,0.0189314108926834,0.0289779292690721,1.02119396678041e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40005,0.0693614306340913,0.0074325010823214,0.0547937285127413,0.0839291327554412,1.16904739400753e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,39862,0.0528104363341244,0.0056690258412095,0.0416991456853538,0.063921726982895,1.36701924856914e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,39784,-0.0750866038049992,0.0080610008908464,-0.0908861655510582,-0.0592870420589403,1.37825689194152e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37420,0.023627695718693,0.00254022133409627,0.0186488619038643,0.0286065295335217,1.59482110454986e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37441,0.0231011200876837,0.00248415042494312,0.0182321852547952,0.0279700549205722,1.62497346440447e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40005,0.0574436197571735,0.00618508438305962,0.0453208543663767,0.0695663851479704,1.77734758331693e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39784,0.0587606073562918,0.00632945863795367,0.0463548684259027,0.071166346286681,1.84408988612692e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40005,0.0306866791315042,0.00331243805580782,0.0241943005421209,0.0371790577208875,2.21038874369699e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37420,0.0157224911876554,0.00169671849975948,0.0123969229281268,0.019048059447184,2.21112960066886e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37384,0.0228584878591665,0.00246796439441233,0.0180212776461183,0.0276956980722147,2.30292640923138e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,39897,0.0246313381066908,0.00266105477756602,0.0194156707426614,0.0298470054707202,2.3798427683477e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39998,0.0414521837170114,0.00447859679542906,0.0326741339979704,0.0502302334360524,2.39171579010202e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40054,0.0344207852118978,0.00371986172090401,0.0271298562389259,0.0417117141848696,2.44422540476567e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,39485,0.0881893595407267,0.00953388652431432,0.0695029419530706,0.106875777128383,2.52744933262095e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39909,0.022982258474013,0.00248471043988263,0.018112226011843,0.0278522909361829,2.53418433144364e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37449,0.015440540737356,0.00167231449614607,0.0121628043249097,0.0187182771498023,3.01466842574006e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39581,0.0287236450758175,0.00311386924113387,0.0226204613631951,0.0348268287884398,3.20609774379346e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39854,0.0228470255352113,0.00248036363481679,0.0179855128109704,0.0277085382594522,3.6185133550631e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39904,0.0433442316671385,0.00470572645696834,0.0341210078114805,0.0525674555227964,3.62411403866328e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39593,0.0188260058710649,0.00204522526400815,0.014817364353609,0.0228346473885209,3.84337514937316e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,39862,0.0549495209109709,0.00597054097029424,0.0432472606091942,0.0666517812127476,3.88652757384141e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39583,0.0330399706416571,0.0035925334516688,0.0259986050763862,0.0400813362069279,4.13960206354867e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39854,0.0477518039241275,0.00520545999552855,0.0375491023328915,0.0579545055153634,5.13081793644842e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,39909,0.0458622692562951,0.00500102975297652,0.0360602509404611,0.0556642875721291,5.26515939219511e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39583,0.0702783262091218,0.0077097921598357,0.0551671335758438,0.0853895188423998,8.76201856407552e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37372,0.0522595363113956,0.0057367495953837,0.0410155071044436,0.0635035655183476,9.41534054778564e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37408,0.0640603815936738,0.0070596319183314,0.0502235030337442,0.0778972601536033,1.30125562299371e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,39858,0.0203604518285109,0.00224521816416305,0.0159598242267513,0.0247610794302705,1.34580570807526e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40048,0.020005156207622,0.00220640306622679,0.0156806061978175,0.0243297062174265,1.362621820571e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37433,0.018684176081282,0.00206281223395626,0.0146410641027277,0.0227272880598362,1.51297988438336e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39784,0.0258613514927,0.00285632852824818,0.0202629475773336,0.0314597554080665,1.5342118416173e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37120,0.0891799033647116,0.00986541265658962,0.069843694557796,0.108516112171627,1.78710009092688e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39864,-0.026766251558315,0.00297102805554454,-0.0325894665471823,-0.0209430365694477,2.30798276408189e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,39683,0.0467322311352944,0.00518763153905657,0.0365644733187435,0.0568999889518453,2.32532011157148e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40054,0.0624182079266298,0.00693394480696142,0.0488276761049854,0.0760087397482742,2.46191360709386e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,39784,0.0616255975249614,0.00684601554959401,0.0482074070477571,0.0750437880021656,2.46977245948689e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39784,0.0687014293653822,0.00766082322246028,0.05368621584936,0.0837166428814043,3.35273218782895e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39827,0.0308371989044772,0.00343871890461763,0.0240973098514267,0.0375770879575278,3.35936212755866e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39449,0.0354104079480917,0.00394919069384321,0.027669994188159,0.0431508217080244,3.40274514797397e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37039,0.0371242235079593,0.00413993381953771,0.0290099532216654,0.0452384937942532,3.44250084128461e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,39716,0.0223978694221068,0.00249838140875042,0.017501041860956,0.0272946969832576,3.44443077550191e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39927,0.0212165566803466,0.00236760193259602,0.0165760568924584,0.0258570564682348,3.55820974468018e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40054,0.0453483309777884,0.00506163338707847,0.0354275295391146,0.0552691324164622,3.61920761465049e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38019,-0.0247380340559948,0.00276914918142631,-0.0301655664515904,-0.0193105016603993,4.63204555169153e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39473,0.0443940531183628,0.00497082513862491,0.034651235846658,0.0541368703900677,4.68801030311956e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37433,0.0500557011005195,0.00561870112497253,0.0390430468955733,0.0610683553054656,5.80932692334535e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39473,0.0885874134202099,0.00995477026359442,0.0690760637035648,0.108098763136855,6.24455106044734e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39858,0.0752852242990639,0.00846510378883755,0.0586936208729423,0.0918768277251855,6.53771018733611e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39927,0.104134452897959,0.0117135174669772,0.0811759586626835,0.127092947133234,6.74230330545075e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39831,0.0284779739842104,0.00320442363975551,0.0221973036502896,0.0347586443181312,6.93173281662305e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37384,0.0744758426692727,0.0083875968350764,0.058036152872523,0.0909155324660225,7.56719340009809e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37343,0.0223590075798271,0.00252092457737828,0.0174179954081657,0.0273000197514886,8.27084702126676e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40048,-0.0271699418988441,0.00306920742120978,-0.0331855884444152,-0.0211542953532729,9.43513316976443e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39451,0.0611810068776605,0.00691636068887798,0.0476249399274596,0.0747370738278613,1.00432276759514e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,39999,0.0154359479004782,0.00174527775570896,0.0120152034992887,0.0188566923016678,1.01375974026094e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39695,0.0237339158409211,0.00268533820370872,0.0184706529616521,0.0289971787201902,1.07210355434109e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40054,0.0592156674458489,0.00670143184910956,0.0460808610215941,0.0723504738701036,1.08960741924036e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39370,0.098368767804279,0.0111341605165678,0.076545813191806,0.120191722416752,1.10803738643297e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,39784,0.0234129006442326,0.00265316998226747,0.0182126874789884,0.0286131138094769,1.21187158894044e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37433,0.0546104308895796,0.00618873874638485,0.0424805029466653,0.066740358832494,1.23611343173544e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39784,0.0692836973444945,0.00785585237432808,0.0538862266908115,0.0846811679981776,1.26838162742e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39784,0.0259652804541485,0.00294943359983607,0.0201843905984698,0.0317461703098272,1.46061406505914e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37441,0.0579733331172066,0.00658698618979998,0.0450628401851986,0.0708838260492145,1.5154348832487e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,39789,0.0634220333529366,0.00722003864386944,0.0492707576109525,0.0775733090949207,1.73319367628923e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,39773,0.0224825644019556,0.00255985868058381,0.0174652413880113,0.0274998874158999,1.75546411950299e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37120,0.0510027926004726,0.00580675631743027,0.0396215502183093,0.0623840349826359,1.7794938263096e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37039,0.055452445414985,0.00631595382843478,0.0430731759112528,0.0678317149187171,1.83851497230566e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39855,0.0750612955548804,0.00856338847564845,0.0582770541426094,0.0918455369671513,2.04578895815301e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37120,0.0455660042877298,0.00519907238330078,0.0353758224164603,0.0557561861589994,2.10649239425263e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40005,0.0360745154716722,0.00412364529097224,0.0279921707013667,0.0441568602419778,2.37832164554929e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,39665,0.0364537595529982,0.00417323443814343,0.0282742200542371,0.0446332990517593,2.67406111482607e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37384,0.0240920970854655,0.00276627014158424,0.0186702076079604,0.0295139865629706,3.41074584938662e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39842,-0.0382817323650964,0.00439693849807211,-0.0468997318213177,-0.0296637329088751,3.43732537949413e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39784,0.0300516381340597,0.0034568162720938,0.0232762782407559,0.0368269980273635,3.85399483034063e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37378,0.0713078108883081,0.00821012084131676,0.0552159740393272,0.0873996477372889,4.20460977828795e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39784,0.0572766262312598,0.00660182735339979,0.0443370446185962,0.0702162078439234,4.49487081618688e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40048,0.015210441811626,0.00175384794834722,0.0117728998328655,0.0186479837903866,4.61816097974606e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,39784,0.0577750847747011,0.00666610488239228,0.0447095192052122,0.0708406503441899,4.85779402127229e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39745,0.0449594335004201,0.00518855877432988,0.0347898583027335,0.0551290086981067,4.93946688377434e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37378,0.0927920377617912,0.0107074149125799,0.0718055045331345,0.113778570990448,4.973086226303e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39368,0.0285365211680992,0.00330081819694124,0.0220669175020943,0.035006124834104,5.8851181659697e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39854,0.0262642424565031,0.00303817553901748,0.0203094184000288,0.0322190665129773,5.89668828347639e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37408,0.0894489525375451,0.010347406523679,0.0691680357511342,0.109729869323956,6.00081670763615e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,39839,0.0394947599174014,0.0045750234947007,0.0305277138677881,0.0484618059670148,6.54992538814159e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39728,0.0305947903248403,0.00354477932811936,0.0236470228417263,0.0375425578079542,6.65437977999026e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39583,0.0426528622974742,0.00495056095918607,0.0329497628174695,0.0523559617774789,7.59957696138186e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37408,0.0657520483060846,0.00763367895311547,0.0507900375579783,0.0807140590541909,7.86812030342571e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39854,-0.0305061511182458,0.00354416730202842,-0.0374527190302215,-0.0235595832062701,8.15801438025473e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,39560,0.0421218128205279,0.0048944677955644,0.0325286559412217,0.0517149696998341,8.27268889613218e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39854,-0.0403647345441867,0.00470271786679005,-0.0495820615630952,-0.0311474075252782,1.00574767026284e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39784,0.0264066965558165,0.00308047249983638,0.0203689704561372,0.0324444226554958,1.10648996907764e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40026,0.0256588317601574,0.00299424838881685,0.0197901049180764,0.0315275586022384,1.13325530321736e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39909,0.0280257543060332,0.00327103226230245,0.0216145310719203,0.034436977540146,1.14886229086395e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37378,0.0543011291842668,0.00633700363502531,0.0418806020596172,0.0667216563089164,1.15705397017667e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39581,0.056773735842708,0.00663524325428021,0.0437686590643188,0.0697788126210972,1.27076953551539e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,39862,0.0211394467294746,0.00247347860343381,0.0162914286667444,0.0259874647922049,1.38250304380404e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39473,0.0570529288730708,0.00667906326927066,0.0439619648653003,0.0701438928808413,1.4388402676654e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39784,0.0474082795823502,0.00555192146794858,0.036526513505171,0.0582900456595294,1.47374343442127e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37120,0.0281128317290872,0.00329589153604077,0.0216528843184473,0.0345727791397271,1.62566077466022e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39784,0.0684583323255604,0.00803079026124665,0.052717983413517,0.0841986812376038,1.67097167468773e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39854,0.0396888220026004,0.00466209446665654,0.0305511168479536,0.0488265271572473,1.84219751145067e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40054,0.0194526374078553,0.00229030246604758,0.014963644574402,0.0239416302413085,2.17745450459095e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37052,0.0299774870054585,0.00352928051757261,0.0230600971910162,0.0368948768199009,2.20980124630257e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39685,0.0325841639004292,0.00383761600244146,0.0250624365356439,0.0401058912652145,2.23361789431795e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37039,-0.0275782205679074,0.00324962716173616,-0.0339474898049103,-0.0212089513309046,2.35364813468033e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39716,0.0177700531820884,0.00209609584641469,0.0136617053231156,0.0218784010410612,2.49697212833341e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37433,0.0508862931026207,0.00600341974718556,0.0391195903981369,0.0626529958071044,2.56422887581456e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37022,0.0438303024797906,0.00518183069461146,0.0336739143183522,0.0539866906412291,2.9929908845145e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39745,0.0256094399980588,0.00302951272369551,0.0196715950596156,0.0315472849365019,3.07438991945066e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37039,0.0237961226762722,0.00281684038534002,0.0182751155210057,0.0293171298315386,3.27699385852639e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40026,-0.0284231807780534,0.00336690632545598,-0.0350223171759471,-0.0218240443801597,3.38311670789951e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40005,0.0592921323191843,0.00702657977505229,0.0455200359600818,0.0730642286782868,3.49074326961646e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40013,0.0936599466600173,0.0111014125459972,0.0719011780698628,0.115418715250172,3.53560250770391e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39864,0.0229464565146053,0.00273001520642574,0.0175956267100108,0.0282972863191998,4.6248241502867e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40007,0.0203890933311131,0.00243073870142255,0.0156248454763249,0.0251533411859013,5.34801183697464e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37295,0.0215389492282975,0.00256767008171594,0.0165063158681343,0.0265715825884608,5.41049827722317e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37433,0.0464593471433265,0.00554485519430899,0.0355914309624809,0.0573272633241721,5.86729358528638e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,39754,0.0578547091707964,0.00690898566651008,0.0443130972644366,0.0713963210771561,6.03754930001168e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,39581,0.0352838370218732,0.00421358444912369,0.0270252115015908,0.0435424625421557,6.04311816309822e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39883,0.0179020737972079,0.00213882829965506,0.013709970329884,0.0220941772645318,6.23049701144972e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37433,0.0210984182366537,0.00252842243834154,0.0161427102575043,0.0260541262158031,7.83721323380075e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,39680,0.0290053138366457,0.0034766536065843,0.0221910727677405,0.035819554905551,7.8422922975781e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39533,0.0378479084185921,0.00453661165593956,0.0289561495729506,0.0467396672642337,7.85550535047406e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40005,0.0436505079243799,0.0052335042051722,0.0333928396822424,0.0539081761665174,7.98267700815465e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40054,0.0193879720585742,0.00232474376802863,0.0148314742732381,0.0239444698439103,8.03187818003695e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37216,0.0419838916636358,0.00503733409513478,0.0321107168371717,0.0518570664901,8.53431315833667e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,39888,0.0282816315969642,0.00339606567714857,0.021625342869753,0.0349379203241754,8.89735327550005e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37401,0.0460842707335486,0.005541596249732,0.0352227420840738,0.0569457993830233,9.95488557007566e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,39927,0.0313472752988847,0.0037771888010489,0.0239439852488289,0.0387505653489406,1.13153619493459e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37385,0.0148771872713454,0.00179352728742089,0.0113618737880004,0.0183925007546903,1.18847323844943e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37052,0.0644212201220195,0.00776941366864289,0.0491931693314794,0.0796492709125595,1.22437517286782e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37433,0.0737028664658071,0.00890677729886671,0.0562455829600284,0.0911601499715859,1.40446890094722e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37120,0.0270463967916749,0.00327035023190933,0.0206365103371326,0.0334562832462172,1.46415012297759e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,39784,0.0671206030520557,0.00812386371418306,0.0511978301722569,0.0830433759318545,1.54222643111315e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39709,0.0719672357672646,0.00871853055167665,0.0548789158859784,0.0890555556485509,1.64425452205789e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37408,0.0355593151138676,0.00430866484559296,0.0271143320165054,0.0440042982112298,1.68675840795477e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37411,0.0332499179524462,0.00403331739628839,0.025344615855721,0.0411552200491715,1.82043187175952e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39862,0.0244197064370324,0.00296353324633681,0.0186111812742123,0.0302282315998526,1.85323220697978e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39862,0.0278274443775576,0.00337852779235005,0.0212055299045515,0.0344493588505637,1.90808912942691e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,39904,0.0435021784621446,0.00528491338843618,0.0331437482208097,0.0538606087034795,1.9915424434988e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37052,0.0657272792980088,0.00798403711236487,0.0500785665577737,0.081375992038244,2.00744076476114e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37433,0.0751770894764804,0.00913618442114568,0.0572701680110349,0.0930840109419259,2.06728365338277e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37420,0.0108095937743373,0.00131398426551905,0.00823418461391994,0.0133850029347546,2.10071371161667e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,39784,0.0617992261226609,0.00751585652086218,0.047068147341771,0.0765303049035507,2.14517687477785e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37441,0.0197905369065857,0.00240669546462603,0.0150734137959187,0.0245076600172527,2.16166596378999e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36760,0.0368739101133282,0.00448421126878791,0.0280848560265039,0.0456629642001525,2.1726386517187e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,39784,0.0210775419010956,0.00256477132086558,0.016050590112199,0.0261044936899921,2.22527340684352e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,39581,0.0283419865770547,0.00345147632021359,0.021577092989436,0.0351068801646733,2.35165482487103e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39473,0.0615358479351055,0.00750680903161366,0.0468225022331427,0.0762491936370683,2.64706441201403e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,39854,0.0388277949447137,0.0047403584572533,0.0295366923684973,0.0481188975209302,2.78707007609649e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39927,0.0481991769505325,0.00589341936539538,0.0366480749943576,0.0597502789067075,3.0876229471812e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,36777,-0.0319526005041091,0.00390984249283905,-0.0396158917900736,-0.0242893092181445,3.30457830123052e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39981,0.0206565839464131,0.00253277940309562,0.0156923363163457,0.0256208315764806,3.72515652430317e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,39716,0.0378892906058333,0.00464751128849618,0.0287801684803808,0.0469984127312858,3.82601881559531e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37120,0.0933008676947514,0.0114435204195655,0.070871567672403,0.1157301677171,3.86184844276639e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,39583,0.0358594874294558,0.00440092833154262,0.0272336678996322,0.0444853069592793,3.97067958465159e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40054,0.0619741456246005,0.00761427692645918,0.0470501628487405,0.0768981284004605,4.2656525349928e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40054,0.0266394327871196,0.00328023740269107,0.0202101674778451,0.0330686980963941,4.94604957716658e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37120,-0.038620113330839,0.00477612957339958,-0.0479813272947022,-0.0292588993669758,6.69394168632488e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,39904,0.0246056510435403,0.00304363855403027,0.018640119477641,0.0305711826094397,6.69546568745779e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,39927,0.0262402648043103,0.00324778719118973,0.0198746019095785,0.0326059276990422,6.96591823118969e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,39904,0.0132772916507181,0.00164451840162739,0.0100540355835284,0.0165005477179078,7.3021878506054e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37378,0.0650088233869204,0.0080510671611975,0.0492287317509733,0.0807889150228675,7.34159240506736e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39833,0.0700311846473646,0.00868307161909798,0.0530123642739326,0.0870500050207967,7.82308805102973e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39784,0.0326759865744534,0.00405582796316508,0.0247265637666498,0.0406254093822569,8.39976864547664e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40005,0.03803853889823,0.00472244588791349,0.0287825449579196,0.0472945328385404,8.50985933145087e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,39745,0.0184422811321347,0.00229226326112036,0.0139494451403388,0.0229351171239306,9.19581272520385e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37120,0.0524934196971155,0.00652408173464686,0.0397062194972077,0.0652806198970234,9.27019449141558e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40005,0.0385867487793089,0.00480729382796012,0.029164452876507,0.0480090446821107,1.06962112786921e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37433,0.0391104573380323,0.00487240872675695,0.0295605362335887,0.0486603784424759,1.08116573068747e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37378,0.102161629345977,0.0127300551668921,0.0772107212188683,0.127112537473085,1.09646709556659e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39784,0.0496400013254868,0.00618987007299618,0.0375078559824143,0.0617721466685593,1.13456689308952e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40054,0.0549394600216109,0.00685613698603229,0.0415014315289876,0.0683774885142342,1.19340321381409e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37373,0.054457788268024,0.00680694054530612,0.041116184799224,0.0677993917368239,1.34136070440046e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37384,0.0594500657789029,0.00743869780692432,0.0448702180773312,0.0740299134804745,1.43469343118869e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40054,0.0323867603211079,0.00405423712331133,0.0244404555594177,0.0403330650827981,1.45862993012889e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39581,0.0286077141110592,0.00358414735266988,0.0215827852998263,0.0356326429222922,1.5419325185454e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,39784,0.0209131249955934,0.00263007218539989,0.0157581835122096,0.0260680664789772,1.96491961492303e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39473,0.0562405774211829,0.00707720213544956,0.0423692612357018,0.0701118936066641,2.04509583798106e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,39832,0.0646973645364232,0.00815339608665706,0.0487167082065753,0.080678020866271,2.24335789518499e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40005,0.0206442540436145,0.00260289088437442,0.0155425879102407,0.0257459201769884,2.31015050827495e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,39854,0.0874708887266337,0.0110356720613943,0.0658409714863009,0.109100805966967,2.40771629098882e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39485,0.031916870065336,0.0040273452210394,0.0240232734320988,0.0398104666985732,2.43375643369383e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39862,0.0586939733690112,0.00740762133540506,0.0441750355516172,0.0732129111864051,2.46105406862677e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37384,0.064865540566606,0.00819425190202666,0.0488048068386337,0.0809262742945782,2.64326897272642e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",37449,0.0116341065239861,0.00147035564371211,0.00875220946231039,0.0145160035856619,2.71816028091304e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39980,0.0517719699405876,0.0065455667792501,0.0389426590532574,0.0646012808279178,2.75145797643961e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37120,0.0452909052993687,0.0057420049890438,0.0340365755208428,0.0565452350778945,3.31946556655224e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37120,0.0207694949202687,0.00263449846000835,0.0156058779386524,0.0259331119018851,3.42659297113251e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36987,0.0337215552193057,0.00427764841884594,0.0253373643183676,0.0421057461202437,3.44184800387452e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37378,0.105015486994116,0.0133265138072532,0.0788955199318996,0.131135454056332,3.51763863302881e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,39864,-0.0400894069751561,0.0050945023057888,-0.0500746314945021,-0.03010418245581,3.79766496243077e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39473,-0.0872983406855615,0.0110958501742629,-0.109046207027117,-0.0655504743440062,3.84902314039435e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39583,0.0658983632738674,0.00838305460678146,0.0494675762445758,0.0823291503031591,4.05977994728272e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,39842,0.0271581938528648,0.00346097478772308,0.0203746832689275,0.033941704436802,4.53017246648607e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39987,0.0179871681497025,0.00229584624294273,0.0134873095135347,0.0224870267858702,4.99267105683486e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40054,0.0303718336082902,0.00387839218079193,0.022770184933938,0.0379734822826424,5.13672808100469e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37052,0.0302054149436301,0.00385763481828463,0.0226444506997922,0.0377663791874679,5.24836666985115e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,39999,0.0426834814795546,0.00545340744629701,0.0319948028848125,0.0533721600742968,5.30737598575181e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39864,-0.0655030439122619,0.00838663311617051,-0.0819408448199561,-0.0490652430045677,6.05192825823221e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,39825,0.0471230498812315,0.00603816886819349,0.0352882388995723,0.0589578608628908,6.35744653089003e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39821,0.0194612431182866,0.00249481016308236,0.0145714151986452,0.024351071037928,6.53593204394949e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,39839,0.0237666352261105,0.00305223229368037,0.0177842599304969,0.029749010521724,7.30149981504075e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37120,0.0608678685616544,0.00781696681663728,0.0455466136010453,0.0761891235222635,7.39078506599029e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,39864,-0.0466589230720312,0.00600816456858952,-0.0584349256264667,-0.0348829205175958,8.59417257688552e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37009,0.0601007905217886,0.00774235190041156,0.044925780796982,0.0752758002465953,8.9335728628821e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39818,0.0331588975964385,0.00427521313487079,0.0247794798520917,0.0415383153407852,9.28639364387551e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37384,0.0178670272358316,0.00230372331061514,0.0133517295470259,0.0223823249246373,9.4110265262992e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,39786,0.0304621095201724,0.00393077972525604,0.0227577812586705,0.0381664377816742,9.769361173207e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,39927,0.0339810345129274,0.00439005218650884,0.0253765322273701,0.0425855367984847,1.04925272741622e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37384,0.0758771380071129,0.00980250401224639,0.05666423014311,0.0950900458711158,1.05960271332248e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40048,0.0274223977531855,0.00354523176353732,0.0204737434966523,0.0343710520097186,1.09458583853931e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37378,0.0551895984038471,0.00713734813955562,0.0412003960503181,0.0691788007573761,1.12881171305086e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39483,0.0338199143158782,0.00437723615033339,0.0252405314612248,0.0423992971705317,1.17404032180819e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39909,0.0507673073465673,0.00658815674503885,0.0378545201262912,0.0636800945668435,1.37553764706748e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39801,0.0793218947352653,0.0103013097563416,0.0591313276128358,0.0995124618576948,1.43826556017931e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40054,0.0363945525344269,0.00473176308757057,0.0271202968827886,0.0456688081860653,1.5370106831278e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,39927,0.070212924169228,0.00913147811494929,0.0523152270639274,0.0881106212745286,1.56710211970393e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37384,-0.0290610566422315,0.00378359437854285,-0.0364769016241755,-0.0216452116602875,1.68928465802013e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37433,0.0627501489778497,0.00817629717804327,0.0467246065088849,0.0787756914468145,1.77175504327021e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37158,0.015654698068231,0.00204025326244509,0.0116558016738386,0.0196535944626233,1.79805247751858e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40054,0.0690464315149784,0.00900546390057485,0.0513957222698517,0.0866971407601052,1.85776354822888e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39485,0.0426922890667077,0.00557564054872431,0.031764033591208,0.0536205445422073,2.0154351465371e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39784,0.0585348706855394,0.00765374390265796,0.0435335326363298,0.073536208734749,2.15967675071081e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,39581,0.0585980462860515,0.00768342869685222,0.0435385260402212,0.0736575665318819,2.54881367339651e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39709,0.0495883392144601,0.00650241708985097,0.0368436017183522,0.062333076710568,2.5557502237929e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37120,0.047805411566493,0.00627756126091927,0.0355013914950913,0.0601094316378948,2.80891913140166e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,39784,0.0380445923569443,0.00500394737516013,0.0282368555016304,0.0478523292122581,3.05635007477689e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37420,-0.0256969810894259,0.00338109656783868,-0.0323239303623897,-0.0190700318164621,3.15062696413461e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37039,0.0434062224720664,0.00572004204802318,0.0321949400579409,0.0546175048861918,3.45471846498396e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37378,0.040799165026021,0.00538005851641711,0.0302542503338435,0.0513440797181986,3.58523345893901e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37449,0.0173846044608384,0.00229429571915693,0.0128877848512908,0.0218814240703859,3.75554008858424e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37120,0.0818382504286846,0.0108014727874043,0.0606673637653721,0.103009137091997,3.78259120887301e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37120,-0.0223908583141807,0.00295665228281983,-0.0281858967885076,-0.0165958198398539,3.88664628522558e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39828,0.0245148806588905,0.00323882177245147,0.0181667899848856,0.0308629713328954,3.96371467387721e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,39864,0.0186171770375569,0.00246007192941424,0.013795436055905,0.0234389180192088,4.00408236032257e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40030,0.0158998010200544,0.002101175713295,0.0117814966219962,0.0200181054181126,4.021589538506e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37378,0.0364005217950928,0.00481297835922526,0.0269670842110113,0.0458339593791743,4.19274224420996e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,39878,0.0425930593377833,0.00563574880958298,0.0315469916710007,0.0536391270045659,4.32542004706748e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39909,0.0147479183427473,0.00195191841587438,0.0109221582476335,0.018573678437861,4.39360144329809e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37408,0.0479254483375274,0.00635249210006003,0.0354745638214098,0.0603763328536451,4.83459951429153e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39904,-0.0526591900215377,0.00698199649172397,-0.0663439031453167,-0.0389744768977587,4.8702838031842e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,39726,0.0192127681310418,0.00254949417708466,0.0142157595439559,0.0242097767181278,5.11050444186307e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,39854,0.0222193994786161,0.00295173139811919,0.0164340059383025,0.0280047930189297,5.44380266829062e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,37449,0.0103377446570644,0.00137357662989014,0.00764553446247968,0.013029954851649,5.55409200420694e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37052,0.033498969274593,0.00445674806609642,0.0247637430650441,0.042234195484142,5.99051995873677e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39944,0.0210592469542687,0.0028076802995241,0.0155561935672015,0.026562300341336,6.68450344051771e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37120,0.0606792467805627,0.00810030311526143,0.0448026526746503,0.0765558408864751,7.2679983835803e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39473,0.0559601978532868,0.00747351143336051,0.0413121154439002,0.0706082802626733,7.37725329880355e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,39784,0.0401373816357683,0.00536798163671954,0.029616137627798,0.0506586256437386,7.98813695261908e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39473,0.0314189043771181,0.00420203420112879,0.0231829173429057,0.0396548914113306,8.00303945636116e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39980,0.0229621247839176,0.00307132369043934,0.0169423303506565,0.0289819192171787,8.03709141080726e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37408,0.0354015531315579,0.00473557234272735,0.0261198313398123,0.0446832749233036,8.1524802625639e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40005,0.0172052974966913,0.00230251069175465,0.0126923765408521,0.0217182184525304,8.27680164422473e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39927,0.0199659232612429,0.00267237210462886,0.0147280739361703,0.0252037725863154,8.35256236385826e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39709,0.0515015702658263,0.00689358675304305,0.0379901402298619,0.0650130003017907,8.37710409763412e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39784,0.0229818494092516,0.0030770731363501,0.0169507860620054,0.0290129127564978,8.51598396235896e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,39927,-0.0434612198744462,0.00582155529013747,-0.0548714682431156,-0.0320509715057767,8.71880210045948e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,39559,0.0334035653361581,0.00447832645338006,0.0246260454875332,0.042181085184783,9.17790902156761e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39862,0.0825741295801594,0.0110767182307622,0.0608637618478656,0.104284497312453,9.46436667509696e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,39927,0.0386584525907094,0.00518916111052343,0.0284876968140835,0.0488292083673354,9.81940323874322e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37378,0.0771781495096596,0.0103602987213762,0.0568719640157621,0.097484335003557,9.94371797902153e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37120,0.0261954934183162,0.00351738079321356,0.0193014270636177,0.0330895597730148,1.01042126010516e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40026,0.0227904788904321,0.00306373302190271,0.0167855621675028,0.0287953956133614,1.06705057448022e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37120,0.040816841964018,0.00548625485732681,0.0300637824436574,0.0515699014843785,1.07007907608517e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39900,0.0480796656593069,0.00646501077823092,0.0354082445339743,0.0607510867846395,1.0827832144801e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40054,0.0465150381024693,0.00625748864396862,0.0342503603602909,0.0587797158446478,1.11041900315568e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37433,0.0597629075863371,0.00804011897179525,0.0440042744016184,0.0755215407710558,1.12437021019392e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39581,0.0652708241626012,0.00878523303262235,0.0480517674186614,0.082489880906541,1.14514777906459e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37264,0.0199191790329098,0.0026842714706234,0.0146580069504879,0.0251803511153317,1.23511770841431e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39825,0.059207017483087,0.00799136091157356,0.0435439500964028,0.0748700848697712,1.33739358283462e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,39904,0.0205415022810026,0.0027740658058663,0.0151043333015046,0.0259786712605005,1.37829150984705e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39862,0.0757574777811085,0.0102321545630584,0.0557024548375139,0.095812500724703,1.38856724789872e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37433,0.0476799213582278,0.0064427833303231,0.0350520660307945,0.060307776685661,1.4362719841753e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40054,0.0305506796057263,0.0041307527072578,0.022454404299501,0.0386469549119516,1.47312160712207e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40048,0.0182870865670796,0.00247602233383856,0.0134340827927561,0.0231400903414032,1.5906814323369e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39927,0.0287650757944945,0.00389513056761049,0.0211306198819779,0.0363995317070111,1.60069468315571e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37120,0.0306885079948198,0.00415732245483303,0.022540155983347,0.0388368600062925,1.6547071037063e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,37449,0.0205167335158619,0.00277975391176526,0.015068415848802,0.0259650511829219,1.66509433027583e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39581,0.0506892870952699,0.00687670964961934,0.037210936182016,0.0641676380085238,1.77572214860451e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39581,0.0622531159073868,0.00845239403817648,0.0456864235925609,0.0788198082222127,1.85727295502288e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39854,0.0788543766102843,0.0107228431220087,0.0578376040911473,0.0998711491294213,2.01874892092202e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39473,0.0415251275139097,0.00564752702374208,0.0304559745473752,0.0525942804804442,2.03726861670408e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37384,0.0432559521596429,0.00588256989716974,0.0317261151611902,0.0547857891580956,2.04576281814991e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37017,0.0396344468443993,0.00539146900646837,0.0290671675917213,0.0502017260970773,2.07839192461422e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40008,0.0194155151993505,0.00264430040682717,0.0142326864019693,0.0245983439967318,2.19791590025835e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37399,0.014942078935579,0.00203517653363951,0.0109531329296456,0.0189310249415125,2.22582894141418e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,39862,0.0373123857660074,0.00508486282970371,0.0273460546197881,0.0472787169122266,2.2732356320097e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,39581,0.0334725404945568,0.00456171298732263,0.0245315830394045,0.0424134979497092,2.2788759143236e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39583,0.0433962100531969,0.00592103069128522,0.0317909898982778,0.0550014302081159,2.42849425126102e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39846,0.037380505726872,0.00512586337460944,0.0273338135126375,0.0474271979411065,3.18439895219827e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37433,0.0420818615709257,0.0057735539233942,0.0307656958810731,0.0533980272607784,3.30186345497979e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,39909,0.0354965962531941,0.00487713726543317,0.0259374072129451,0.0450557852934431,3.54061765933488e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37408,0.0654902500295583,0.0089978407029111,0.0478544822518525,0.083126017807264,3.56290736656215e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,39909,0.0256018458268988,0.00352162790014525,0.0186994551426141,0.0325042365111835,3.7635904391547e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36957,0.0364811584076182,0.00502522947010422,0.0266317086462139,0.0463306081690225,4.10131760404354e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40026,-0.016322953121827,0.00225091572251211,-0.0207347479379507,-0.0119111583057032,4.30225736671114e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,39709,0.052239067132234,0.00720961503659788,0.0381082216605022,0.0663699126039659,4.49857625101797e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,39862,0.0319369550135748,0.00440853945320302,0.0232962176852969,0.0405776923418527,4.54353721204462e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40005,0.027411697736973,0.00378746868075997,0.0199882591226834,0.0348351363512625,4.77688778961864e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39801,0.022016568002579,0.00304308465502296,0.016052122078734,0.027981013926424,4.86890118049616e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,36870,0.0528256848130427,0.00730545395523209,0.0385069950607878,0.0671443745652976,5.06273825312271e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39858,0.024666892578743,0.00341262266251591,0.0179781521602118,0.0313556329972742,5.11795737077776e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40048,0.0104736695854578,0.00145014364360406,0.00763138804399385,0.0133159511269218,5.33092950031462e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37449,0.0159664129702896,0.00221193915490534,0.0116310122266752,0.0203018137139041,5.54405112042301e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39754,0.0169848769016035,0.00235424057713331,0.0123705653704222,0.0215991884327848,5.65388058067639e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39473,0.0440882456044811,0.0061156030165363,0.0321016636920699,0.0560748275168922,5.88858444061767e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39909,0.0474062361606356,0.00657960963130738,0.0345102012832731,0.060302271037998,6.06138159351743e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39864,-0.0254423239122419,0.00353511430417568,-0.0323711479484262,-0.0185134998760576,6.42692132858658e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39927,0.0785502202316283,0.0109145581674932,0.0571576862233417,0.0999427542399149,6.43522789517775e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37165,0.0835213227655414,0.011630482760139,0.0607255765556689,0.106317068975414,7.27502714831025e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37369,0.0385690731386095,0.00537694499128081,0.0280302609556991,0.0491078853215199,7.71659649052477e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37384,0.0294659840255731,0.00410937603142777,0.0214116070039747,0.0375203610471716,7.86461201735339e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40005,0.0420645113563345,0.00586955861953536,0.0305601764620452,0.0535688462506238,8.0234559299646e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,39864,0.0498533491085861,0.0069573130095453,0.0362170156098773,0.0634896826072949,8.0821576792064e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39927,0.0275346084006265,0.00384555266233247,0.0199973251824548,0.0350718916187981,8.40983742334381e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39784,0.0614512193540918,0.00859787960951795,0.0445993753194366,0.078303063388747,9.23725113276286e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39854,0.0501576612513228,0.0070210187259747,0.0363964645484124,0.0639188579542332,9.46100860228387e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40005,0.0385137251160613,0.00539363119526578,0.0279422079733403,0.0490852422587822,9.68896463996175e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39862,0.0472574703822023,0.00661867902903063,0.0342848594853022,0.0602300812791023,9.7332549647379e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39745,0.0609822703421517,0.00854656055281695,0.0442310116586305,0.0777335290256729,1.00748758670976e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,39864,0.0403388740078245,0.00565453950914684,0.0292559765698966,0.0514217714457523,1.01749801374695e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,39881,0.0152193468299322,0.0021362038962204,0.0110323871933402,0.0194063064665242,1.08919811266294e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39485,0.0479732020958493,0.00673433839822713,0.0347738988353241,0.0611725053563745,1.09677727934012e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39581,0.0261639318949368,0.00367327936247055,0.0189643043444945,0.0333635594453791,1.10363526305727e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37408,0.041235545434196,0.00579820884946992,0.0298710560892349,0.052600034779157,1.20306891971935e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37364,0.0268982488489729,0.00379739039092662,0.0194553636827567,0.0343411340151891,1.47676973393963e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39927,0.0245865004736057,0.00347738325748775,0.0177708292889297,0.0314021716582817,1.608445804198e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39784,0.0797172926999804,0.0112765435031687,0.0576152674337698,0.101819317966191,1.62180086159278e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37174,0.0230658104753354,0.00326237041774429,0.0166715644565566,0.0294600564941142,1.62353849562018e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,37449,0.0350829500621422,0.00496589500002473,0.0253497958620937,0.0448161042621906,1.68703681964141e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37408,0.0483220190272847,0.00684716377337872,0.0349015780314624,0.061742460023107,1.78111660769442e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,39784,0.0656332399740518,0.00930616804645456,0.0473931506030009,0.0838733293451027,1.82748854309074e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40054,0.0215617577260372,0.00305748341087259,0.0155690902407269,0.0275544252113475,1.8332695614129e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37120,0.0343650981488264,0.0048749705846897,0.0248101558028346,0.0439200404948182,1.88726409436105e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40027,0.0260026509335131,0.00369479157702709,0.01876085944254,0.0332444424244862,2.03359795383533e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,39745,0.041278465977108,0.00586899905586338,0.0297752278276157,0.0527817041266002,2.09922111790584e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39541,-0.0478026303348359,0.00680519452254156,-0.0611408115990174,-0.0344644490706545,2.23774985601466e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39864,0.0423370894998831,0.0060277017835668,0.0305227940040922,0.054151384995674,2.246806693296e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39473,0.0488356051303746,0.00695691278852247,0.0352000560648706,0.0624711541958787,2.31463578654572e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39691,0.016703818919878,0.00238092673363907,0.0120372025219455,0.0213704353178106,2.3810540151721e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39485,0.0450430153825419,0.00642862120207775,0.0324429178264695,0.0576431129386143,2.54086134561737e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37433,0.0253316983856764,0.00362375827077275,0.0182291321749618,0.032434264596391,2.86808198048456e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,39784,0.0264378399208063,0.00378283480003968,0.0190234837127285,0.0338521961288841,2.8804638976596e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,39945,-0.0196447529389418,0.00281188892130012,-0.02515605522469,-0.0141334506531935,2.9325465097835e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39745,0.0467261494508607,0.00669343064951984,0.0336070253778018,0.0598452735239196,3.04910757818703e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37433,0.0144407520788513,0.00206851420299958,0.0103864642409721,0.0184950399167304,3.06226871247552e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39855,0.0318201905685303,0.00455871528999938,0.0228851086001315,0.0407552725369291,3.066051952755e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39822,0.0408440292116202,0.00585364625394337,0.0293708825538912,0.0523171758693492,3.12210460289686e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37384,0.0225022177527421,0.00322522623311539,0.016180774335836,0.0288236611696483,3.15709467943929e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39927,0.0694074154865382,0.00995988843038568,0.0498860341629823,0.0889287968100942,3.32325390946808e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,39854,-0.0226992314088134,0.00325752702731171,-0.0290839843823443,-0.0163144784352824,3.33453218152151e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37120,0.0174863541928831,0.00250921474418906,0.0125682932942726,0.0224044150914937,3.34629274983832e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37069,0.0413711664604938,0.00593972197588062,0.0297293113877678,0.0530130215332198,3.43537823994644e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37408,0.0221867276772175,0.00318677601488663,0.0159406466880397,0.0284328086663953,3.50616891710042e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,39826,0.0496990548531435,0.0071421736615741,0.0357003944764583,0.0636977152298287,3.57199713342062e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37426,0.0302396517213487,0.00434706914207374,0.0217193962028841,0.0387599072398132,3.6525642787973e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39862,0.023102799649727,0.00332490276849828,0.0165859902234704,0.0296196090759836,3.83662094140562e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,39864,0.0160467526556129,0.00230959846451277,0.0115199396651679,0.0205735656460579,3.85180532498843e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,39864,0.0220576778750649,0.00317526590773337,0.0158341566959075,0.0282811990542223,3.88282915750927e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37408,0.0486255223609685,0.00700278458980656,0.0349000645649477,0.0623509801569894,3.99249249345556e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,39832,0.0434125239552038,0.00625792026744125,0.031147000231019,0.0556780476793887,4.15263202569205e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39864,0.0506749068398301,0.00730705773024303,0.0363530736885538,0.0649967399911065,4.21575753246801e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,39915,0.0367725748989788,0.00530354863243309,0.0263776195794099,0.0471675302185476,4.25959664301455e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39927,0.0156563899903604,0.00225905372330063,0.0112286446926912,0.0200841352880297,4.35270736518848e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,37449,-0.045355117520221,0.00654879056459372,-0.0581907470268247,-0.0325194880136173,4.53249687265493e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37120,0.0552569412185691,0.00798204908057917,0.039612125020634,0.0709017574165043,4.63663452260536e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40005,0.0417620406471457,0.00603418100423196,0.0299350458788511,0.0535890354154404,4.65621960280657e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,37433,0.0285537638441476,0.00412653393419563,0.0204657573331242,0.036641770355171,4.73395521589354e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,39653,0.0659698670393016,0.00953859810215557,0.0472742147590767,0.0846655193195265,4.82066701334931e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37408,0.0534389220021313,0.00772764003466871,0.0382927475341806,0.068585096470082,4.87812599378529e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37364,0.0499128218665753,0.00722343836873225,0.0357548826638601,0.0640707610692905,5.06942596133833e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39862,0.0348707781038153,0.00504895305216151,0.0249748301215788,0.0447667260860519,5.15324081224839e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39862,0.0341450747089785,0.00494862023793557,0.0244457790426248,0.0438443703753322,5.39836795146375e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39473,0.0356232298633569,0.00516872499654701,0.0254925288701248,0.045753930856589,5.70897177503541e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39662,0.022501514466901,0.00326576746794109,0.0161006102297365,0.0289024187040655,5.78525764541002e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39473,0.0328528872246332,0.00477124796035528,0.0235012412223368,0.0422045332269295,5.97403105517278e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37039,0.0383517474256628,0.00557453598309746,0.0274256568987918,0.0492778379525338,6.26392132319924e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40054,0.033232953926642,0.00483479675403777,0.023756752288728,0.0427091555645561,6.48393008135328e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40054,0.0166034231800275,0.00241569823544662,0.0118686546385521,0.0213381917215028,6.50964855505069e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39716,0.0555766535374628,0.0080906311372544,0.0397190165084442,0.0714342905664814,6.6935208470601e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39822,0.042332345629495,0.00616468718295113,0.0302495587509107,0.0544151325080792,6.80276954363957e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39854,0.0257656962011329,0.0037554093539193,0.0184050938674511,0.0331262985348147,7.09105024566804e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39909,0.0587931142484222,0.00857006582097749,0.0419957852393064,0.0755904432575381,7.12331738081481e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37378,0.0475496806515568,0.00693726536183889,0.0339526405423526,0.061146720760761,7.48011222531964e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,39779,0.0449062862599892,0.00655329472763701,0.0320618285938206,0.0577507439261577,7.52452055870603e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39613,-0.0181286510391549,0.00264645538938891,-0.0233157036023572,-0.0129415984759527,7.64964832787937e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,39899,0.0339098647609688,0.00495059846336747,0.0242066917727685,0.043613037749169,7.67211075091095e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37039,0.0524002835902451,0.00764899916211739,0.037408245232495,0.0673923219479952,7.68026062498017e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37052,0.0523155633802832,0.00764141418058467,0.0373383915863372,0.0672927351742291,7.91267124796156e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37358,0.0439835621610354,0.00642468472731813,0.0313911800954918,0.0565759442265789,7.92107019670723e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39473,0.0502068203636785,0.00733609132532878,0.035828081366034,0.0645855593613229,7.99837617230339e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,39981,0.0431400109512648,0.00630812321147406,0.0307760894567756,0.0555039324457539,8.27262553066843e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40030,0.0164263104656208,0.00240314078102597,0.0117161545348099,0.0211364663964317,8.47281074155636e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39958,0.0212683140254979,0.0031117236328994,0.0151693357050151,0.0273672923459807,8.50086774622186e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39784,0.0240237865109352,0.0035150885389231,0.0171342129746459,0.0309133600472245,8.52917042143215e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37039,0.0474513088372017,0.0069437766935653,0.0338415065178137,0.0610611111565897,8.64227430435489e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39854,0.0232270947789851,0.00340096380472452,0.0165612057217251,0.0298929838362452,8.82416285018209e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40005,0.0393863638597239,0.00576727052162385,0.0280825136373412,0.0506902140821067,8.83795931669836e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39862,0.0520158859750047,0.00761723031245915,0.0370861145625848,0.0669456573874246,8.87620261947402e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,39980,0.0380718786898558,0.00557627313311787,0.0271423833489448,0.0490013740307669,8.95048147527232e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36705,0.0676678729004559,0.00991083335089934,0.0482426395326932,0.0870931062682186,9.0187654467158e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37433,0.0288533639234714,0.00423636839089624,0.0205500818773148,0.037156645969628,1.01092501961068e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37035,0.0258961198067485,0.00380970467808582,0.0184290986377003,0.0333631409757967,1.11103258298799e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37384,0.0655011735866761,0.00963810005244035,0.046610497483893,0.0843918496894591,1.12017164900996e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37364,0.0437453926174329,0.00643772843168492,0.0311274448913304,0.0563633403435353,1.1272884396615e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39387,0.0358376567181998,0.00527760901513484,0.0254935430485355,0.0461817703878641,1.15791494532181e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39734,0.0226574723451841,0.00333837326920861,0.0161142607375352,0.0292006839528329,1.18558557733275e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37433,0.0604556627416822,0.00891378020878474,0.0429846535324641,0.0779266719509003,1.23199360642955e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,39871,0.0289701823993881,0.00427392159354355,0.0205932960760427,0.0373470687227334,1.25790829429222e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37052,0.055757643828941,0.00823267209150339,0.0396216065295944,0.0718936811282877,1.31732021010182e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37120,0.0338485143628343,0.00500096769412313,0.024046617682353,0.0436504110433156,1.35695821063202e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,39786,0.0249334453561346,0.00368817009918714,0.0177046319617278,0.0321622587505414,1.42407112591512e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39726,0.057887206507227,0.00857546257379384,0.0410792998625911,0.074695113151863,1.52621737634722e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39476,0.067797917557328,0.0100531144998037,0.0480938131377127,0.0875020219769433,1.59523259557162e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39989,0.0347134708295955,0.00515002718980755,0.0246194175375727,0.0448075241216183,1.63254537175965e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37120,0.0525120826070448,0.00778938693813747,0.0372448842082953,0.0677792810057942,1.63256707490196e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37017,0.0416973153487192,0.00618561324046603,0.0295735133974058,0.0538211173000326,1.63841973324543e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40048,0.0249774171289919,0.00371515088159357,0.0176957214010685,0.0322591128569153,1.83814661047814e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39864,0.0297200356666755,0.00442070139621091,0.0210554609301021,0.0383846104032489,1.84136087778645e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39745,0.0302841830272913,0.00450777674200343,0.0214489406129646,0.0391194254416181,1.90221997894658e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37023,0.0221083867018876,0.00329051032034241,0.0156589864740165,0.0285577869297587,1.90722164328293e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39909,0.0555206895012271,0.00826551528847529,0.0393202795358155,0.0717210994666387,1.91541553375425e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39927,0.0645104527171804,0.00961148188239861,0.0456719482276791,0.0833489572066816,1.98653365894488e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,39784,0.0198692814433031,0.00296098535840083,0.0140657501408374,0.0256728127457687,2.00691126530909e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,39760,0.0410922949078429,0.0061238082988596,0.0290896306420781,0.0530949591736077,2.00851516669682e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39474,0.0338969525485374,0.00505247807590426,0.0239940955197651,0.0437998095773098,2.02733444153605e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39379,0.0116818165316529,0.00174286663706567,0.00826579792300418,0.0150978351403016,2.11734032953322e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39485,0.0377139540333053,0.0056342392868877,0.0266708450310054,0.0487570630356052,2.24992562395387e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,39822,-0.0606915230944487,0.00906719357964322,-0.0784632225105494,-0.042919823678348,2.25108846694112e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40026,0.0163085831487995,0.00243681068258138,0.01153243421094,0.021084732086659,2.26455748375559e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37408,0.0364709517966317,0.00545687846525487,0.0257754700047321,0.0471664335885312,2.42456265837293e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37120,0.044900001239542,0.00671897083464104,0.0317308184036455,0.0580691840754384,2.44167110884929e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,39909,0.0381877937293694,0.00571729970209201,0.0269818863132691,0.0493937011454698,2.47903913624926e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,39862,0.0537869916875965,0.00805277646970515,0.0380035498069744,0.0695704335682186,2.47979264827518e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,39909,0.0162797829352125,0.00243818971850227,0.011500931086948,0.0210586347834769,2.51890272450978e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,39784,0.0428060100511438,0.00641595912786494,0.0302307301605285,0.055381289941759,2.61010259117426e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37120,-0.0147566831779432,0.00221432860038127,-0.0190967672346905,-0.0104165991211959,2.76666348310982e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40054,0.0252214214583012,0.00378597683083785,0.017800906869859,0.0326419360467434,2.79206980147812e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39862,0.072681879425526,0.0109255910881801,0.051267720892693,0.0940960379583589,2.97612806584175e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37364,0.0330376996868073,0.00497261237686662,0.0232913794281487,0.0427840199454659,3.17128840527228e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,39966,0.0360899062613166,0.00543823425348187,0.0254309671244921,0.046748845398141,3.31853442964122e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39858,0.0158642299651735,0.00239179756990676,0.0111763067281563,0.0205521532021908,3.40017186771536e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,39862,-0.0194606989137996,0.00293475621075663,-0.0252128210868825,-0.0137085767407166,3.43831444551332e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37378,0.0283748586535628,0.00428745756001887,0.0199714418359259,0.0367782754711998,3.77539369026041e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39581,0.050669773903306,0.00765832065166576,0.0356594654260412,0.065680082380571,3.80189365804e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37378,0.0127803509134659,0.00193215943998489,0.00899331841109549,0.0165673834158363,3.86721910926185e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37039,0.054549032860071,0.00825685188737845,0.0383656031608092,0.0707324625593328,4.08581441040393e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39485,0.0404686687746127,0.00613250202275748,0.0284489648100081,0.0524883727392174,4.27121708981575e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,39808,0.0284420786742272,0.00431480181332867,0.019985067120103,0.0368990902283514,4.48319865456811e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39745,0.0364321120629527,0.00554243829202212,0.0255689330105893,0.047295291115316,5.07449419548387e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37120,0.0398643355496726,0.00606518310436934,0.0279765766651087,0.0517520944342365,5.12756717123745e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39784,0.0138647311920616,0.00211297968053243,0.00972329101821805,0.0180061713659052,5.48404939427352e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37120,0.0290756421902601,0.0044314142125836,0.0203900703335963,0.037761214046924,5.53383903855817e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37334,0.026610182631999,0.00405757983559586,0.0186573261542311,0.0345630391097669,5.64698115419058e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39862,0.0571612020519575,0.00871905492298278,0.0400718544029112,0.0742505497010037,5.700160389525e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,39745,0.019704188253042,0.00300825974795895,0.0138079991470424,0.0256003773590415,5.92928067679957e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40048,0.0252944838120454,0.00386932666571939,0.0177106035472354,0.0328783640768554,6.45639832096648e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37052,0.0157017774443533,0.00240275308703105,0.0109923813937725,0.0204111734949342,6.59861770203291e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37378,-0.0422893017840117,0.00647189204028581,-0.0549742101829719,-0.0296043933850515,6.61965039871256e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39909,0.0328658420873682,0.00503101501513007,0.0230050526577133,0.0427266315170231,6.65611020189778e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37302,0.0555132342324814,0.00849765140118749,0.0388578374861539,0.0721686309788088,6.68871927310108e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39583,0.0217986059293828,0.00333815120565263,0.0152558295663036,0.028341382292462,6.77215044291067e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37378,0.0173027122583031,0.00264941679654197,0.0121098553370808,0.0224955691795254,6.77753046072227e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40054,0.033794068916268,0.00517764782901132,0.0236458791714059,0.0439422586611302,6.91320347368181e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39840,0.0131440541462155,0.00201385751290887,0.00919689342091412,0.0170912148715169,6.92101478948581e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37245,0.0184646681110572,0.00282981673509267,0.0129182273102756,0.0240111089118389,7.04300303348441e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37382,0.0162941595975465,0.00249800369917948,0.0113980723471547,0.0211902468479383,7.14271109535628e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39694,0.016285348424026,0.00249763070883353,0.0113899922347123,0.0211807046133397,7.22813486696852e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37408,0.0323358409096617,0.00496314332048744,0.0226080800015063,0.0420636018178171,7.51612322022062e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37433,0.0167912141100593,0.00257734257847943,0.0117396226562396,0.021842805563879,7.52867742998979e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,39854,0.0300133028079861,0.00460760171634104,0.0209824034439577,0.0390442021720146,7.54260096439924e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,39778,0.0242719722335767,0.00372934948568567,0.0169624472416328,0.0315814972255206,7.82428373741152e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37433,0.0448334217042514,0.00689126008146307,0.0313265519445838,0.058340291463919,7.9971092943782e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39862,0.0292017647095524,0.00449175580308217,0.0203979233355114,0.0380056060835935,8.20446036429623e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39695,0.0236433824886951,0.00363773144627091,0.0165134288540041,0.030773336123386,8.30033841338875e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39473,0.0171438068389246,0.00263954290701703,0.0119703027411712,0.022317310936678,8.5548522801232e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,39862,0.0492554393885436,0.00760272364497262,0.0343541010443972,0.0641567777326899,9.5243890009882e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37384,0.0314718754591623,0.00485938757795596,0.0219474758063686,0.040996275111956,9.71133457082295e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39745,0.0339089963605478,0.00524469540771602,0.0236293933614244,0.0441885993596712,1.03985789291661e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39842,0.0185003436631438,0.0028619200186102,0.0128909804266678,0.0241097068996198,1.04708947538736e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39784,0.0685170873619193,0.0105997443192882,0.0477415884961144,0.0892925862277242,1.04913252811997e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37408,0.0350120442737628,0.00541766512363932,0.0243934206314297,0.0456306679160958,1.06461272821513e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39473,0.0448973621642304,0.00695905156188237,0.031257621102941,0.0585371032255198,1.13895874645898e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39784,0.0257402582644683,0.00399047267572943,0.0179189318200387,0.033561584708898,1.14750146402395e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37433,0.0431487752226239,0.00669012020910842,0.0300361396127714,0.0562614108324764,1.15925404592891e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39854,0.027146971264511,0.00421019969147545,0.0188949798692191,0.0353989626598029,1.16656328796511e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37433,0.0309995320758658,0.00480852790999424,0.0215748173722771,0.0404242467794545,1.18114086749455e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39473,0.0496403401679506,0.00770154935282877,0.0345453034364062,0.064735376899495,1.18598294241001e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37408,0.0394891189017621,0.00612944269121474,0.0274754112269812,0.051502826576543,1.2146925039099e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,39745,0.032521827633182,0.00505234457432323,0.0226192322675085,0.0424244229988556,1.25369721904094e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39473,0.029607855916639,0.00460069955947985,0.0205904847800585,0.0386252270532195,1.26644529256371e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,39862,0.049769174736721,0.00773691243764777,0.0346048263589313,0.0649335231145106,1.28921109408448e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40005,0.0381191296069807,0.00592680123487718,0.0265025991866215,0.04973566002734,1.29771154581425e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40007,0.0335726976380567,0.00522314273233949,0.0233353378826713,0.0438100573934421,1.33197065456312e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,37449,0.0175877509297333,0.00273846620888676,0.0122203571603153,0.0229551446991514,1.38531636054069e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37384,0.021428542325456,0.00334668525173503,0.0148690392320553,0.0279880454188567,1.57474236509311e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37039,0.0272097758354551,0.00425325735205821,0.018873391425421,0.0355461602454891,1.63390274382907e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37039,0.0289829728281178,0.00453135733559931,0.0201015124503432,0.0378644332058925,1.64789032714935e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37035,0.0702048306788906,0.0109779665957945,0.0486880161511333,0.0917216452066478,1.65895282535121e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39881,0.0191622371026502,0.002996975361048,0.0132881653949961,0.0250363088103043,1.66226937172881e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37120,0.05540197304367,0.00866536010550228,0.0384178672368855,0.0723860788504544,1.67564999769899e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37364,0.0482514705289351,0.00757365027401998,0.0334071159918559,0.0630958250660142,1.93934339122023e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,39895,0.0172436485630433,0.00270709336867306,0.0119377455604442,0.0225495515656425,1.94428009429411e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39745,0.0467850295465059,0.00734677268741135,0.0323853550791797,0.0611847040138322,1.96633363548794e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39784,0.0614031096212837,0.00965206261194209,0.0424850669018772,0.0803211523406902,2.05036274614543e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39502,0.0455056684423016,0.00715576593547594,0.0314803672087687,0.0595309696758344,2.08298214882817e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39581,0.064741787894041,0.0101819386083235,0.0447851882217269,0.0846983875663551,2.0936451995196e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40054,0.0543569567204427,0.00856684548048192,0.0375659395786981,0.0711479738621873,2.28276357216388e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37384,0.0173409525692336,0.0027332388588327,0.0119838044059215,0.0226981007325457,2.30302952768755e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,39854,0.015034657291488,0.00237064268453817,0.0103881976297931,0.0196811169531828,2.32862517720546e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39927,0.0192869362259262,0.00304346709934191,0.013321740711216,0.0252521317406363,2.4027387719836e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40054,0.0368624845900328,0.00582170999219529,0.0254519330053301,0.0482730361747356,2.48538932444693e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37039,0.0587257505927882,0.0092885806012051,0.0405201326144262,0.0769313685711502,2.65907387077545e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,39784,-0.0267807833554924,0.00423685261053728,-0.0350850144721455,-0.0184765522388394,2.66938217260417e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39745,0.0454739928264947,0.00719671176356158,0.031368437769914,0.0595795478830754,2.70767139487967e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37120,0.0164570647947944,0.00260502904075783,0.011351207874909,0.0215629217146797,2.74463956525333e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,39980,0.0280693406226507,0.00444928212420529,0.0193487476592083,0.036789933586093,2.88662966727006e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39485,0.038460387440038,0.0060964208160992,0.0265114026404836,0.0504093722395925,2.88994083606951e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37336,0.0268892528103752,0.00426907587835968,0.0185218640887902,0.0352566415319602,3.09653122059815e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39473,0.0280843672099274,0.00446012219330051,0.0193425277110584,0.0368262067087964,3.12035429349204e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37408,0.0435739536042543,0.00692633955003202,0.0299983280861915,0.057149579122317,3.25021834150873e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40005,0.0317914185530268,0.00505555400721443,0.0218825326988865,0.0417003044071671,3.28970621721959e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40048,0.0296474226291133,0.00471532431261335,0.0204053869763911,0.0388894582818354,3.30967133776601e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39864,0.0387145579083999,0.00616241956216309,0.0266362155665602,0.0507929002502395,3.42081487739057e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37384,0.021457691881553,0.00341885896107438,0.0147567283178472,0.0281586554452588,3.57370566833942e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37364,0.0537108662207132,0.00855807114120576,0.0369370467839499,0.0704846856574764,3.57901766981125e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37120,-0.0126067566698159,0.0020113361693453,-0.0165489755617327,-0.00866453777789914,3.77402068089147e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,39784,-0.0745425783480758,0.0118984312730843,-0.0978635036433211,-0.0512216530528306,3.82628007244284e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37364,0.0483452341067358,0.00772158642216606,0.0332109247192903,0.0634795434941813,3.93973232083901e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37393,0.0227723778552177,0.00363939314194189,0.0156391672970116,0.0299055884134238,4.03786626598572e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37120,-0.0530278352595798,0.0084747589518392,-0.0696383628051846,-0.036417307713975,4.0413966133274e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37408,0.0440777165822304,0.00705857244980622,0.0302429145806102,0.0579125185838506,4.37672142306083e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,39854,0.0217138540691176,0.0034801738437294,0.0148927133354079,0.0285349948028272,4.50589043737826e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,39864,0.0391594412433909,0.00627635721013078,0.0268577811115346,0.0514611013752472,4.5087698808772e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39745,0.0443380935787463,0.00710689729501547,0.030408574880516,0.0582676122769766,4.52278619583216e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,39854,0.0255694704745201,0.0040987241885997,0.0175359710648647,0.0336029698841755,4.53194136810275e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37384,0.0372774414129,0.00598257900039744,0.025551586572121,0.0490032962536789,4.77218553828246e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40005,0.0187135470111999,0.00300528285482214,0.0128231926157486,0.0246039014066513,4.8757062123713e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39928,0.0631615001164894,0.0101469345694317,0.0432735083604033,0.0830494918725754,4.9448963717625e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,39735,0.0326861994073689,0.00525154443051493,0.0223931723235596,0.0429792264911781,4.96452992131499e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37384,0.0216186512242571,0.00347376752783911,0.0148100668696925,0.0284272355788218,5.00849817731566e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37441,0.0267026016669036,0.00429092854812887,0.018292381712571,0.0351128216212361,5.01955909391545e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39451,0.022091097949416,0.00355277029013256,0.0151276681807562,0.0290545277180759,5.16384474335203e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37433,0.0474690867471675,0.00763545230998572,0.0325036002195955,0.0624345732747395,5.21818971750638e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,37408,0.0241267432276416,0.00388113873493999,0.0165197113071592,0.031733775148124,5.23584932503966e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37039,0.0407089357527371,0.00655401494123818,0.0278630664679102,0.0535548050375639,5.41290176751233e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37378,0.0327606916986197,0.00527477339885199,0.0224221358368698,0.0430992475603696,5.42514709301558e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39835,0.0532730374415103,0.00858028966824581,0.0364556696917486,0.0700904051912721,5.47207803588054e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37052,0.0441837457237075,0.00711692306873709,0.0302345765089828,0.0581329149384322,5.51788593405223e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39745,0.0567936510556221,0.00915883751759039,0.0388423295211449,0.0747449725900993,5.75049235754242e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39473,0.0264578918448569,0.00426747359470199,0.018093643599241,0.0348221400904728,5.79213653119114e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,39959,0.0384074753520277,0.00619754886818766,0.0262602795703799,0.0505546711336755,5.88737890944644e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40005,0.0370477289499383,0.00598199240100414,0.0253230238439702,0.0487724340559064,6.03785024750547e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,39862,0.0174397882386573,0.00281705154819708,0.011918367204191,0.0229612092731236,6.13214550989685e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40005,0.0189073138842998,0.00306019844152342,0.0129093249389139,0.0249053028296857,6.62820679155876e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37433,0.0401770647212751,0.00650454150477419,0.0274281633719176,0.0529259660706325,6.72936076672538e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39862,0.041912108229478,0.0067934526977821,0.028596940941825,0.0552272755171309,7.0160814519677e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,39832,0.0494674587354769,0.00802159966578083,0.0337451233905465,0.0651897940804073,7.13705784234598e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39831,0.024714628535939,0.00400931204269321,0.0168563769322603,0.0325728801396176,7.24935039723298e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39927,0.0704519693344291,0.0114316656148895,0.0480459047292458,0.0928580339396125,7.31385181515026e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39745,0.0247310051945223,0.0040153834256148,0.0168608536803173,0.0326011567087273,7.49377370809556e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39013,0.0199431952655916,0.00323833704234509,0.0135960546625952,0.026290335868588,7.53060633783681e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39473,0.0289978603136067,0.00470903930030427,0.0197681432850103,0.038227577342203,7.55137661438122e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39927,0.0476792800067657,0.00775293796721777,0.0324835215910189,0.0628750384225125,7.939935051426e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37433,0.0186303094798777,0.00302932636487548,0.0126928298047218,0.0245677891550337,7.9665224588907e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39784,0.0453106192982116,0.00736899780558064,0.0308673835992735,0.0597538549971496,7.99254746407605e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39864,-0.0233012485010607,0.00378961404550205,-0.0307288920302447,-0.0158736049718767,7.9968462459255e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39784,0.0501301850490208,0.00815881890401212,0.0341388999971571,0.0661214701008846,8.22305727147701e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,39784,0.0284460289902448,0.0046307555858117,0.0193697480420539,0.0375223099384357,8.29811974849571e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39784,0.0314857932407311,0.00512716599022402,0.021436547899892,0.0415350385815701,8.39640163789916e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37384,0.0255453750710527,0.00416323961026809,0.0173854254349272,0.0337053247071781,8.70218289166841e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37408,0.0584520136960153,0.00953003812876264,0.0397731389636405,0.0771308884283901,8.838550205861e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,39909,0.0315597148299429,0.00514765263094711,0.0214703156732866,0.0416491139865993,8.94312644081476e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37378,0.0420699911915956,0.00686173374563939,0.0286209930501424,0.0555189893330489,8.97017649889267e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37120,0.024277611264253,0.0039645831633862,0.0165070282640161,0.03204819426449,9.40554025238167e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40048,0.0177168150716193,0.00289639855842253,0.0120398738971111,0.0233937562461274,9.76415592953761e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40026,0.0194233608051843,0.00317568974175468,0.0131990089113452,0.0256477126990235,9.79982057911981e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,39864,0.0375090102372617,0.00613413802987575,0.0254860996987052,0.0495319207758182,9.89251972045402e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37341,0.0488148582622069,0.00798298728280881,0.0331682031879016,0.0644615133365121,9.93107437597307e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37408,0.0382381676726727,0.00626429551595407,0.0259601484614027,0.0505161868839426,1.06173609547433e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39473,0.0376722313079979,0.0061762181484774,0.0255668437369822,0.0497776188790136,1.08866762217761e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37084,0.0572458988372655,0.00939294875597664,0.0388357192755513,0.0756560783989797,1.12788919848923e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37364,0.0211465343415449,0.00347075745263084,0.0143438497343885,0.0279492189487014,1.13988762537337e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37120,0.0139619968044493,0.00229280258963818,0.00946810372875845,0.0184558898801401,1.16401423868956e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39864,0.0429139139061972,0.00704968580683958,0.0290965297247916,0.0567312980876028,1.17413151421639e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39583,0.0264141989050935,0.00434223127827554,0.0179034255996735,0.0349249722105136,1.20616324002533e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37441,0.0336914131828029,0.00554673383113084,0.0228198148737865,0.0445630114918194,1.28014978298019e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37039,-0.0398673018427748,0.00656451648920909,-0.0527337541616246,-0.027000849523925,1.28874720746471e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,39613,0.0382724330674398,0.00630784390774441,0.0259090590082608,0.0506358071266189,1.32943704623673e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,37449,0.0100073615367935,0.00164944961274312,0.00677444029581702,0.0132402827777701,1.33707682724886e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39998,0.0174971317484044,0.00288565633177872,0.0118412453381181,0.0231530181586907,1.36171339811044e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39784,0.0755668951993208,0.012472047215877,0.0511216826562019,0.10001210774244,1.40140529924449e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39807,0.0490166097018513,0.00809632943189126,0.0331478040153445,0.0648854153883582,1.44300634570485e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,37449,0.00802734304546394,0.00132663027394049,0.00542714770854058,0.0106275383823873,1.47800540833893e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,39967,0.0624691816937082,0.0103252449423832,0.0422317016066372,0.0827066617807793,1.47922064983233e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37433,0.0479810088302597,0.00793276264789538,0.0324327940403848,0.0635292236201346,1.50078322836773e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37017,0.0365317059091734,0.00604031178352028,0.0246926948134736,0.0483707170048732,1.50646125669726e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39862,0.0237390037127922,0.00392787234393571,0.0160403739186782,0.0314376335069062,1.53930978131545e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37039,0.024982750121888,0.00413530520652163,0.0168775519171056,0.0330879483266704,1.56966140274831e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40005,0.0631338135050395,0.0104548888749677,0.0426422313101028,0.0836253956999761,1.5877667581022e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39943,-0.0139316802253478,0.00230838446756466,-0.0184561137817746,-0.00940724666892112,1.62199009168169e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39864,0.0701063366829907,0.011628803783926,0.0473138812664957,0.0928987920994857,1.68934766618148e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37384,0.0413124393663026,0.00685421922804656,0.0278781696793313,0.0547467090532739,1.71057458421387e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39784,0.0418881579640559,0.00695487381517493,0.0282566052863131,0.0555197106417988,1.75141353735888e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39958,0.0227992645012963,0.00379534759022898,0.0153603832244475,0.0302381457781451,1.92864380225396e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37441,0.0287469318943611,0.00479258276319275,0.0193534696785033,0.0381403941102189,2.04570486350141e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37161,0.0236508048789935,0.00395235179631192,0.0159041953582221,0.0313974143997649,2.23344832257518e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,39904,0.0446177849558639,0.00746583232129145,0.0299847536061327,0.0592508163055952,2.33145683522767e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,39784,0.0293110716917909,0.00490590644812747,0.0196954950534611,0.0389266483301208,2.35498119129251e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39473,0.0204089630421831,0.00341686188405275,0.0137119137494397,0.0271060123349265,2.37966871981655e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39472,0.0378747658467683,0.00634110565098102,0.0254461987708455,0.0503033329226911,2.38138413440028e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39864,0.0450984561961297,0.00755435735657048,0.0302919157772515,0.0599049966150078,2.42474995652582e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40054,0.0297427945115102,0.00498225208722021,0.0199775804205586,0.0395080086024618,2.425802596042e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37449,0.0092137863425726,0.00154339298191695,0.00618873609801539,0.0122388365871298,2.43428053671354e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,39695,0.0363854992094615,0.00610523012842479,0.0244192481577489,0.0483517502611741,2.58021739704168e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40054,0.0363896411244142,0.00613283026844148,0.0243692937982689,0.0484099884505595,3.0244145977843e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37110,0.0254567115374588,0.00429296845920038,0.017042493357426,0.0338709297174915,3.10739264394595e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39927,0.0146229534155555,0.00246722748583866,0.00978718754331172,0.0194587192877993,3.15066851312766e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37052,0.0266770055085638,0.00451064050945712,0.0178361501100279,0.0355178609070998,3.41667372164788e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,39852,0.0211064230274697,0.00356924482452713,0.0141107031713965,0.0281021428835429,3.41914543477348e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37433,0.0119045477069329,0.00201327206191432,0.00795853446558085,0.015850560948285,3.43933266242294e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37433,0.0400680333837513,0.0067791790825692,0.0267808423819157,0.053355224385587,3.49349293763945e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37285,0.0231019186627259,0.0039105174240354,0.0154373045116165,0.0307665328138353,3.55452561013654e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39854,0.0135569886622213,0.00229541239629415,0.00905798036548472,0.0180559969589578,3.5735178331039e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39717,0.0313672430633078,0.00531312315240201,0.0209535216845999,0.0417809644420158,3.62629181187221e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39784,0.0288724697345932,0.00489077676162162,0.0192865472818148,0.0384583921873715,3.63206518521409e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39583,0.0298656218738835,0.00505918174115694,0.0199496256612159,0.0397816180865511,3.63742722144552e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37433,0.0162237842227661,0.00275058609533182,0.0108326354759158,0.0216149329696165,3.7600443853281e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37378,0.0527643102923445,0.00895579936837743,0.0352109435303248,0.0703176770543643,3.91487992483932e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36991,0.0270234052625859,0.00458788119447935,0.0180311581214064,0.0360156524037654,3.95238350011705e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37384,0.0333383201705523,0.00566446941706227,0.0222359601131102,0.0444406802279943,4.06213957768129e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40005,0.0236868943023493,0.00402913550801187,0.015789788706646,0.0315839998980525,4.21139534776018e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39980,0.0315499747410627,0.00536843147624749,0.0210278490476176,0.0420721004345078,4.26150459982111e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37120,0.0440217463926421,0.00749448206111485,0.029332561552857,0.0587109312324272,4.35896316095222e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39745,0.0205711632656582,0.00350783994137788,0.0136957969805575,0.0274465295507588,4.59875582710764e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37017,0.0299066263787734,0.00510023880186354,0.0199101583271208,0.0399030944304259,4.63333162444332e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37017,0.0214621963339028,0.00366267626448975,0.0142833508555029,0.0286410418123027,4.74792265468982e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,39784,0.0154234332930774,0.00263553924076297,0.010257776381182,0.0205890902049728,4.94944070776107e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,39927,0.0492884056123528,0.00842290571500959,0.032779510410934,0.0657973008137716,4.96010005080156e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37408,0.0672812175430271,0.0114969759171905,0.0447471447453337,0.0898152903407205,4.96686593685557e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37378,0.0405995818927197,0.0069421894039884,0.0269928906609025,0.054206273124537,5.0828525357072e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39581,0.0257651440026298,0.00440777325725648,0.0171259084184071,0.0344043795868525,5.15398826426584e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,39832,0.0484781398152321,0.00829976301227335,0.0322106043111763,0.0647456753192878,5.29264356595886e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,39709,0.0339708259494034,0.00581861081784415,0.0225663487464289,0.0453753031523779,5.37654736711638e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39360,-0.052901349454382,0.00906518042776323,-0.0706691030927979,-0.035133595815966,5.4646022230534e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37039,0.0299957898295397,0.00514158377723943,0.0199182856261504,0.040073294032929,5.53983943287187e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36870,0.0282652107742753,0.00484565738394942,0.0187677223017344,0.0377626992468161,5.57000788807481e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,39862,0.034392701725734,0.00589714936986011,0.0228342889608082,0.0459511144906599,5.57930233894199e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39485,0.0420502843519517,0.00721012396977361,0.0279184413711955,0.056182127332708,5.5809555689728e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37364,-0.0198539018363338,0.00340712101284519,-0.0265318590215104,-0.0131759446511572,5.76580347552441e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,39745,0.0511747661319861,0.00878474581618562,0.0339566643322623,0.0683928679317099,5.80734623965147e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39473,0.0354459155878088,0.00608654414698364,0.0235162890597209,0.0473755421158968,5.8706936944074e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,39864,0.0646628995822241,0.0111069322731466,0.0428933123268567,0.0864324868375914,5.93138985190501e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,39784,0.0402809478382688,0.0069249874815903,0.0267079723743519,0.0538539233021858,6.11520484824776e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37120,0.0307108712428031,0.00528109013921879,0.0203599345699343,0.041061807915672,6.19376862328418e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37433,0.0478748042752957,0.00824140739570449,0.0317216457797149,0.0640279627708765,6.4233907256401e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,39981,0.0157956582852295,0.0027204495148082,0.0104635772362054,0.0211277393342536,6.50822126309311e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39862,0.0331653932420366,0.00571558563266273,0.0219628454020176,0.0443679410820555,6.65191639631386e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,39854,0.029685805637228,0.00511752636086694,0.0196554539699288,0.0397161573045272,6.72412849325303e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,37120,0.040978418370585,0.00706507518852678,0.0271308710010725,0.0548259657400975,6.77713345435212e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39473,0.0424661460311674,0.00732668509863015,0.0281058432378523,0.0568264488244825,6.918719320805e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,39794,0.0159820707760292,0.00275755243425508,0.0105772680048892,0.0213868735471691,6.93037510319952e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39678,0.0166964220028962,0.00288181387984033,0.0110480667984092,0.0223447772073833,7.01529324986048e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37408,0.037998040612848,0.00655941714181668,0.0251415830148873,0.0508544982108087,7.07183382617976e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39745,0.0496586534792252,0.00857921228158229,0.0328433974073239,0.0664739095511265,7.24633275565633e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40054,-0.0206199588635425,0.00356461986101004,-0.0276066137911221,-0.0136333039359628,7.4018819576876e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40054,0.0259581848824638,0.00448894216842835,0.0171598582323442,0.0347565115325833,7.48676571105621e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37384,0.0523276336540435,0.00905037160660127,0.034588905305105,0.070066362002982,7.55279982533386e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37384,0.0512305229150212,0.0088630945863153,0.0338588575258432,0.0686021883041992,7.62545519325634e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37449,0.0157192023748263,0.00272282072065908,0.0103824737623345,0.0210559309873181,7.95116460948234e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37017,0.0314149728491012,0.0054488255183112,0.0207352748332112,0.0420946708649912,8.32651649941562e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37378,0.0338462974331726,0.00587666640000963,0.0223280312891537,0.0453645635771915,8.62307234989183e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37408,0.0244889065733543,0.00425719332822928,0.0161448076500249,0.0328330054966837,8.99079183897213e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37408,-0.0265729436617893,0.00461979942642364,-0.0356277505375796,-0.017518136785999,9.01153290453439e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37035,0.0688532353299511,0.0119719558155109,0.0453882019315498,0.0923182687283524,9.05744887404161e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,39876,0.0304376684313207,0.00529550697846708,0.0200584747535252,0.0408168621091162,9.20413956075168e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39757,0.0187606201442673,0.00327120679668882,0.0123490548227572,0.0251721854657774,9.92398848958812e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39571,0.0155411826404707,0.00271056117027987,0.0102284827467222,0.0208538825342193,1.00147156255698e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37035,0.0255670924153937,0.00446026765907995,0.016824967803597,0.0343092170271904,1.01316523205551e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,39862,-0.0399551820339735,0.00698138718808104,-0.0536387009226123,-0.0262716631453347,1.06470141850809e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37052,0.0210011364104497,0.00367451232177567,0.0137990922597694,0.0282031805611301,1.1184532607953e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39709,0.0156121782295171,0.00273241130768357,0.0102566520664573,0.0209677043925769,1.12531738516131e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,39835,0.0250607188866607,0.00438784695150928,0.0164605388617025,0.0336608989116189,1.1404888563092e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39449,0.0242651836469893,0.0042521433461283,0.0159309826885779,0.0325993846054008,1.17366013299143e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37120,0.0426995227672943,0.00748256493794928,0.0280336954889137,0.0573653500456749,1.1776597595638e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37120,0.0583899031515327,0.0102341972939604,0.0383308764553703,0.078448929847695,1.18571299784799e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40048,0.016121285898026,0.00282859132338829,0.0105772469041849,0.021665324891867,1.22320266142382e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37433,0.0145271000020638,0.00255085728605394,0.00952741972139809,0.0195267802827296,1.25939308785711e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39485,0.0265695878857017,0.00467053269071791,0.0174153438118946,0.0357238319595088,1.30249649723746e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37364,0.0322482955714174,0.00567085523453722,0.0211334193117245,0.0433631718311104,1.32222995229441e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37052,0.0408845640769739,0.00718970446443434,0.0267927433266826,0.0549763848272652,1.32386927360529e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,39909,0.0174340230157579,0.00306708912466941,0.0114225283314059,0.02344551770011,1.33691833407199e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39854,0.0120364855031283,0.00212437666443027,0.00787270724084501,0.0162002637654117,1.4878212812004e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,37449,0.0115708327591504,0.00204306697796095,0.00756642148234695,0.0155752440359539,1.51354918646341e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37433,0.0550607875656323,0.00972496438707797,0.0359998573669595,0.0741217177643051,1.52830301398517e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,39877,0.0548059931443701,0.00969837446338436,0.0357971791961368,0.0738148070926035,1.62185948749908e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39745,0.0272966356140779,0.00483036310920488,0.0178291239200363,0.0367641473081195,1.6220572761335e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,37449,0.0162687798571625,0.00287868489703623,0.0106265574589715,0.0219110022553535,1.62285412689869e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37378,0.0528605122823952,0.00936319043064143,0.034508659038338,0.0712123655264524,1.67950941494279e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40005,0.0311942485225544,0.00552988383580206,0.0203556762043824,0.0420328208407264,1.71869259118684e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,39862,-0.0218275517449973,0.00387304759176438,-0.0294187250248555,-0.0142363784651391,1.7723032504128e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,39864,0.0345840459006339,0.00613686393809158,0.0225557925819744,0.0466122992192934,1.77535094106297e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37165,0.0578494440335355,0.0102679604137865,0.0377242416225139,0.077974646444557,1.79672870814927e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40005,0.0239679547864745,0.00426828952148744,0.0156021073243591,0.0323338022485899,1.99392182097582e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37052,0.0143814112099565,0.0025617602436518,0.00936036113239895,0.019402461287514,2.01831700925686e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40026,0.0653327553510859,0.0116666920791553,0.0424660388759416,0.0881994718262302,2.17918197096777e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,39862,0.032443370863812,0.00579529745568708,0.0210845878506653,0.0438021538769587,2.20116186508954e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40026,0.0301978352115317,0.00540127498313482,0.0196113362445874,0.0407843341784759,2.29586588039351e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37052,0.0158031150122784,0.00282935559036916,0.0102575780551549,0.021348651969402,2.37757795794325e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,40005,0.0121253849037939,0.0021720265704242,0.00786821282576246,0.0163825569818253,2.40872976004469e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39837,0.0429021401585824,0.00768725937299174,0.0278351117875186,0.0579691685296462,2.43108860858047e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39784,-0.0275070830129089,0.00492875848582045,-0.037167449645117,-0.0178467163807008,2.43129462490546e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,39862,0.0344870292757522,0.00618094153667618,0.0223723838638669,0.0466016746876375,2.45015087890671e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40048,0.0296270712559875,0.00531006808625199,0.0192193378069336,0.0400348047050414,2.45196018141931e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37017,0.0612352820136047,0.0109800743508595,0.0397143362859202,0.0827562277412893,2.49602169602001e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39473,0.0222931980062903,0.00400150852066744,0.0144502413057821,0.0301361547067985,2.57172590993273e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37361,0.0210864919727429,0.00378994698592144,0.0136581958803369,0.0285147880651489,2.68990845291711e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40026,0.0149308343263197,0.00269067165633832,0.00965711787989658,0.0202045507727428,2.91636282115868e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37279,0.0159352177599658,0.00287427717246192,0.0103016345019404,0.0215688010179911,3.01085533952199e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39473,0.0176613669153383,0.00318797273332545,0.0114129403580204,0.0239097934726561,3.07361276733543e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37120,0.0341141046114321,0.00616151834113473,0.0220375286628081,0.0461906805600562,3.14191188767066e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37165,0.0356862390924459,0.00644923952310171,0.0230457296271666,0.0483267485577253,3.20013176476213e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39473,0.0328690424719087,0.00594230641137531,0.0212221219056131,0.0445159630382043,3.2285974515369e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37120,0.0144681634751708,0.00261753794296038,0.00933778910696847,0.0195985378433731,3.31160077880999e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39881,0.0119127270789933,0.00215792948498637,0.00768318528842004,0.0161422688695666,3.43397660443621e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39904,0.0245637692774427,0.00445071806354065,0.015840361872903,0.0332871766819824,3.46103172535028e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37416,0.0169209575774746,0.00306733906569281,0.0109089730087167,0.0229329421462325,3.52166921958249e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37433,0.030753661881273,0.00557507207443722,0.0198265206153761,0.04168080314717,3.52585665513698e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39734,0.0239813991120878,0.00435018550233626,0.0154550355275088,0.0325077626966669,3.58817970826358e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37039,0.0265673935070025,0.00482040820232956,0.0171193934304365,0.0360153935835684,3.62594913932982e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37408,0.0487019392993299,0.00884060489956308,0.0313743536961863,0.0660295249024736,3.67684760687591e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37378,0.0428461355954512,0.00777790055181283,0.027601450513898,0.0580908206770043,3.68096224214459e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,39909,0.0108074900676981,0.0019623165039103,0.00696134972003394,0.0146536304153623,3.69522827807612e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39975,0.0286680337377571,0.00520569420845978,0.0184648730891759,0.0388711943863382,3.70471326876958e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37441,0.0128853457223253,0.00234063417217639,0.00829770274485955,0.017472988699791,3.75725628103075e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37408,0.0381512999150807,0.0069302785653282,0.0245679539270375,0.051734645903124,3.75846892314603e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39909,0.0416782992931604,0.00758423192066812,0.0268132047286509,0.0565433938576699,3.95789556250698e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37165,0.0174371505457499,0.00317484708862955,0.011214450252036,0.0236598508394638,4.04059828175996e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39784,0.00985246391135748,0.00179426363742626,0.00633570718200201,0.013369220640713,4.05573308970477e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37017,0.0310672638328941,0.00565857855268,0.0199764498696413,0.0421580777961469,4.08702127741253e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37433,-0.0133261041765,0.00242779497060833,-0.0180845823188923,-0.00856762603410764,4.11530502457723e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37039,0.0323689048112174,0.00590033410054664,0.020804249974146,0.0439335596482888,4.18853759048152e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37441,0.0341297267751563,0.00622271553078904,0.0219332043348097,0.0463262492155028,4.21578773072827e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37120,0.0264052885593012,0.00482437296879463,0.0169495175404637,0.0358610595781386,4.49732820441613e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39782,0.0132571743246665,0.00242342643927925,0.00850725850367921,0.0180070901456539,4.55727390379072e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37378,0.014651172890803,0.00267888090518317,0.00940056631664404,0.0199017794649621,4.60261622371789e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39864,0.0385388081255327,0.00704757239308256,0.0247255662350908,0.0523520500159745,4.60970727541435e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37039,-0.017190228819733,0.00314679211440968,-0.023357941363976,-0.01102251627549,4.77244822400754e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37120,0.0342199557844835,0.00628031860681619,0.0219105313151238,0.0465293802538433,5.16275008675724e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37022,0.0391648549704894,0.00719828390541897,0.0250562185158683,0.0532734914251106,5.39723979028605e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37052,0.0156986476436395,0.00288541149381863,0.0100432411157549,0.021354054171524,5.40197340676558e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37384,0.0185726543987413,0.00341603120366121,0.0118772332395653,0.0252680755579172,5.51533551681105e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37364,0.0239069452632445,0.0043996792781778,0.015283573878016,0.032530316648473,5.61254058625799e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39904,0.0427427517475683,0.00787295744252257,0.0273117551602241,0.0581737483349125,5.74750888635284e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37052,0.020188532151719,0.00372428613032187,0.0128889313362882,0.0274881329671499,6.0383648726447e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37237,0.0114462558361068,0.00211218230807004,0.00730637851228956,0.0155861331599241,6.09167850520605e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39473,0.0334425463914243,0.00617483771434303,0.021339864471312,0.0455452283115366,6.1869725254037e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39900,0.0248551978071171,0.00459727636941748,0.0158445361230588,0.0338658594911753,6.51854422430545e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37433,-0.0113541149827223,0.00209991876669881,-0.0154699557654519,-0.00723827419999263,6.51989599538676e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40048,0.0123670505214756,0.00229166998929404,0.00787537734245933,0.016858723700492,6.89003564288345e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40036,0.0187876142389532,0.0034819622719055,0.0119629681860184,0.025612260291888,6.9218280238232e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39904,0.0438028868033698,0.00811923653488047,0.0278891831950041,0.0597165904117355,6.95138627547589e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39485,0.0416711408138383,0.00772579241986366,0.0265285876709055,0.056813693956771,6.99985736741854e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,39745,-0.0705539216281761,0.0130906607480272,-0.0962116166943093,-0.0448962265620429,7.16069274310967e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,37433,0.013134098426615,0.0024367905992224,0.0083579888521391,0.0179102080010909,7.16686336840602e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39862,0.0510726667392396,0.00947885824552834,0.0324941045780041,0.0696512289004752,7.22292695092451e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37384,0.0287917986775301,0.0053433208503371,0.0183188898108694,0.0392647075441908,7.22903747406331e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37035,0.0299990692585987,0.00556857720031405,0.0190846579459832,0.0409134805712143,7.27918082444468e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39862,-0.0118761342042412,0.00220655694606581,-0.0162009858185302,-0.0075512825899522,7.46166662310069e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39784,0.0136653669819931,0.00253915176632104,0.00868862952000386,0.0186421044439823,7.47620223013059e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,39963,-0.0199196772597613,0.00370491820340691,-0.0271813169384388,-0.0126580375810837,7.69850143629341e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,39745,0.0301274216306682,0.00560660495105733,0.0191384759265958,0.0411163673347405,7.82861121909351e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37378,0.0125758036804556,0.00234493571763216,0.00797972967389652,0.0171718776870146,8.32152054240677e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37354,0.052923947204263,0.00987365279816166,0.0335715877198662,0.0722763066886598,8.45359338970581e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,39776,0.0325177731546646,0.00606948693617364,0.0206215787597642,0.0444139675495649,8.55163999883358e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39814,0.0532527907233296,0.00994560836001047,0.0337593983377091,0.0727461831089501,8.70280183284261e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39695,0.0137568477523685,0.00256943836026758,0.008720748566244,0.0187929469384929,8.72165981751862e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37378,0.0173646855188305,0.00324603973809592,0.0110024476321625,0.0237269234054985,8.9635657439688e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39854,0.018025310252117,0.00337556496033898,0.0114092029298526,0.0246414175743814,9.42485516716202e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37433,0.0225036255643203,0.0042190326314285,0.0142343216067204,0.0307729295219202,9.77028049709697e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37378,0.0313466226018925,0.00588845381690894,0.019805253120751,0.042887992083034,1.03471348750816e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37384,0.0406098207454689,0.00763013962241718,0.0256547470855312,0.0555648944054066,1.04105137294813e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39473,0.0307238097908606,0.00577345756262071,0.019407832968124,0.0420397866135972,1.04301477087335e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37433,0.0346613716543004,0.00652681154422263,0.021868821027624,0.0474539222809767,1.10980690244309e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37433,0.0191560410363466,0.00360882681825039,0.0120827404725759,0.0262293416001174,1.12513604379739e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39864,0.0134762962221562,0.00254224202029968,0.00849350186236882,0.0184590905819435,1.16731062818066e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39909,0.013014284064795,0.00245880404528794,0.00819502813603061,0.0178335399935594,1.21954054672894e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39854,0.0115315666198115,0.00217980037036,0.00725915789390586,0.0158039753457171,1.23796721426414e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,37449,0.00923762603450387,0.00174792073799046,0.00581170138804257,0.0126635506809652,1.27702408999328e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39473,0.0276223817667178,0.0052272610572918,0.0173769500944258,0.0378678134390097,1.27886921580041e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40007,0.0312358654752668,0.0059123812556421,0.0196475982142082,0.0428241327363253,1.28645570999973e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37378,0.0323850204512854,0.00613047806854882,0.0203692834369297,0.0444007574656411,1.2932165066908e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39909,0.0166577222647281,0.00315522746327383,0.0104734764367114,0.0228419680927448,1.31292712071674e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,39862,0.0254597166051234,0.00482554605850717,0.0160016463304494,0.0349177868797975,1.33734380073302e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39952,0.0132584101125733,0.00251318461458547,0.00833256826798577,0.0181842519571608,1.34079324154712e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39745,0.0257720322990363,0.00488562280517985,0.0161962116008838,0.0353478529971888,1.3444204423593e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36987,0.0475461723604148,0.00901669541728208,0.029873449342542,0.0652188953782877,1.36248029005375e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39927,0.0128291646502234,0.0024332628461061,0.0080599694718554,0.0175983598285913,1.36385263255827e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39909,0.0119749524748037,0.00227161336665572,0.00752259027615845,0.0164273146734489,1.37018953826998e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37165,0.0170498867392242,0.00324419214003106,0.0106912701447633,0.0234085033336851,1.49895642593126e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37039,0.0438368767644811,0.00834140233695505,0.0274877281840492,0.060186025344913,1.50059273528518e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,39885,0.0140665341730339,0.00267770429929023,0.00881823374642507,0.0193148345996428,1.51386352630584e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37344,0.0275390385369543,0.00524416219658832,0.0172604806316412,0.0378175964422674,1.53266774503229e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39986,0.0220040461969615,0.00419073263069211,0.013790210240805,0.0302178821531181,1.5349182176501e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39473,0.0243505828644262,0.00463907244421502,0.0152580008737647,0.0334431648550876,1.54913088829645e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39753,0.0127206828516037,0.00242358529266385,0.00797045567798253,0.0174709100252248,1.55142452339601e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37183,0.0118750977906407,0.00226277052567471,0.00744006756031827,0.0163101280209631,1.560901211783e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,39583,0.0381325920936793,0.00726691883094337,0.0238894311850303,0.0523757530023283,1.56245304737073e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40026,0.0260230758557215,0.00496248588158834,0.0162966035278084,0.0357495481836347,1.59146487383738e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39581,0.0432296828821517,0.00826249757675315,0.0270351876317155,0.0594241781325878,1.69806278851499e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39864,0.0413258404412043,0.00790026338762217,0.0258413242014649,0.0568103566809438,1.70771523405236e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39927,0.0416613969771451,0.00798699595264261,0.0260068849099656,0.0573159090443246,1.84944962059434e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39862,0.0478102417270023,0.00917782396958271,0.0298217067466202,0.0657987767073844,1.91882655607785e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37017,0.0291936421597052,0.00560486202311412,0.0182081125944016,0.0401791717250089,1.93113508813956e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,39743,0.0107373865596378,0.00206311501332447,0.00669368113352187,0.0147810919857538,1.9699082208069e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39485,0.0289807798415159,0.00557454797049773,0.0180546658193404,0.0399068938636915,2.03142733678129e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37052,0.025738349733705,0.00495113823858497,0.0160341187860785,0.0354425806813316,2.03936191860532e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,39825,0.0312989809658597,0.0060217511414608,0.0194963487285965,0.0431016132031229,2.04306291323876e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37433,0.0159843252536315,0.00307912763650555,0.00994923508608059,0.0220194154211823,2.11975605497389e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,39862,0.0303994680515935,0.00585767231655285,0.0189184303111499,0.0418805057920371,2.1322605924427e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37017,0.0317711822313655,0.0061349597124099,0.0197466611950422,0.0437957032676889,2.26722189252274e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37165,0.0347459109850157,0.00671104375665432,0.0215922652219732,0.0478995567480581,2.28252189303096e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,39784,0.0206787916556878,0.00399898016670271,0.0128407905289505,0.0285167927824251,2.35644258731012e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37378,0.0236276271073982,0.00457046195437288,0.0146695216768274,0.0325857325379691,2.37895731381372e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,39669,0.0155621759964173,0.00301070610189013,0.00966119203671263,0.0214631599561219,2.38286244424674e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37433,-0.0122910749210929,0.00237855796131733,-0.0169530485252749,-0.00762910131691097,2.4067784999599e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39784,-0.0394115633952975,0.00762960537409258,-0.054365589928519,-0.0244575368620761,2.42547432723746e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,39862,0.0247724430305989,0.00479940593804515,0.0153656073920304,0.0341792786691674,2.47825334995483e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,39862,-0.0158667619408987,0.0030759362245096,-0.0218955969409375,-0.00983792694085992,2.52107146663059e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39473,0.0206286575519321,0.00399910469071108,0.0127904123581383,0.0284669027457258,2.52226111070392e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40054,0.0162218467849819,0.00314657099918722,0.010054567626575,0.0223891259433889,2.56062639747227e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39583,0.0186093092125188,0.00361065565128807,0.0115324241359942,0.0256861942890435,2.58080095123008e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40048,0.0315144961230793,0.00612266950524083,0.0195140638928073,0.0435149283533513,2.67522613630029e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,39998,0.0125324881468025,0.00243638720827884,0.00775716921857597,0.017307807075029,2.72269828193453e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39927,0.00938447985526448,0.00182465377426223,0.0058081584577105,0.0129608012528185,2.73336068229397e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40005,0.0447706884930628,0.00870681694316573,0.027705327284458,0.0618360497016677,2.74966498279134e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37364,0.037478098542698,0.00728943525822962,0.0231908054365679,0.051765391648828,2.76471505606479e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37384,0.0333413747974311,0.00648508645814688,0.0206306053394632,0.046052144255399,2.76743020777522e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37364,0.024280116477893,0.00473359079674874,0.0150022785162655,0.0335579544395206,2.94814034572485e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39927,0.0139148184984778,0.00271303771959809,0.00859726456806551,0.01923237242889,2.94875620232972e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,39980,0.0109486745846895,0.00213473863033862,0.00676458686922576,0.0151327623001531,2.94954458454562e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39909,0.0285476046730786,0.00557244779255945,0.0176256069996621,0.0394696023464952,3.04210665061895e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39485,0.0522757743432609,0.0102134080308438,0.0322574946028071,0.0722940540837147,3.11880588752521e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,39887,0.0129339204881087,0.00252837037178933,0.00797831455940157,0.0178895264168158,3.16494218350792e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39452,0.0424019091420105,0.00829330904074379,0.0261470234221527,0.0586567948618683,3.21201129967827e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37384,0.0139286857241036,0.00273981892188878,0.00855864063720162,0.0192987308110056,3.74904638759195e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39862,0.0425555036185394,0.00837884737688747,0.0261329627598399,0.0589780444772388,3.83851351082258e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37362,0.0376710065915938,0.00741758754939532,0.023132534994779,0.0522094781884086,3.85281986842354e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,39745,0.0167447973514407,0.00330132033072435,0.010274209503221,0.0232153851996605,3.97773901213998e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39927,-0.0208533217188476,0.00412439271235429,-0.0289371314350621,-0.0127695120026332,4.32635726057504e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39485,0.0327273613035076,0.00647395861105253,0.0200384024258446,0.0454163201811705,4.3472858532229e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37307,0.0329599259668649,0.00652163766948052,0.0201775161346831,0.0457423357990468,4.38485822804948e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37305,0.0115110956998034,0.00227781541378359,0.00704657748878757,0.0159756139108192,4.39325830990921e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37378,0.0468125381941384,0.009265493003745,0.0286521719067982,0.0649729044814786,4.42095545007447e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,39581,-0.0579388762757629,0.011477182324307,-0.0804341536314045,-0.0354435989201212,4.51025071263964e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39473,0.0207134183983455,0.00410366794217889,0.0126702292316749,0.0287566075650162,4.52574712775551e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,39581,0.0344061146814227,0.00682649791326901,0.0210261787714154,0.0477860505914299,4.70498867144933e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37052,0.0275283654520627,0.00546272475403699,0.0168214249341502,0.0382353059699752,4.73398032433635e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,39909,0.0134198847058068,0.00266443576842198,0.0081975905996997,0.0186421788119139,4.78839296990046e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37378,0.0401778974223757,0.00798831475930865,0.0245208004941308,0.0558349943506207,4.97848695200915e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39485,0.027762167396495,0.00552069186242911,0.016941611346134,0.0385827234468561,4.99162346647397e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40026,-0.00752454137402815,0.00149659768828653,-0.0104578728430698,-0.00459120990498655,5.01538252247726e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40054,0.0353448338995948,0.00704045902433549,0.0215455342118973,0.0491441335872924,5.2153360901989e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37033,0.0194116447575076,0.00386778080905691,0.0118307943717561,0.0269924951432592,5.26719502813108e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,39842,0.0169479054098453,0.0033773884196338,0.0103282241073631,0.0235675867123276,5.275912896371e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39581,0.0292343542873606,0.00583067393367497,0.0178062333773577,0.0406624751973636,5.39212559989921e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,39746,0.0299431706031845,0.00597724265257242,0.0182277750041426,0.0416585662022265,5.51491355017434e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,39762,0.0238275004999598,0.00475683555841325,0.0145041028054698,0.0331508981944498,5.5269274907767e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39864,0.0284097988600791,0.00567165718107714,0.0172933507851679,0.0395262469349903,5.5272672961883e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37384,0.0183262648161106,0.00365937585156838,0.0111538881470366,0.0254986414851846,5.56830414779715e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39862,0.045601733343173,0.00911070360485827,0.0277447542776508,0.0634587124086952,5.63698337973037e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,39699,0.0205783348274618,0.00411145481367269,0.0125198833926633,0.0286367862622603,5.64255686667913e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40005,0.0320889166943813,0.00641329605445793,0.0195188564276438,0.0446589769611189,5.68909949860513e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,39854,-0.0120712095700839,0.0024143831558985,-0.0168034005556449,-0.00733901858452283,5.80249118473562e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39763,0.0210611371205892,0.00421691947755896,0.0127959749445736,0.0293262992966047,5.96331780631322e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37017,0.016509425979201,0.00331129727420527,0.0100192833217586,0.0229995686366433,6.24957692826756e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39473,0.0211757813569955,0.00424810989667796,0.0128494859595066,0.0295020767544843,6.27056189025094e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,39969,-0.0241511069294493,0.00484608764280827,-0.0336494387093535,-0.0146527751495451,6.30498578611246e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37384,0.0248890899096066,0.00500841071781184,0.0150726049026954,0.0347055749165178,6.79613892423108e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,39864,0.0240209065546442,0.00483482961781344,0.0145446405037298,0.0334971726055585,6.82378039056356e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39473,0.0291334947830974,0.00587046788509151,0.0176273777283181,0.0406396118378768,7.02445768442926e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39864,0.0146683106036889,0.00295779378426163,0.00887103478653607,0.0204655864208416,7.15069389161198e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,39839,0.0174449423650588,0.00351868056185586,0.0105483284638213,0.0243415562662963,7.20238792526346e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39865,0.0258318249197495,0.00521741088226245,0.0156056995905151,0.0360579502489839,7.45537171950716e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37035,0.0308574079190603,0.00623560068540946,0.0186356305756578,0.0430791852624628,7.56780579822466e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37364,0.0371037905419738,0.00750056294766313,0.0224026871645541,0.0518048939193936,7.6351143438083e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,39929,-0.0288312413833645,0.00582888411025608,-0.0402558542394664,-0.0174066285272625,7.64128167129997e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39485,0.016651781667667,0.00336684576274211,0.0100527639726925,0.0232507993626416,7.66152729763468e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39862,0.0271044569755723,0.00548116775659359,0.0163613681726489,0.0378475457784958,7.69096604480318e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37378,0.0179277583691483,0.00363166618932384,0.0108096926380736,0.025045824100223,8.04813128144665e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,37052,0.0143059855014765,0.00290071517720493,0.00862058375415489,0.0199913872487982,8.24328716335343e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39473,0.0181677233478429,0.00368961305125308,0.0109360817673869,0.025399364928299,8.56511897300667e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37052,0.0230076343711992,0.00467294500282567,0.0138486621656609,0.0321666065767375,8.60017751612809e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39784,0.0256896963341611,0.00522031631629796,0.0154578763542171,0.0359215163141051,8.69195634069495e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37120,0.0126299926896643,0.002567209905204,0.00759826127546442,0.0176617241038641,8.77014129510487e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39862,0.01789194592976,0.003657014270031,0.0107241979604992,0.0250596938990207,1.00530877029357e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37165,0.0371482168844259,0.00759797938141346,0.0222561772968555,0.0520402564719962,1.02416621656442e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40054,-0.0122488945942338,0.00250695315793446,-0.0171625227837854,-0.00733526640468231,1.03905482805459e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39516,0.039449927627775,0.00809196480025608,0.023589676619273,0.0553101786362769,1.09765448713189e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39784,0.0293864325044033,0.00602994233467003,0.0175677455284501,0.0412051194803566,1.107393913221e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,39583,-0.0190220871793933,0.00390370415177534,-0.026673347316873,-0.0113708270419136,1.11082915455821e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37378,0.0236591397332503,0.00485529764000035,0.0141427563588497,0.033175523107651,1.11247095984038e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37052,0.0400795608668137,0.00823636907830201,0.0239362774733417,0.0562228442602856,1.15098044218598e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,39444,-0.0524558490704227,0.0107978346423131,-0.0736196049693565,-0.031292093171489,1.1973145632023e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,39581,0.0142769318445862,0.00294087501977626,0.00851281680582477,0.0200410468833477,1.2175544237677e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37433,-0.0299451261788337,0.00616877990602227,-0.0420359347946373,-0.01785431756303,1.22155687727098e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,39784,-0.0157753752760281,0.00325480108955996,-0.0221547854115656,-0.00939596514049057,1.26650274218722e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37408,0.016901278265454,0.00348837196834794,0.0100640692074921,0.023738487323416,1.27991735866482e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37052,0.0229503167000138,0.00473788027781914,0.0136640713554882,0.0322365620445393,1.28693145132378e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40026,-0.018968062953498,0.00391676842454591,-0.026644929065608,-0.011291196841388,1.2921728534694e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40048,0.0389463444826924,0.00805191074702856,0.0231645994185165,0.0547280895468684,1.33087951249653e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37433,0.0139634941913844,0.0028915240604287,0.00829610703294418,0.0196308813498247,1.38639225601734e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40005,0.0127445136401463,0.00263934467119857,0.0075713980845971,0.0179176291956955,1.38710076298778e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37433,0.0115373636345386,0.00238936377917843,0.00685421062734883,0.0162205166417283,1.38971825481343e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37035,0.0350549156590992,0.00726053981385001,0.0208242576239531,0.0492855736942452,1.39360806470617e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39473,0.0323301724726558,0.0067031974375801,0.0191919054949988,0.0454684394503128,1.42679391292541e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39751,0.0105089336094858,0.00217978391673788,0.00623655713267954,0.014781310086292,1.44097221030365e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39485,0.0295517418809397,0.00613084188650093,0.0175352917833979,0.0415681919784815,1.44779821286179e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37035,0.0294876822260748,0.00612666295367966,0.0174794228368626,0.0414959416152869,1.5032450139471e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39864,0.0120512868350314,0.00250734240955436,0.00713689571230485,0.0169656779577579,1.55068673850136e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39473,0.0214404408540518,0.0044650017703936,0.0126890373840803,0.0301918443240232,1.58633794216441e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37358,0.017626327812819,0.00367103513044131,0.010431098957154,0.024821556668484,1.59203100317273e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,39862,0.0183471064722061,0.00382198683067148,0.01085601228409,0.0258382006603222,1.59771464398033e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39784,0.0496090638352659,0.0103343926388378,0.0293536542631437,0.0698644734073881,1.59798941410077e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37039,0.0261792340419667,0.00545957303655967,0.0154784708903098,0.0368799971936237,1.64366204893836e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37017,0.0281898167778775,0.00588125745218656,0.0166625521715918,0.0397170813841631,1.65968646767003e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37165,0.0242672242386709,0.00506407145055047,0.014341644195592,0.0341928042817498,1.66878980525392e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,39583,0.0225188760820786,0.00470184009635866,0.0133032694932157,0.0317344826709416,1.6882664360352e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37378,-0.0127768387768773,0.00266790700207061,-0.0180059365009357,-0.00754774105281887,1.6931897037344e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37378,-0.0424106893552361,0.00886375918428888,-0.0597836573564423,-0.0250377213540299,1.73027591681382e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39583,0.0304975364288001,0.00637830861511017,0.0179960515431841,0.042999021314416,1.75615494750671e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37378,0.0460010499571163,0.00962470607290747,0.0271366260542176,0.0648654738600149,1.77602640399901e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39790,0.0112306393642217,0.00235140157077929,0.00662189228549427,0.0158393864429491,1.80276528830957e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40048,0.0101198683814498,0.00211952904603514,0.00596559145122088,0.0142741453116786,1.8165500847676e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37084,0.0373130080304314,0.00782369644692032,0.0219785629944676,0.0526474530663952,1.86904873270025e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39927,0.0163871760035288,0.00343673918610134,0.00965116719877018,0.0231231848082874,1.8747782198681e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39927,0.0449088419175194,0.00942482232507822,0.0264361901603661,0.0633814936746727,1.90549180996179e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37433,-0.0112794978070805,0.00236718173463953,-0.015919174006974,-0.00663982160718704,1.90859396335646e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40026,0.0121216308062745,0.00254421044223856,0.00713497833948692,0.0171082832730621,1.91064219340559e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37039,0.0440039423054637,0.00923701711213127,0.0258993887656864,0.062108495845241,1.91940339906228e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37433,0.0352945760487172,0.00741008212886416,0.0207708150761435,0.049818337021291,1.92663059453915e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39900,0.0144029270750401,0.0030241014070301,0.00847568831726109,0.0203301658328191,1.92677811623293e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39673,0.0156321188372395,0.00329051624666403,0.00918270699377796,0.022081530680701,2.04536523647919e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,39583,0.0206210436006422,0.00434772253249256,0.0120995074369568,0.0291425797643277,2.12474491105508e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40048,0.0308117907262303,0.00650066168870106,0.0180704938163763,0.0435530876360844,2.15756263953611e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39862,0.0242471353485675,0.00511744821306059,0.0142169368509688,0.0342773338461663,2.17552804983351e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40036,0.0224747452656977,0.00474467908462063,0.0131751742598413,0.0317743162715541,2.18928831536475e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39485,0.0116966942589038,0.00246942550983657,0.00685662025962414,0.0165367682581835,2.19238016968209e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,36987,0.023583955832856,0.00497940669370378,0.0138243187131966,0.0333435929525154,2.19935263417176e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37039,0.031828328958725,0.00672458560035157,0.0186481411820359,0.045008516735414,2.23384188897073e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39485,0.0192376733374194,0.0040670302426751,0.0112662940617762,0.0272090526130626,2.26312928427294e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39854,0.0377881484274297,0.00800373613197178,0.022100825608765,0.0534754712460944,2.36313411532421e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37384,0.0309562798964264,0.00655639458178836,0.0181057465161212,0.0438068132767316,2.36414757062878e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37120,0.0446400224600541,0.00947592444453239,0.0260672105487706,0.0632128343713376,2.49142352184212e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39784,0.0232780918629073,0.00496002217805236,0.0135564483939247,0.0329997353318899,2.71279002180999e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37039,0.0232174637215806,0.0049495164898297,0.0135164114015143,0.0329185160416468,2.74798732142642e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,36875,0.029428231090152,0.00628277554040983,0.0171139910309488,0.0417424711493553,2.84239429583366e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37378,0.0140646203938094,0.00300831013847194,0.00816833252240435,0.0199609082652144,2.96425127830736e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37384,0.00901155133621594,0.00192937391538381,0.00522997846206366,0.0127931242103682,3.03045954496233e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39485,-0.015006259354862,0.00321425846110012,-0.0213062059386183,-0.0087063127711058,3.05700679464714e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40026,0.0274546571736232,0.00588416029257605,0.0159217030001741,0.0389876113470723,3.09795368840306e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39485,0.0114995362034346,0.00246525870119138,0.0066676291490995,0.0163314432577697,3.1172461742211e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,39854,-0.0184645358095044,0.00395919163045091,-0.0262245514051882,-0.0107045202138206,3.13065442931194e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,39842,0.0119082705277192,0.0025552618139036,0.00689995737246812,0.0169165836829702,3.18307229628193e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,39862,0.0387323923045761,0.00831540468189825,0.0224341991280556,0.0550305854810967,3.2200859459257e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,39745,0.037496697472728,0.008064826621941,0.0216896372937236,0.0533037576517323,3.35562708663695e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39862,0.0193405115265003,0.00416155369594006,0.0111838662824578,0.0274971567705428,3.38783979057845e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39583,0.0278163495426688,0.00598825986125542,0.0160793602146081,0.0395533388707294,3.42587442712314e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37165,0.0160069095780812,0.00344759444598406,0.00924962446395241,0.0227641946922099,3.46802460085343e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40005,-0.0129852658306672,0.00279973768852439,-0.018472751700175,-0.00749777996115936,3.54505824660787e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37364,0.0290615884801744,0.0062710876348117,0.0167702567159435,0.0413529202444053,3.61640393204553e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39883,0.050360242528944,0.0108743613137471,0.0290464943539996,0.0716739907038883,3.6658853037814e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39927,0.0117400834932846,0.00253823688022042,0.00676513920805254,0.0167150277785166,3.76990859332424e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37378,0.0200349502489522,0.00434016410846613,0.0115282285963586,0.0285416719015459,3.94478418124637e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39900,-0.0268769997502939,0.00582999947492197,-0.038303798721141,-0.0154502007794469,4.05540304894952e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39839,0.0252222501081182,0.00548178637650908,0.0144779488101604,0.035966551406076,4.23494638011436e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,39787,0.0447757050910702,0.00973493722954619,0.0256952281211597,0.0638561820609808,4.26796632614752e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37039,0.0257184558472368,0.00559265815698422,0.0147568458595477,0.0366800658349258,4.29276041015475e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37035,0.0256124450492487,0.0055818656688883,0.0146719883382277,0.0365529017602698,4.50541776487163e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37165,0.0207079180345075,0.00451540478485382,0.011857724656194,0.029558111412821,4.55808060237369e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,39804,0.0430039957877988,0.00938675458234014,0.0246059568064121,0.0614020347691855,4.6548701275128e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39709,0.0463676074097701,0.0101246096304437,0.0265233725341004,0.0662118422854397,4.69202441785905e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37120,0.0174537273227561,0.00381770713820551,0.00997102133187332,0.0249364333136389,4.87965196762823e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,39904,0.0119696457423729,0.00262204212696782,0.006830443173516,0.0171088483112298,5.03182340298185e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39473,0.014135501817544,0.00309677282874083,0.00806582707321201,0.0202051765618761,5.04286975127552e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39473,0.0232995005179029,0.00511074419155334,0.0132824419024583,0.0333165591333474,5.18064784947441e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39862,-0.0190776153752223,0.00418650916030166,-0.0272831733294136,-0.0108720574210311,5.22914057723069e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37408,0.0272539237635034,0.00599056115828219,0.0155124238932703,0.0389954236337365,5.42463153391826e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37408,0.019360097272915,0.00425554623287086,0.0110192266564881,0.0277009678893418,5.42714181057859e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37084,0.0155592240914068,0.00342278984388564,0.00885055599739098,0.0222678921854227,5.52196324562897e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39864,0.0139787856376379,0.00307989273808146,0.0079421958709982,0.0200153754042775,5.70075423405944e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37165,0.0302026523860769,0.00665712198129243,0.0171546933027437,0.04325061146941,5.75884997581035e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39910,0.0123164185955065,0.00272253406014682,0.00698025183761878,0.0176525853533943,6.11513634336508e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37360,0.0230374815898132,0.00509598543302597,0.0130493501410823,0.0330256130385441,6.21562720337314e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,39862,0.0161273384469078,0.00357275523169513,0.00912473819278539,0.0231299387010303,6.4076540495835e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,39970,0.010399817913702,0.00230547587928131,0.00588108519031067,0.0149185506370934,6.5002999233437e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37441,0.0373569174827982,0.00829407180114791,0.0211005367525483,0.0536132982130481,6.72261381204868e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37408,0.0487918148882154,0.0108342576774908,0.0275566698403335,0.0700269599360974,6.74094033408185e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37384,0.0282583282407043,0.00627915398747865,0.0159511864252461,0.0405654700561624,6.84109806668458e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37408,0.0326632308470873,0.00727120705474006,0.0184116650197967,0.0469147966743778,7.10965506127631e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39927,0.0114516033724019,0.00255020830138171,0.00645319510169373,0.01645001164311,7.15649257261643e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39500,0.0201097067024499,0.00447903404116718,0.0113307999817623,0.0288886134231376,7.18192278256763e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37120,0.0316807637390571,0.0070580152327911,0.0178470538827865,0.0455144735953276,7.22893684902559e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,39854,-0.0104347742468517,0.00232698217035027,-0.0149956593007382,-0.00587388919296518,7.36791731573613e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37017,0.0173662972851289,0.00387251301996766,0.00977617176599229,0.0249564228042655,7.37024897502818e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39862,0.0246929858680784,0.00550896836285011,0.0138954078768922,0.0354905638592646,7.43467405256077e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37120,0.0110026357283937,0.0024548602307715,0.00619110967608155,0.0158141617807058,7.45731410271487e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39745,0.0413930488436558,0.00924891724043037,0.0232651710524123,0.0595209266348994,7.67812948046446e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37035,0.0214121705171573,0.00478460176936282,0.0120343510492062,0.0307899899851084,7.69707953916543e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37039,0.0389876465606299,0.00871403881595069,0.0219081304813665,0.0560671626398932,7.7369511318347e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39583,0.0138840084056585,0.00310672719138649,0.00779482311054097,0.019973193700776,7.91297249252581e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37120,0.0270590517800186,0.00605493342274873,0.015191382271431,0.0389267212886061,7.92645306723103e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37433,0.0371411109945282,0.0083184360309565,0.0208369763738535,0.053445245615203,8.07465900533313e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39581,0.0214450861065761,0.00480439987364182,0.0120284623542381,0.030861709858914,8.1141205216841e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39784,0.00877129116470643,0.00196827903221641,0.00491346426156226,0.0126291180678506,8.39453398448357e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39485,0.0139517064891016,0.0031365856004529,0.00780399871221387,0.0200994142659893,8.72493503988997e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37364,0.0292746525636077,0.00658112851949799,0.0163756406653917,0.0421736644618238,8.72555227330297e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37017,0.0203637325629051,0.00458087227569778,0.0113852229025375,0.0293422422232728,8.84532977078126e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37039,0.0145311019026569,0.00327022497816796,0.00812146094544773,0.0209407428598662,8.92471278046639e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37084,0.0123689395315781,0.00278927073422467,0.00690196889249775,0.0178359101706584,9.30431491448947e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37165,0.0215598140021689,0.00486229451246181,0.0120297167577438,0.0310899112465941,9.32062521617128e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37017,0.0201360336976107,0.00454128646781416,0.011235112220695,0.0290369551745265,9.32530685970674e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39784,0.00902872794256145,0.00203718611592499,0.00503584315534847,0.0130216127297744,9.40039777231764e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,39862,0.0182910756936694,0.0041347357367993,0.0101869936495427,0.026395157737796,9.76382784409025e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37120,0.0202755279799127,0.0045834011307106,0.01129206176372,0.0292589941961055,9.7804153453066e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37364,0.021007957314248,0.00475149587870873,0.0116950253919789,0.0303208892365171,9.88586612658881e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39784,0.0156763805567782,0.00354834247474499,0.00872162930627797,0.0226311318072783,1.00301507265266e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39581,0.0376947759435242,0.00853806647381323,0.0209601656548502,0.0544293862321981,1.01726789439179e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37364,0.0213409426801677,0.00483746750255535,0.0118595063751592,0.0308223789851762,1.03406852008351e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37416,0.0142169087940933,0.00322380327347007,0.00789825437809194,0.0205355632100946,1.0417626092437e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39473,0.0158764959188043,0.00360136748919645,0.00881781563997927,0.0229351761976294,1.04801715515513e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37408,0.0309179816962493,0.00702857645814205,0.0171419718382908,0.0446939915542077,1.09633036123924e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,39781,0.0349743817064624,0.00795964983641688,0.0193734680270853,0.0505752953858395,1.12023884943104e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,39854,0.0156957176298286,0.00357292384517708,0.00869278689328154,0.0226986483663757,1.12535706532511e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37052,0.00660690570661406,0.001504179394719,0.00365871409296482,0.00955509732026331,1.12997942653572e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39581,0.0226733152653606,0.00516471411722802,0.0125504755955937,0.0327961549351276,1.14067824659395e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39864,0.0225706125566716,0.00514236934887282,0.0124915686328808,0.0326496564804623,1.14525098279687e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39485,0.0194330001832224,0.00442855273707339,0.0107530368185586,0.0281129635478863,1.15086450869118e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37433,0.0441061383750267,0.0100659992760381,0.0243767797939921,0.0638354969560614,1.18643373914974e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,39583,0.0235120594942664,0.00537076636514532,0.0129853574185816,0.0340387615699513,1.20665417360579e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37384,0.0163144233854699,0.00372804379239781,0.00900745755237015,0.0236213892185696,1.21707632782581e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39745,0.0228331973666439,0.00521872547853525,0.0126044954287148,0.033061899304573,1.2206985350118e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39415,0.0214823166083729,0.00494238222264349,0.0117952474519916,0.0311693857647541,1.39172728704382e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39473,0.0221747311762181,0.00511624757876822,0.0121468859218324,0.0322025764306038,1.4722051767372e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37052,0.0229520262961978,0.00529710488375351,0.0125697007240409,0.0333343518683547,1.48221214971735e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37052,0.0381952099928509,0.00882925711081185,0.0208898660556597,0.0555005539300422,1.52970227163896e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37035,0.02070201298818,0.00478807634450197,0.0113173833529561,0.0300866426234039,1.54589497343481e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40026,0.0259206989418853,0.00599653767046632,0.0141674851077713,0.0376739127759992,1.55115565383342e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39784,0.02335499404886,0.00540904086757316,0.0127532739484166,0.0339567141493034,1.58566320844953e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37320,0.0238920766242069,0.00554325656149563,0.0130272937636754,0.0347568594847383,1.64328680179649e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39909,0.0264830189089325,0.00615224349434525,0.0144246216600158,0.0385414161578492,1.68270556742745e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37052,0.0350912942275644,0.00815201160907799,0.0191133514737715,0.0510692369813572,1.68481208141152e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,39837,0.0259631339671858,0.00603287708642315,0.0141386948777965,0.0377875730565752,1.69039138850128e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40005,0.00884823014320453,0.00205609539454922,0.00481828316988806,0.012878177116521,1.69176001429731e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39864,0.0338763953048225,0.00787807300172112,0.0184353722214491,0.0493174183881959,1.71742339612109e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39862,0.0239227932123125,0.00556882443013676,0.0130078973292444,0.0348376890953805,1.75057700434551e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37017,0.0263746542947425,0.00614114037201998,0.0143380191655833,0.0384112894239016,1.76145580970825e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39583,0.0139412828089577,0.00324740970262469,0.00757635979181332,0.0203062058261021,1.77293143894929e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,39864,0.0298233484145635,0.00695016977727205,0.0162010156511103,0.0434456811780168,1.78895311643348e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39583,0.023157721252961,0.00539729287843854,0.0125790272112214,0.0337364152947005,1.79241538576056e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37039,0.0455099206315908,0.010607814766604,0.0247186036890469,0.0663012375741347,1.79764291439164e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39449,0.0184562558870468,0.00430547793316502,0.0100175191380433,0.0268949926360502,1.82443187873782e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37367,0.0329443515805234,0.00768720224979427,0.0178774351709266,0.0480112679901201,1.83500993724355e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37408,0.0143248625410818,0.00334787346115021,0.00776303055722741,0.0208866945249362,1.89198341641143e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37035,0.0227151129733762,0.0053116662237025,0.0123042471749193,0.0331259787718331,1.91229005125881e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,39781,0.0276504110696636,0.00646684448207476,0.014975395884797,0.0403254262545301,1.91630842572484e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39473,0.0223802743201281,0.00523575007185313,0.012118204179296,0.0326423444609602,1.92693207917856e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37017,0.0268867154344314,0.00629102672750126,0.0145563030485289,0.0392171278203339,1.93504746867332e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37120,0.0143160502179385,0.00335083366106066,0.00774841624225958,0.0208836841936174,1.94742537686274e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37243,0.00312168569547479,0.000730790462143379,0.00168933638967377,0.00455403500127581,1.95366433018862e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,39862,0.0313196409459352,0.00734666099317198,0.0169201853993181,0.0457190964925523,2.02754189489786e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39862,-0.0203089930814486,0.00478242950509157,-0.0296825549114281,-0.0109354312514692,2.18278835744551e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37433,0.0116081371620601,0.00273469889486732,0.00624812732812011,0.016968146996,2.20283250527972e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,39927,0.0150423927487308,0.00354478408651793,0.0080946159391557,0.021990169558306,2.21265988495741e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37039,0.0294363326853525,0.00694060111408414,0.0158327545017476,0.0430399108689574,2.23865934854325e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39389,0.0266407551433212,0.0062849127425573,0.0143223261679089,0.0389591841187335,2.25973210359819e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37039,-0.00875240714457693,0.00206801537057261,-0.0128057172708992,-0.00469909701825462,2.32906707218092e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39784,0.00786695488026479,0.0018589201611001,0.0042234713645086,0.011510438396021,2.32916602712294e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39473,0.0181328737784746,0.00428938861700586,0.00972567208914307,0.026540075467806,2.37773212677199e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37384,-0.010181832300562,0.00242500835402936,-0.0149348486744595,-0.00542881592666441,2.70194268888973e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37408,0.0182427855800595,0.00434797941210271,0.00972074593233818,0.0267648252277808,2.73771854983516e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37441,0.00849801589240629,0.00202550239967741,0.00452803118903857,0.012468000595774,2.73987970574802e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37378,0.0191055436450704,0.00455380133955168,0.0101800930195491,0.0280309942705917,2.73989723094078e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36987,0.0234546980349734,0.00559166612757994,0.0124950324249167,0.0344143636450301,2.75171811281485e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37441,0.0100567574481893,0.00239784435637545,0.00535698250969343,0.0147565323866852,2.75716620273605e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37449,0.00666183948192648,0.00158933466477412,0.0035467435389692,0.00977693542488375,2.7875886889757e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,39862,0.030896540889347,0.00738569704610434,0.0164205746789825,0.0453725070997116,2.88847358225527e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39473,0.022825774890856,0.00546838633578973,0.0121077376727081,0.0335438121090038,3.00743120361741e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39581,0.0199882637521628,0.00478878923954644,0.0106022368426518,0.0293742906616739,3.00947503854859e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37039,0.0160629423279303,0.00384821933475602,0.00852043243180848,0.0236054522240521,3.01056598890703e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37408,0.0402678610079999,0.00965362952690303,0.0213467471352699,0.0591889748807298,3.04798613746204e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,39854,0.0274090038474972,0.00657716932570762,0.0145177519691103,0.0403002557258841,3.09855936104351e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37039,0.0290049584911042,0.00696149912822433,0.0153604201997845,0.0426494967824239,3.11309434192374e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39818,0.0153231573735037,0.00367953654830589,0.00811126573882413,0.0225350490081832,3.1377709425162e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39927,-0.0106179262640679,0.0025500452265633,-0.0156160149081319,-0.0056198376200038,3.14600946314634e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37378,0.0268178609933027,0.00644295157495812,0.0141896759063848,0.0394460460802206,3.16930968241052e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39473,0.0348316996993263,0.00838465299685511,0.0183977798254903,0.0512656195731623,3.28134663891183e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37052,0.0237804875626662,0.00572532973022345,0.0125588412914283,0.0350021338339042,3.29406501475313e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37364,0.0164734672302988,0.00396965238856271,0.00869294854871594,0.0242539859118818,3.3473042583999e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40054,0.0135459445553214,0.00326774430276189,0.00714116572190807,0.0199507233887347,3.41021105243113e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37441,-0.00958967889057748,0.00231355248243482,-0.0141242417561497,-0.00505511602500524,3.41872979544196e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37120,-0.0122433953670088,0.00295420975565803,-0.0180336464880985,-0.00645314424591906,3.42836685380444e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40048,0.0130619418665392,0.00315626720988867,0.00687565813515744,0.019248225597921,3.514829493138e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,39948,0.0147436369344105,0.00356690952710086,0.00775249426129278,0.0217347796075281,3.5917073591962e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37039,0.0241198760710648,0.00584143218857086,0.0126706689814659,0.0355690831606637,3.66425072894355e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37408,0.0167745602812617,0.00406477244355531,0.00880760629189328,0.0247415142706301,3.70023482928146e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39909,0.00876946476950984,0.00212590985907199,0.00460268144572873,0.0129362480932909,3.72536991628301e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37353,0.0118836467755329,0.00288323778849228,0.006232500710088,0.0175347928409777,3.7844538488798e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39745,-0.0193902720826188,0.00470843307562445,-0.0286188009108427,-0.0101617432543949,3.83774005922109e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,39862,0.0320347611139755,0.00777957736529676,0.0167867894779938,0.0472827327499571,3.84422982115006e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37052,0.021371212608849,0.00518979882111387,0.0111992069194659,0.0315432182982322,3.84624991515852e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39473,0.0180461780465877,0.00438519673599054,0.00945119244404629,0.0266411636491292,3.8874650238723e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39485,0.0274333106564189,0.00667463565352875,0.0143510247755026,0.0405155965373353,3.97535012746852e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,39981,0.0266295988505914,0.00648005408049207,0.013928692852827,0.0393305048483559,3.98526301346865e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37408,0.0183344300948681,0.00446282708162576,0.00958728901488166,0.0270815711748546,4.01004313121982e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37433,0.00807504329897837,0.001965836921172,0.00422200293348125,0.0119280836644755,4.01984806262474e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39831,-0.00647209332341116,0.00157766741266167,-0.00956432145222804,-0.00337986519459428,4.11059874090866e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39927,0.0102825353520211,0.00250704545805372,0.0053687262542358,0.0151963444498064,4.12581451777322e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37433,0.0305486744694789,0.00745592364291208,0.0159350641293712,0.0451622848095865,4.20542417691724e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39399,0.0316303723460736,0.00772619025954221,0.0164870394373708,0.0467737052547763,4.26293335576462e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,39909,0.026141501360604,0.00639064886312843,0.0136158295888722,0.0386671731323357,4.32384055091366e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39837,0.0226955134351711,0.00556197862564213,0.0117940353289125,0.0335969915414297,4.51621035318344e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39808,0.02162785451713,0.00530533329371537,0.0112294012614479,0.0320263077728121,4.59156371183461e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39473,0.0363807658638627,0.00892570547278512,0.0188863831372038,0.0538751485905215,4.60528787615637e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37364,0.0134205009449968,0.00329307524493824,0.00696607346491784,0.0198749284250757,4.62040229651659e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37052,0.0166620798173608,0.00409427481379972,0.00863730118231332,0.0246868584524082,4.7367312144136e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40026,0.00927346722823773,0.00228077160561793,0.00480315488122659,0.0137437795752489,4.80669871686579e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,39862,0.0142142669839876,0.00349648064531492,0.00736116491917038,0.0210673690488048,4.81986490835877e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37035,0.0294725146987564,0.00725742914888338,0.015247953566945,0.0436970758305678,4.91429458628223e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39709,0.0268925539504713,0.00663484735299421,0.0138882531386026,0.0398968547623399,5.07566944651266e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37052,0.012218402181812,0.00301864875311212,0.00630185062571226,0.0181349537379118,5.20319757849355e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39909,0.01092875757706,0.00270037273094654,0.00563602702440483,0.0162214881297153,5.20926173722982e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39473,0.0280152081124135,0.00692417567392913,0.0144438237915124,0.0415865924333146,5.23511993273157e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37378,0.0175312634949342,0.00433403525728938,0.00903655439064703,0.0260259725992214,5.2609077221747e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37384,0.0140592915584237,0.00347942146048229,0.00723962549587844,0.020878957620969,5.35870503246248e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37035,0.0295778170892146,0.00735866089778603,0.0151548417295539,0.0440007924488752,5.86571504371833e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37017,0.0272379683639163,0.00678101018970604,0.0139471883920925,0.0405287483357402,5.93213999193546e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37017,-0.0275723192283812,0.00686522676811929,-0.041028163693895,-0.0141164747628674,5.94654409344698e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40005,0.00979501489845484,0.00244257963974011,0.00500755880456424,0.0145824709923455,6.09633349691847e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37441,0.00897543547646524,0.00224283551290264,0.00457947787117606,0.0133713930817544,6.31894238453015e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37039,0.0109605875080393,0.00274854705165995,0.00557343528678585,0.0163477397292928,6.70558848137948e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37017,0.0221281639016836,0.00555581357753484,0.0112387692897153,0.0330175585136519,6.84502838129279e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37131,0.0234897204190139,0.00591165225196512,0.0119028820051623,0.0350765588328655,7.12103155837412e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37384,0.0388053632624273,0.00977068845833108,0.0196548138840984,0.0579559126407562,7.17583323604999e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37378,0.0374352684355817,0.00942584023075618,0.0189606215832996,0.0559099152878638,7.17742118197557e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39473,0.0261705311267348,0.00659079795351494,0.0132525671378455,0.0390884951156241,7.19623547073883e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40054,0.0107415817532992,0.00270995888214262,0.0054300623442997,0.0160531011622988,7.41002411363883e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39485,0.0262558143048509,0.0066282104967903,0.0132645217311419,0.0392471068785598,7.48980459802147e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37364,0.0116350015848184,0.0029376201801466,0.00587726603173106,0.0173927371379057,7.51173026803723e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37052,0.0137495943216769,0.00347175973828078,0.0069449452346466,0.0205542434087072,7.52140866738287e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37433,0.0230894550207983,0.00583540271229441,0.0116520657047013,0.0345268443368954,7.63506434834207e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39927,0.00941768241093975,0.00238054175129116,0.00475182057840907,0.0140835442434704,7.65076168993277e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,39858,-0.0126058572674993,0.00318727949206695,-0.0188529250719505,-0.00635878946304811,7.68476007582889e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37039,0.0111625762682497,0.00282592250273952,0.00562376816288026,0.0167013843736192,7.85369715006594e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37386,0.0390368339238533,0.00989886728108064,0.0196350540529352,0.0584386137947713,8.06837321497263e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40005,0.00893954058449333,0.00226773441243565,0.00449478113611947,0.0133843000328672,8.11260841039347e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,39881,0.0115751258571459,0.00293679070288755,0.00581901607948631,0.0173312356348055,8.13446178835736e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39858,0.0105874556493783,0.00268787509253064,0.00531922046801822,0.0158556908307383,8.21798403345947e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36842,0.0117155384715895,0.00297560361172603,0.00588335539260649,0.0175477215505725,8.2869286487487e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39583,0.0240091439194953,0.00610960574149338,0.0120343166661683,0.0359839711728223,8.54026998061731e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39967,-0.00814905782514841,0.00207523864967031,-0.0122165255785022,-0.00408159007179461,8.64402007476621e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37035,0.0114389127270665,0.00291450210126687,0.00572648860858346,0.0171513368455496,8.72338126435856e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39716,-0.0163058233753083,0.0041558354355966,-0.0244512608290776,-0.00816038592153894,8.76045961562922e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37381,0.0342668716518007,0.0087355815089296,0.0171451318942987,0.0513886114093027,8.80031204488657e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39745,0.0167428950313297,0.00427050674662957,0.00837270180793577,0.0251130882547237,8.87042226889311e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40005,0.00948855352526631,0.00242353696243972,0.00473842107888446,0.0142386859716482,9.07126139028735e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37039,0.0166481232659126,0.00425212253228034,0.00831396310264317,0.0249822834291821,9.07653080554414e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37384,0.0232929094940653,0.00595483692873376,0.0116214291137472,0.0349643898743835,9.21369584294992e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37408,0.0232604431711888,0.00595176999532126,0.0115949739803592,0.0349259123620185,9.34558488400612e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,39611,0.0264505271477282,0.00677524184274824,0.0131710531359417,0.0397300011595148,9.50109891176222e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37120,0.0267713570155139,0.00686515520181218,0.013315652819962,0.0402270612110658,9.68268382042101e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37364,0.0179761157485015,0.00461584088463414,0.0089290676146186,0.0270231638823844,9.88998529213714e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37433,0.0172469532069319,0.00443339899086595,0.00855749118483459,0.0259364152290291,0.000100626104803384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37408,0.0242506157438472,0.00623376755113872,0.0120324313436153,0.0364688001440791,0.000100639607341913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,39745,0.0124088665005547,0.00319027211615903,0.00615593315288299,0.0186617998482264,0.000100820732469357
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39485,0.020439644994041,0.00525595800200511,0.010137967310111,0.030741322677971,0.000101136207861785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37017,0.021933371919987,0.00564244824974349,0.0108741733504897,0.0329925704894842,0.000101901483367234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37384,0.0114911006429175,0.00295715045973144,0.00569508574184383,0.0172871155439911,0.000102450574563379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37052,0.013280733833529,0.00341856941719079,0.00658033777583508,0.019981129891223,0.000102880305871547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37017,0.0138138000908792,0.00355722297768113,0.00684164305462422,0.0207859571271343,0.000103547899763325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37039,0.0257231901888001,0.00663594007637035,0.0127167476391142,0.038729632738486,0.000106551674586233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37408,0.0219701528404505,0.00567876740045862,0.0108397687355516,0.0331005369453494,0.000109873501246924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39854,0.00999989807366904,0.00258864952710849,0.0049261450005364,0.0150736511468017,0.000112454382426831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39862,0.0291797379289253,0.00755606951234823,0.0143698416847228,0.0439896341731278,0.0001130155352392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37364,0.0124974036247551,0.00324215129803256,0.00614278708061124,0.0188520201688989,0.000116425613499325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37433,0.0186501685956152,0.00483863403286261,0.00916644589120446,0.0281338913000259,0.000116534862299453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39485,0.0105740866846677,0.00274520227463406,0.00519349022638493,0.0159546831429504,0.000117700435498174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37384,0.0213468956819519,0.00554724124500271,0.0104743028417466,0.0322194885221572,0.000119535690332221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37378,0.00868466973291661,0.00225728207963624,0.00426039685682958,0.0131089426090036,0.00011992596820237
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39449,0.0230600864700347,0.00599553243232718,0.0113088429026734,0.0348113300373959,0.000120435513399886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39822,0.0172900606226537,0.00449868286122731,0.0084726422146482,0.0261074790306593,0.000121831234753166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37441,0.0137185694683255,0.00357050869655435,0.00672037242307898,0.020716766513572,0.000122496741118938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40048,0.0193910890366571,0.00504818319013494,0.0094966499839926,0.0292855280893216,0.000122900377344204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37384,0.0306223620399645,0.00797990820785328,0.0149817419525721,0.046262982127357,0.000124892695231753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39449,0.0156369999956693,0.00407769022583176,0.00764472715303907,0.0236292728382996,0.000126176893377139
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37344,0.0152359853978026,0.00397535405704577,0.00744429144599285,0.0230276793496123,0.000127366062968604
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39854,0.0182250886739305,0.00475730085771204,0.00890077899281493,0.0275493983550461,0.000128125442488851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39877,0.0170412996519504,0.00445689931651725,0.0083057769915766,0.0257768223123242,0.00013202741961912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40038,0.0112011656020386,0.00292992534478183,0.00545851192626625,0.016943819277811,0.000132320682954416
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37165,-0.0149712852635446,0.0039216846182343,-0.0226577871152838,-0.00728478341180532,0.000135386406116337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39854,0.0192642383893497,0.00505640754527838,0.00935367960060406,0.0291747971780953,0.000139562049875444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37433,-0.0134988923515642,0.00354361294977383,-0.0204443737331209,-0.00655341097000745,0.000139941944977275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39473,0.0162495112442467,0.00426635652904721,0.00788745244731415,0.0246115700411792,0.000140202465530686
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37329,0.0166523599785179,0.00437750362244506,0.00807245287852558,0.0252322670785102,0.000142962988919129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37052,0.0153849812999092,0.00405717187930912,0.00743292441646336,0.0233370381833551,0.000150077515995291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40007,0.0182850775600582,0.00483048038363917,0.00881733600812545,0.027752819111991,0.000154045225824352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37408,0.0130488844902629,0.00345301269577572,0.00628097960654245,0.0198167893739833,0.000158143406963269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37378,0.0286461271117268,0.00758156901423641,0.0137862518438234,0.0435060023796302,0.000158522785669224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,37384,-0.0396297569168682,0.0105079930933546,-0.0602254233798433,-0.0190340904538931,0.000163031259245465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,39904,0.0298314220921619,0.00791540840022319,0.0143172216277244,0.0453456225565994,0.000164635713386087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37384,0.0328382615403467,0.00871344541408754,0.0157599085287351,0.0499166145519583,0.000164804758992819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37378,0.0203349750820165,0.00540001347407743,0.00975094867282475,0.0309190014912083,0.000166769119061899
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39858,0.0175832017148512,0.00467772432028611,0.00841486204709043,0.026751541382612,0.000171253695294803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37039,0.0147128897900943,0.00392572699067124,0.00701846488837862,0.0224073146918099,0.000179144966103376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40048,-0.0083959225329216,0.00224110385068031,-0.012788486080255,-0.00400335898558819,0.000180060619226412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40005,-0.00720472658647905,0.00192810072983606,-0.0109838040169577,-0.00342564915600038,0.000187096462499565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,39817,0.0229410853707377,0.00614410572180786,0.0108986381559943,0.0349835325854811,0.000189240618923397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39909,-0.00966824480454548,0.00259094219236256,-0.0147464915015761,-0.00458999810751486,0.000190957240919112
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40048,0.014320236199323,0.00383878549400496,0.00679621663107327,0.0218442557675727,0.000191822730939601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37017,0.012791010071467,0.00342879162331085,0.00607057848977771,0.0195114416531562,0.000191924875728698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37408,0.0210578302324802,0.00564493277704543,0.00999376198947112,0.0321218984754892,0.000191959858710394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37039,0.0175940986421785,0.00471838392531181,0.00834606614856735,0.0268421311357897,0.00019316904238523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39411,0.0102136936910545,0.00274016690609743,0.00484296655510356,0.0155844208270055,0.000194152181693511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37408,0.0228141260027443,0.00613495136099601,0.0107896213351922,0.0348386306702965,0.000201047671289674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37384,0.00734823975453578,0.00198331897000757,0.00346093457332095,0.0112355449357506,0.000212214919201756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,39485,0.0173105225576451,0.00468549387783727,0.00812695455708405,0.0264940905582061,0.000221077953578125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40026,-0.0127327577246749,0.00344826589565306,-0.0194913588801549,-0.00597415656919492,0.000222781938841332
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39473,0.0149763446388503,0.00405665004567273,0.00702531054933177,0.0229273787283689,0.000223429845954208
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37376,0.0105670381544212,0.00286344938943761,0.00495467735112346,0.0161793989577189,0.000224853839084754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37441,0.0241666491926035,0.00655375583052627,0.011321287764772,0.0370120106204349,0.000227395146013605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37408,0.0222673713670462,0.00603909523765805,0.0104307447012364,0.0341039980328559,0.000227617949901276
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,39864,0.0143356560122004,0.00389034498567239,0.00671057984028256,0.0219607321841183,0.00022951843598085
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,39583,0.0159093632424666,0.00431939863469691,0.00744334191846064,0.0243753845664725,0.000231063901562655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37165,0.0224227129848253,0.00608837572619513,0.0104894965614828,0.0343559294081677,0.000231533583935288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,39581,0.0192997953048107,0.00524630652603144,0.00901703451378903,0.0295825560958323,0.000235171570713759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37384,0.02895588453503,0.0078713827190882,0.0135279744056171,0.0443837946644429,0.000235402110417117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40010,0.0312129762832767,0.00849618986043159,0.0145604441568307,0.0478655084097226,0.00023977806772104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37120,-0.0131580221776832,0.00358315456385775,-0.0201810051228443,-0.00613503923252197,0.000241426544822068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37250,0.00850146986977159,0.00231520020444781,0.00396367746905389,0.0130392622704893,0.00024157387472373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39927,0.0136562498453122,0.00372219956651878,0.00636073869493539,0.020951760995689,0.000244416544197712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37376,0.0154846846426474,0.00422746050660764,0.00719886204969642,0.0237705072355984,0.000250346956611685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37433,0.0139497128563454,0.00380915849978536,0.00648376219676604,0.0214156635159247,0.00025105705452378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,39583,0.00933196241572689,0.00254838169443376,0.00433713429463673,0.0143267905368171,0.000251155849532928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37052,0.0265967767783503,0.00726413201651871,0.0123590780259737,0.040834475530727,0.000251836585062165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37017,0.0235509640495759,0.00643434341512935,0.0109396509559223,0.0361622771432294,0.000253007603086334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39745,0.0163602081058606,0.00447139976383509,0.00759626456874382,0.0251241516429774,0.00025416332787261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,39878,0.0305474681356934,0.00835413253890411,0.0141733683594413,0.0469215679119455,0.000256431198988599
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37408,0.0143349445718628,0.00392068560621709,0.00665040078367733,0.0220194883600483,0.0002569161952884
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,39862,0.0315507327939706,0.00863463432271229,0.0146268495214545,0.0484746160664866,0.000259037261878915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,39784,0.022808526674093,0.00624231079099426,0.0105735975237442,0.0350434558244418,0.000259157209372386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37052,0.0158189350908317,0.00433509538994709,0.0073221481265354,0.024315722055128,0.000264237961408403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37378,-0.0375167700545433,0.010298645456605,-0.057702115149489,-0.0173314249595976,0.000270609017495702
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37017,0.0139639163574799,0.00384198556040827,0.00643362465907966,0.0214942080558801,0.000279519652533085
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,37449,0.00847557023176023,0.00233675999979386,0.00389552063216426,0.0130556198313562,0.000287715528250262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37017,0.0154695669881387,0.00426515147053769,0.00710987010588482,0.0238292638703926,0.000287853389227811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37378,0.0354268791917678,0.0097983016656593,0.0162222079270756,0.05463155045646,0.000300726086670247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39485,0.0277954586131344,0.00768801300566146,0.0127269531220379,0.0428639641042308,0.000300794830967797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,39583,0.0146661939767399,0.00406019572334227,0.00670821035898908,0.0226241775944908,0.000304569154895251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39485,0.0122816105039074,0.00340216478559779,0.00561336752413571,0.0189498534836791,0.00030722583144229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39945,0.0066047717965085,0.00183011813507661,0.00301774025175834,0.0101918033412587,0.000308393380119193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,40036,0.00635064138286511,0.00176077822231351,0.00289951606713064,0.00980176669859958,0.00031102062993611
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37408,0.013664278192517,0.00379631944204859,0.00622349208610175,0.0211050642989322,0.000320153255678266
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39864,0.0207192741484393,0.00575732897663266,0.00943490935423929,0.0320036389426393,0.000320696949816688
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37408,0.0154783184912756,0.00430753660735092,0.00703554674086778,0.0239210902416834,0.000327660282055513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37364,-0.0212523111289743,0.00592064228002384,-0.032856769997821,-0.00964785226012758,0.000332451123253308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39864,0.0236412631969572,0.00658761707013141,0.0107295337394996,0.0365529926544148,0.00033326895283298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37165,0.0345743796148781,0.00963618683862717,0.0156874534111689,0.0534613058185874,0.000334455213734274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,39583,-0.00964043585446885,0.00268802950023598,-0.0149089736749314,-0.00437189803400632,0.000336249796110027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,39927,0.0147099977814003,0.00410742417704598,0.0066594463943902,0.0227605491684104,0.000342872698453265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39473,-0.0170069295763052,0.00475524266327065,-0.0263272051963157,-0.00768665395629473,0.000349332902352167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39784,0.0174519275985976,0.00488020525176083,0.00788672530514633,0.0270171298920488,0.000349839247634693
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39745,0.0102299189180533,0.00286709029148666,0.00461042194673943,0.0158494158893671,0.000360708241471888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,39951,0.0110976486139846,0.00311597352120571,0.00499034051242137,0.0172049567155478,0.000369757541421278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39705,-0.00889215384362716,0.00249932382105199,-0.0137908285328891,-0.00399347915436526,0.000375032154514303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39581,0.0102734172483891,0.00289312085425733,0.0046029003740447,0.0159439341227334,0.000384919817864068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37017,0.02160557561404,0.00609865015420239,0.00965222131180337,0.0335589299162767,0.000397452044390457
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36958,0.0181616582589936,0.00513725617139998,0.00809263616304959,0.0282306803549375,0.000408743224390653
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37039,-0.00770415708195575,0.0021839682754976,-0.0119847349019311,-0.00342357926198045,0.000420778777823464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40026,0.0172551339746218,0.00489351951552317,0.00766383572419643,0.0268464322250472,0.000422864311550953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37165,0.0236210411905792,0.00670951827351091,0.0104703853744978,0.0367716970066606,0.000432130380219705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37441,0.00721465902544197,0.00204978674756609,0.00319707700021244,0.0112322410506715,0.000433429897824404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39784,0.0190705925824614,0.00543033733336698,0.00842713140906208,0.0297140537558606,0.000446211717438719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39784,0.0121756332985397,0.00347305634963539,0.00536844285325437,0.0189828237438251,0.000456591791832398
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,37449,0.00650649150005227,0.00185662447706414,0.00286750752500655,0.010145475475098,0.00045898369472552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39745,0.0109625778827845,0.00313337076700693,0.00482117117945096,0.0171039845861181,0.000468893830944275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39862,0.0246545785577348,0.00705240770239421,0.0108318594610422,0.0384772976544275,0.000473728646047667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37052,0.0109834529986054,0.00314272867474041,0.00482370479611416,0.0171432012010966,0.000475835419968802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,39767,0.0177520234777577,0.00508263497718082,0.00779005892248331,0.0277139880330321,0.000479495522527535
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40026,0.0112290615859192,0.00321628423264303,0.00492514448993881,0.0175329786818995,0.000481931382076922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37384,0.015272404741971,0.00437614519673385,0.00669516015637268,0.0238496493275694,0.000484700584945505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39485,0.0204597764882613,0.00586341076783469,0.00896749138330529,0.0319520615932173,0.000485442485643509
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39473,0.0200967099419551,0.00578574344449951,0.00875665279073601,0.0314367670931741,0.000515132809069569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39751,0.00728341695481752,0.00209787584353045,0.00317158030149785,0.0113952536081372,0.000518344737237018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39909,0.0261300454461996,0.00752671108962305,0.0113776917105384,0.0408823991818607,0.000518647003669394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,39795,0.0111317448264585,0.00320936681023271,0.00484138587840241,0.0174221037745146,0.000524720753288314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39813,0.0124398419153908,0.00358685783949237,0.00540960054998576,0.0194700832807959,0.000525392639154465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37017,0.0102731942639752,0.00296332392369093,0.00446507937354093,0.0160813091544094,0.000528413484136223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36987,0.0175910156406924,0.00508294884657428,0.0076284359014068,0.027553595379978,0.000540306747779738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,39687,-0.0149048831310294,0.00431606582580735,-0.0233643721496118,-0.00644539411244694,0.000555119938260156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37052,0.00913090494943945,0.00264407941299225,0.00394850929997465,0.0143133005989043,0.000555428985478643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,39745,0.0110317480401488,0.00319513256774368,0.00476928820737123,0.0172942078729265,0.000556507123287251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37433,0.0235723135054841,0.00683885057439414,0.0101681663796716,0.0369764606312966,0.000568936644750618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39862,0.0323857387284237,0.00940213339171078,0.0139575572806706,0.0508139201761768,0.000573562556169012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37039,0.0217304432566485,0.00631689809945929,0.00934932298170827,0.0341115635315887,0.000583408928430355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37378,0.00794098345096046,0.00230856381223074,0.00341619837898821,0.0124657685229327,0.00058391503029465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37017,0.00861219977532262,0.0025040590086404,0.00370424411838744,0.0135201554322578,0.000585037540762556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39784,0.00959251157652891,0.00279023124370955,0.00412365833885818,0.0150613648141996,0.000587762231330298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,39581,0.0187829500132725,0.0054644542075556,0.00807261976646353,0.0294932802600815,0.000589072631894541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37353,0.0112319631715229,0.00327342263765518,0.00481605480171874,0.0176478715413271,0.000602585467438432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37165,0.0223038252559259,0.00650937127374786,0.0095454575593801,0.0350621929524717,0.00061344786213683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37052,0.0106105545835565,0.00309738559928229,0.00453967880896323,0.0166814303581498,0.00061520184468849
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37052,0.0200193467583648,0.00584737031337606,0.00855850094414777,0.0314801925725819,0.000619740624685109
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37441,0.0443724968784383,0.0129773747540582,0.0189368423604842,0.0698081513963924,0.000629855106565133
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39927,-0.0101205241918823,0.00296130054532114,-0.0159246732607117,-0.00431637512305283,0.000633337984793811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39311,0.0078509902030288,0.00230254042041731,0.00333801097901087,0.0123639694270467,0.000651987140573701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37017,0.00800409466748192,0.00234794697683135,0.00340211859289247,0.0126060707420714,0.000654028327537502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39864,0.00976912425660196,0.00287218102156013,0.0041396494543441,0.0153985990588598,0.000672323020335825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40026,0.0115425743658419,0.00339370494027982,0.00489091268289346,0.0181942360487904,0.00067259969006673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37433,0.0132046596683043,0.00388277729453112,0.00559441617102327,0.0208149031655853,0.000673755666195399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39581,-0.00941999436843238,0.00277514501516926,-0.0148592785981641,-0.00398071013870062,0.000689452387466573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37017,-0.0158218680940136,0.00466682346825557,-0.0249688420917945,-0.00667489409623266,0.000700248323766876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,39590,0.0162146749205491,0.0047850600411235,0.00683595723994702,0.0255933926011511,0.000704216510824896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39784,0.0243828463799781,0.00720225394665713,0.0102664286445302,0.0384992641154261,0.000712341383639712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39210,-0.0115689500231736,0.00341855211864006,-0.0182693121757082,-0.00486858787063913,0.000715732744245395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37052,0.0061617693770982,0.0018209443004168,0.00259271854828128,0.00973082020591512,0.000716897959276134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37035,0.0209355219582738,0.00618829881794802,0.0088064562750957,0.0330645876414519,0.000718859476587783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37364,-0.0121487050371872,0.00359469450679821,-0.0191943062705117,-0.00510310380386271,0.000727912618683783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39709,0.0071891821583985,0.0021291557722712,0.00301603684474694,0.0113623274720501,0.000735797516898738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39473,0.0179995343054464,0.00533189459335034,0.00754902090247973,0.0284500477084131,0.000737745178491715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39473,0.00917053583224658,0.00271775660062103,0.00384373289502937,0.0144973387694638,0.000741827625626253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37364,0.00886777625917626,0.00262860079470352,0.00371571870155736,0.0140198338167952,0.000744079975277348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37384,0.0416970739899826,0.0124201552802228,0.0173535696407459,0.0660405783392193,0.000789502342631654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37165,0.0203667790339001,0.0060708258774439,0.00846796031411002,0.0322655977536901,0.000796267036489749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37433,0.00887487034653706,0.00264614695020617,0.00368842232413297,0.0140613183689411,0.000799037911241892
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37364,0.0103621480195161,0.00309073164358514,0.0043043139980892,0.016419982040943,0.000802611101127723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,39656,0.0114403627658955,0.00341294125628909,0.00475099790356891,0.0181297276282221,0.000804026498371093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37408,0.0111484292308288,0.00332842852759074,0.00462470931675093,0.0176721491449066,0.000811909497507049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37052,0.00894914317735357,0.00267527979181336,0.0037055947853994,0.0141926915693078,0.000824750826164682
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39805,-0.0198661756242521,0.00593984873330535,-0.0315082791415305,-0.00822407210697357,0.00082603436901069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39581,0.00971323438128436,0.00290481297346159,0.00401980095329964,0.0154066678092691,0.000828199550712798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39473,0.0267955186960527,0.0080145057796311,0.0110870873679757,0.0425039500241296,0.00082959819975965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,39745,0.0127010426975811,0.00380295634510744,0.00524724826117049,0.0201548371339917,0.0008403736809249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39904,0.00869645517042599,0.00260519668933689,0.00359026965932569,0.0138026406815263,0.000845396541869713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37017,0.0203037652709936,0.00608378212199455,0.00837955231188426,0.0322279782301029,0.000848130656124809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,36958,0.017058012090673,0.00511290834574039,0.0070367117330218,0.0270793124483241,0.000851486386367392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,39945,0.00836605980692249,0.00250871517742141,0.00344897805917654,0.0132831415546684,0.000855541760513966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,39784,-0.00963379376150551,0.00288938888712159,-0.0152969959802638,-0.00397059154274719,0.000857410477252145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39745,-0.0333301738011349,0.00999738998648892,-0.0529250581746532,-0.0137352894276166,0.000858371239350765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40026,0.0116312198757869,0.00349462503982161,0.00478175479773653,0.0184806849538372,0.000875675047418293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37408,0.0202356830635388,0.00608858585294542,0.00830205479176579,0.0321693113353118,0.000891170080414729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39909,-0.013667413472501,0.00411421329586036,-0.0217312715323873,-0.00560355541261472,0.000895745656217173
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39581,0.0111293040725667,0.00335260325845431,0.00455820168599627,0.0177004064591372,0.00090351298755452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,39854,0.0124540643904265,0.00375249843209608,0.00509916746351817,0.0198089613173348,0.000905835083867935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37408,0.00878292663773625,0.00264675604376864,0.00359528479194972,0.0139705684835228,0.00090781773678988
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37035,0.0136464413136272,0.00412014975807303,0.0055709477878041,0.0217219348394504,0.000928401444981126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37052,0.0350887512480214,0.0106253527982625,0.0142630597634269,0.0559144427326159,0.000961294760939533
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37408,0.0144217033243401,0.00436770391149348,0.00586100365781288,0.0229824029908673,0.000962822091183247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37039,-0.00531340842304167,0.0016094032541939,-0.00846783880126172,-0.00215897804482163,0.000964327973853656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37378,0.0202273363463254,0.00614878836207676,0.00817571115665495,0.0322789615359958,0.00100570113893728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,39854,0.0159091101966383,0.0048377970096928,0.00642702805764042,0.0253911923356362,0.00100939126192167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37408,0.00832250957517361,0.00253178309680086,0.00336021470544392,0.0132848044449033,0.00101441894707044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,39858,0.00660470676850165,0.00200933556721833,0.00266640905675371,0.0105430044802496,0.0010147528418544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39473,0.0176079074875463,0.00536189801415124,0.00709858737980981,0.0281172275952827,0.00102608477622173
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40008,0.0133764622707697,0.00407441731196092,0.00539060433932626,0.0213623202022131,0.00102913460219424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40008,-0.0184587701704677,0.00562270884235342,-0.0294792795014804,-0.007438260839455,0.00102964749002985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39862,0.0164282553872408,0.00500689536761975,0.00661474046670613,0.0262417703077756,0.00103614725226551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37408,0.0112386025435746,0.00342878977767722,0.0045181745793272,0.0179590305078219,0.00104913763597336
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,39864,-0.00916450493692149,0.00280022851396288,-0.0146529528242887,-0.00367605704955425,0.00106724675369387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37433,0.0190870099499708,0.00583332600202232,0.00765369098600703,0.0305203289139345,0.00107032425412017
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37376,0.00754968083561934,0.00230743113317179,0.00302711581460263,0.0120722458566361,0.00107095719009987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,39927,0.0151799576605669,0.00465058606222867,0.00606480897859867,0.0242951063425351,0.00110043657771536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39449,0.0123726485165412,0.0037907429823516,0.00494279227113206,0.0198025047619503,0.0011012230992945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39927,0.00595643264900217,0.00182885342428288,0.00237187993740772,0.00954098536059661,0.00112860982563137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39460,0.0173914409760203,0.00534275620290946,0.00691963881831773,0.0278632431337228,0.00113576429885664
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40030,0.0164077276049768,0.00504638074678661,0.00651682134127503,0.0262986338686786,0.00115079284801827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37039,0.0171949567551849,0.00528969968289838,0.00682714537670409,0.0275627681336657,0.00115430977685911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40020,0.0202298089352395,0.00622548710273739,0.00802785421387419,0.0324317636566048,0.00115838624102348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,39862,0.0195990645689526,0.00603337544918319,0.00777364868855354,0.0314244804493516,0.00116278519350601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39854,0.0103897483607908,0.00321370575235751,0.00409088508617009,0.0166886116354115,0.00122767563449784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39583,0.0152513052941845,0.00472429791719041,0.00599168137649132,0.0245109292118777,0.00124797149338893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39244,0.00860600665308618,0.00266882954873069,0.00337510073757403,0.0138369125685983,0.00126395757496274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,39542,0.0211419822697771,0.00655870172713047,0.00828692688460136,0.0339970376549528,0.00126892784314601
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37027,0.00815664173402575,0.00253038642462645,0.0031970843417579,0.0131161991262936,0.00126953085612981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,39790,0.024568960504212,0.00764687738334045,0.00958108083286467,0.0395568401755593,0.00131644915489665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,39852,0.0179793488792292,0.00559704649689245,0.00700913774531995,0.0289495600131384,0.00131941063429362
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40005,0.0136833820928585,0.00426131772647572,0.00533119934896607,0.0220355648367509,0.00132501483916443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37096,-0.0165234854126403,0.00514604074055389,-0.026609725264126,-0.00643724556115473,0.0013263035193835
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,39854,0.0130684817570367,0.0040708184201393,0.00508967765356371,0.0210472858605098,0.00132865945187847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,39745,0.00970648148969686,0.00302403291273053,0.00377937698074502,0.0156335859986487,0.00133100424384676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37384,0.0136542326034856,0.00425999097216502,0.00530465029804212,0.022003814908929,0.00135270024506909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37052,0.0129098026597954,0.00402839956542476,0.00501413951156284,0.0208054658080279,0.00135526128363603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37364,0.0165215185586711,0.00516157142502929,0.00640483856561366,0.0266381985517285,0.00137330459545251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,37433,-0.0106393104264316,0.00332456241072487,-0.0171554527514523,-0.00412316810141083,0.00137641631314122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39745,-0.00663706799325465,0.00207778054950423,-0.0107095178702829,-0.00256461811622636,0.00140440842743436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37408,-0.0073116491732934,0.00228996856542759,-0.0117999875615315,-0.00282331078505532,0.00141171817255005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,39721,0.0142011554009151,0.00445524935954672,0.00546886665620355,0.0229334441456267,0.00143781492831557
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39417,0.0133222880551761,0.00418730845154852,0.00511516349014105,0.0215294126202112,0.00146758013102132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37418,0.00701259741797633,0.00220466250351349,0.00269145891108989,0.0113337359248628,0.00147198157764591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39473,0.0157189990805827,0.00495329879382469,0.00601053344468631,0.0254274647164791,0.001509358530391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37120,0.024390118387215,0.00768656371337196,0.00932445350900595,0.039455783265424,0.00151172700336874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37408,0.0159246989395336,0.00501877460574313,0.00608790071227708,0.0257614971667901,0.00151196317028922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39347,-0.0244970466836413,0.00773239283380339,-0.0396525366378959,-0.00934155672938665,0.00153733186653092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,39909,-0.0108959251094154,0.00343977086936072,-0.0176378760133624,-0.0041539742054684,0.00153974346754151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37364,-0.0230811217668917,0.0072900497462903,-0.0373696192696207,-0.00879262426416275,0.00154834150281808
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40048,0.0209216063384183,0.00661537952093109,0.0079554624773934,0.0338877501994433,0.00156671450957217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37039,0.00925198699967348,0.00292908337171231,0.00351098359111735,0.0149929904082296,0.00158852596774301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39805,0.00988860902093601,0.0031315466372651,0.00375077761189642,0.0160264404299756,0.00159293880025642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37017,0.0228674310316837,0.00724356191253237,0.00867004968312021,0.0370648123802471,0.00159798529772855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39473,0.0175349495394552,0.0055559303075932,0.00664532613657258,0.0284245729423379,0.00160209925300717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39784,0.00595902171615306,0.00188821424305519,0.00225812179976489,0.00965992163254124,0.00160299877597171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37433,-0.013286607568297,0.00421509479326244,-0.0215481933630914,-0.00502502177350264,0.00162426109445572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,39864,0.019900013712504,0.00631367088006975,0.00752521878756731,0.0322748086374407,0.00162515057750959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37364,0.0307629419131513,0.00977378796802234,0.0116063174958275,0.0499195663304751,0.00165034518298154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37364,0.028386156433802,0.00902195660256202,0.0107031214927805,0.0460691913748236,0.00165685977562029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39862,0.0133203289167969,0.00423390815872629,0.00502186892569341,0.0216187889079005,0.00165762551573144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37052,0.0120620370541254,0.00383846491614151,0.00453864581848804,0.0195854282897628,0.00167933139136618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39862,0.0301989779200882,0.00962045858365114,0.0113428790961319,0.0490550767440444,0.00169811947887254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37378,0.0143665856609646,0.00457891786077734,0.00539190665384099,0.0233412646680882,0.0017073187911991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40048,-0.00896957553341854,0.00286188315991165,-0.0145788665268454,-0.0033602845399917,0.00172659677591443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,37449,0.011734094333235,0.00374926967487598,0.0043855257704781,0.0190826628959919,0.00175354546138988
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37384,0.0185029922047393,0.00592883078808393,0.00688248386009481,0.0301235005493838,0.00180709414486665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,36987,0.0111606533009938,0.00357629566924208,0.00415111378927928,0.0181701928127082,0.00180794546555848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39668,0.0332898004544677,0.0106701141801625,0.0123763766613492,0.0542032242475861,0.00181231462728564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39485,0.0188733797691114,0.00605821357051629,0.00699928117089952,0.0307474783673234,0.0018406715103639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37052,0.0155636916937786,0.00501133793150453,0.00574146934802973,0.0253859140395275,0.0019023425150678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39473,0.0110792051588635,0.00357163545149284,0.00407879967393757,0.0180796106437895,0.00192562180539961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37384,0.00804200669739047,0.00259725497897502,0.00295138693859943,0.0131326264561815,0.00196320584477813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39473,0.0085545485091037,0.0027662843612651,0.0031326311610241,0.0139764658571833,0.00198873189260531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37039,0.00821847766116104,0.00265817210794296,0.00300846032959283,0.0134284949927293,0.00199376972411826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37408,-0.012516414258615,0.00405013741129403,-0.0204546835847513,-0.00457814493247871,0.00200313990702115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37052,0.0121030724460118,0.00392014749455884,0.00441958335667651,0.0197865615353471,0.0020233297956136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37384,0.00869323314977016,0.00281871044105472,0.00316856068530292,0.0142179056142374,0.00204568699055722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,39583,0.0221102921286478,0.00717324237614147,0.0080507370714105,0.0361698471858851,0.00205743076126253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37120,0.0140295618071445,0.00456592836616013,0.00508034220947065,0.0229787814048184,0.00212587748909891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,39927,-0.00755134735962044,0.00245942253249582,-0.0123718155233122,-0.00273087919592864,0.00214147557106396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39340,-0.016621350865067,0.00541359248770278,-0.0272319921409644,-0.0060107095891695,0.00214214524257667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39864,0.00783011778459907,0.00255159635391591,0.00282898893092389,0.0128312466382742,0.00215342243236264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37245,0.0305411366159402,0.00997632656867121,0.0109875365413446,0.0500947366905358,0.00220770001100499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,39864,0.0175639346077965,0.00573893905362208,0.00631561406269721,0.0288122551528958,0.00221345011545218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37017,0.012852110353884,0.00420308675113311,0.00461406032166312,0.0210901603861049,0.00223431658741304
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37017,0.0165890641507106,0.00543557543235711,0.00593533630329063,0.0272427919981305,0.00227818889481862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,36987,0.0117651041088095,0.00385877378285556,0.00420190749441258,0.0193283007232064,0.00230120617195428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37408,-0.0123806365470808,0.00406731324994246,-0.020352570516968,-0.00440870257719355,0.00233953479326091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39583,0.0161087670943522,0.00529448007923018,0.00573158613906105,0.0264859480496433,0.00234962897417874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39999,0.0164387397538229,0.00542868560838465,0.005798515961389,0.0270789635462568,0.00246464722812814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37364,0.0313440884744985,0.0103553597773712,0.011047583310851,0.0516405936381461,0.00247584834680081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37039,0.0193695411865007,0.00640576648946099,0.0068142388671572,0.0319248435058443,0.00250129481094203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37052,0.0144911820988476,0.004815800338201,0.00505221343597366,0.0239301507617216,0.00262525271996716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37364,0.017437382460394,0.00580069516824695,0.00606801993063001,0.028806744990158,0.00265121408878576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39473,0.0149883055341042,0.00499123559234103,0.00520548377311576,0.0247711272950926,0.0026782182207665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39473,0.0145066439316044,0.00483454024026083,0.00503094506069313,0.0239823428025156,0.00269851260318293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,37248,0.0143440977556372,0.00478123445853101,0.00497287821691644,0.023715317294358,0.00270403208563262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37433,-0.00725424099720689,0.00241802091657723,-0.0119935619936983,-0.00251492000071553,0.00270404214581845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37018,0.0105484392312606,0.00351946196495343,0.00365029377995187,0.0174465846825693,0.00273003736043237
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39473,0.0264812190814916,0.0088482576192657,0.00913863414773082,0.0438238040152523,0.00276847421968783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39485,0.0105245905736023,0.00352316526099579,0.00361918666205052,0.017429994485154,0.00281932410962374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37364,0.0110564857993886,0.00370756473559538,0.00378965891762165,0.0183233126811555,0.0028674980273197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39888,-0.00951216192731586,0.00318983509626353,-0.0157642387159924,-0.00326008513863934,0.00286780937515168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37120,0.0058388852363534,0.00195846881347677,0.00200028636193892,0.00967748411076788,0.00287499741139016
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39784,0.0115699243910873,0.00388311811318405,0.00395901288924659,0.0191808358929281,0.00289112563529219
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37035,0.0133340501302732,0.00447597758547284,0.00456113406274648,0.0221069661978,0.00289694005871159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36938,0.00681726004346006,0.00228919367023628,0.00233044044979696,0.0113040796371232,0.00290650945148079
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,36958,0.0248324762338728,0.00834698031124775,0.00847239482382724,0.0411925576439184,0.00293499010954844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37364,0.0160022495111262,0.00540957170692643,0.00539948896555036,0.026605010056702,0.00310041822255749
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39909,-0.00637645267226001,0.00215798038659843,-0.0106060942299929,-0.00214681111452708,0.00313301595365541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37364,0.00977690337382123,0.0033105264665797,0.00328827149932502,0.0162655352483174,0.00314960840441784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37039,0.0107409744005978,0.00365187553855236,0.00358329834503517,0.0178986504561604,0.00327489377652014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37378,0.0223734374672408,0.00761070435871988,0.0074564569241498,0.0372904180103317,0.00329051318858902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,39854,-0.0083826272836079,0.00285489983520174,-0.0139782309606033,-0.00278702360661249,0.00332706763592165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37039,0.0136966605474589,0.00467518970512524,0.00453328872541344,0.0228600323695044,0.00339927862041444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,39583,0.0209605053396317,0.00717219884899933,0.00690299559559305,0.0350180150836704,0.00347766402590129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39909,0.00700514166610731,0.00239831794696366,0.00230443849005853,0.0117058448421561,0.00349557042445853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39754,0.0198132376619098,0.00678368559352589,0.00651721389859907,0.0331092614252205,0.00349715869366587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37253,0.0283472906918328,0.00971671250690858,0.00930253417829193,0.0473920472053736,0.00353577983233162
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39465,0.0155582234702053,0.00533938507235962,0.00509302872838046,0.0260234182120302,0.0035749613602062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,39583,0.0125235497375338,0.00429935505983582,0.00409681382025564,0.020950285654812,0.00358604294841131
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37017,-0.0155771210132493,0.00535143282441359,-0.0260659293490999,-0.00508831267739866,0.00361072664846509
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37120,-0.00838768347554218,0.00288523451253903,-0.0140427431201187,-0.00273262383096568,0.00365393560269032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37039,0.0132414796800167,0.004554971248504,0.00431373603294889,0.0221692233270846,0.0036547570957053
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,39583,0.0300632154235839,0.0103640388116528,0.00974969935274449,0.0503767314944234,0.00372817737367286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37378,-0.0254373669291611,0.00877145652014095,-0.0426294217086374,-0.00824531214968482,0.00373744298471505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,39714,0.0118875384357299,0.00410132526027608,0.00384894092558877,0.019926135945871,0.00375510869353657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40026,0.00867006065604144,0.00299513531587696,0.0027995954369226,0.0145405258751603,0.0038001166300768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39473,0.0133886030723005,0.00462566981584271,0.00432229023324877,0.0224549159113522,0.00380393096854305
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37017,0.0112168056046161,0.00387841224458342,0.00361511760523263,0.0188184936039996,0.00383287616352984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36958,0.0129592434581325,0.00448585884544536,0.00416696012105961,0.0217515267952054,0.00387213209164058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39927,0.00863679207952437,0.00299090263158056,0.00277462292162647,0.0144989612374223,0.00388603092224133
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,39583,0.0127706597313558,0.00442474344560311,0.00409816257797375,0.0214431568847379,0.00390464726683616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37039,0.0132731478320413,0.00460143991581982,0.00425432559703442,0.0222919700670481,0.00392591268118323
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39485,-0.0132356686948895,0.00459060853272172,-0.022233261419024,-0.00423807597075488,0.00394187383519513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37378,0.0112648253117624,0.00391352577434917,0.00359431479403801,0.0189353358294868,0.00400281543129059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37384,0.0201429082251229,0.00700065951749272,0.0064216155708372,0.0338642008794087,0.00401737939904465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,39581,0.0117282810417338,0.00407631732853663,0.00373869907780203,0.0197178630056656,0.00401792154583462
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37017,-0.0106180452417485,0.00369847393288495,-0.017867054150203,-0.00336903633329406,0.0040992423743445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37292,0.00715832395452822,0.00250110696569711,0.00225615430176187,0.0120604936072946,0.00421544633756682
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37364,0.00932415745727558,0.0032635838774832,0.00292753305740851,0.0157207818571427,0.00428278417660223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37017,0.0145568540068415,0.00510639082705192,0.0045483279858197,0.0245653800278632,0.00436891825090399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,36987,0.0136722689446362,0.00480302753916284,0.00425833496787701,0.0230862029213953,0.00442582150882954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39745,0.00750915921480719,0.00263912001494276,0.00233648398551939,0.012681834444095,0.00444226188683288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39434,0.011201970069155,0.00394157750455228,0.00347647816023254,0.0189274619780775,0.00448894982857892
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37017,0.00944385976881052,0.00332308249127087,0.00293061808591961,0.0159571014517014,0.00449148770994957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39745,-0.00925316015506885,0.00325848221482472,-0.0156397852961253,-0.00286653501401239,0.00452112366995986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,37165,0.0107225430788605,0.00378558795238637,0.00330279069218325,0.0181422954655378,0.00462601156190827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36987,0.0185816553278957,0.00657960559539145,0.00568562836092847,0.0314776822948629,0.00474807283563167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37433,0.0144702442191124,0.00512689119649962,0.00442153747397318,0.0245189509642517,0.00477319030759906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37039,0.0229578701215339,0.00814537499112298,0.00699293513893284,0.0389228051041349,0.00483180917877807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37035,0.025692407962541,0.00912026480225433,0.00781668895012253,0.0435681269749595,0.00485363384085669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39234,0.00784808025066751,0.00278784910686662,0.00238389600120895,0.0133122645001261,0.00488237301425674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37017,0.01124156264787,0.00399439683024645,0.00341254486058691,0.019070580435153,0.00489511391240855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37364,0.0106257297600206,0.00377635830951393,0.00322406747337324,0.0180273920466679,0.0049038006743646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39473,0.017956665520777,0.00642901924656565,0.00535578779750829,0.0305575432440456,0.00522748301376073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40054,0.00227757788288195,0.000815500189738749,0.000679197510994008,0.0038759582547699,0.00523055874121842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39473,0.014718383403459,0.00527979605449858,0.0043699831366418,0.0250667836702762,0.00531510756320851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39581,0.0365731112376502,0.0131200273154049,0.0108578576994566,0.0622883647758438,0.00531672627858234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,39581,0.0133074951138057,0.00477767216922828,0.00394325766211829,0.0226717325654931,0.00535337633873341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39583,0.00907690411456938,0.00326147213512879,0.00268441872971696,0.0154693894994218,0.00539114940616602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37165,0.0129430473304341,0.00465505089078299,0.00381914758449942,0.0220669470763688,0.00543630995939135
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39485,0.0129680432988098,0.00467736565546404,0.00380040661410026,0.0221356799835193,0.00556916799392061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37039,0.0143295309867341,0.00517723209919431,0.00418215607231323,0.0244769059011549,0.00565152429121198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37017,0.0168463134831931,0.00608668774352734,0.00491640550587952,0.0287762214605067,0.00565269557262924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37017,0.00993064569831791,0.00359665985879092,0.00288119237508772,0.0169800990215481,0.0057691374770542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37017,0.0110099247613005,0.00400601905560147,0.00315812741232162,0.0188617221102794,0.00599784754447464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39485,0.0161622092225528,0.00588573741321944,0.00462616389264265,0.0276982545524629,0.0060396584712258
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37378,0.0174679234609916,0.00637224173562962,0.00497832965915756,0.0299575172628257,0.00612858939737358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36927,0.019603488272016,0.00715947287954727,0.00557092142810339,0.0336360551159287,0.00618753914192709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37378,0.0104346414435567,0.00381454748945615,0.00295812836422261,0.0179111545228907,0.00623694698676878
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37433,-0.0145225930893586,0.00532531135277167,-0.0249602033407911,-0.00408498283792614,0.00639780718926098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37335,-0.0118880326849999,0.00436374870870295,-0.0204409801540577,-0.00333508521594212,0.00645267526023416
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,37449,0.0046613275808183,0.00171640943902244,0.00129716508033433,0.00802549008130228,0.00662107474824218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39784,0.024043404285141,0.00885389071365125,0.0066897784863846,0.0413970300838975,0.00662321443071354
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37338,0.023612697750505,0.00871877874865152,0.006523891403148,0.040701504097862,0.00677228858733542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39583,0.017376445359692,0.0064207943975108,0.00479168834057082,0.0299612023788132,0.00681157686958923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37433,0.0123916444896023,0.00458305392606199,0.00340885879452078,0.0213744301846838,0.00686376906799855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40048,0.00754720625876708,0.00279185519086105,0.00207517008467943,0.0130192424328547,0.00687275892055122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37364,0.0136146519845982,0.00504831829407486,0.00371994812821149,0.023509355840985,0.00700816893522128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39909,0.0241916952787276,0.00897265736042071,0.00660528685230296,0.0417781037051521,0.00702176974251779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39583,0.00885915034797051,0.00328977469526485,0.00241119194525141,0.0153071087506896,0.00709010908992302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37052,0.0111340065379879,0.00413504994891286,0.00302930863811866,0.0192387044378571,0.00709882939528959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37433,-0.0200241365074495,0.00745286862933535,-0.0346317590209468,-0.00541651399395225,0.00722346931590232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39581,0.0149256770242401,0.00556458581359449,0.00401908882959493,0.0258322652188853,0.00732025942206967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37267,0.0152891347137407,0.00571050488577083,0.00409654513762986,0.0264817242898515,0.00742929818596524
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39583,0.011056875130919,0.00413077473179808,0.00296055665659478,0.0191531936052433,0.00744266646521359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39473,0.00900861526613753,0.00336698993632605,0.00240931499093847,0.0156079155413366,0.00746802358159783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37165,0.00691441253876803,0.00258555090496663,0.00184673276503344,0.0119820923125026,0.00749878444474743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37408,-0.00852140086182229,0.00318654015155025,-0.0147670195588608,-0.00227578216478379,0.0075000783801708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37017,0.00861173316057942,0.00324317656617333,0.0022551070908797,0.0149683592302792,0.00793241876561295
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37052,0.0100683269682362,0.00379476958232422,0.00263057858688077,0.0175060753495917,0.00798253680923174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37408,0.00641583162230109,0.002420368498443,0.00167190936535282,0.0111597538792494,0.0080402724398239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40014,0.004986355609172,0.00188329572087042,0.00129509599626597,0.00867761522207803,0.00811260184045484
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39862,0.010473152851723,0.00395697145404296,0.00271748880179878,0.0182288169016472,0.00813466230514877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37039,-0.0142752790341469,0.00540341940181937,-0.0248659810617129,-0.00368457700658092,0.00825404192053242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,39864,0.0257982900187671,0.00978731484934969,0.0066151529140417,0.0449814271234925,0.00839977589944571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,39709,0.0145263893004651,0.00551275990887743,0.00372137987906531,0.0253313987218648,0.0084207129545602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,39745,0.0079082397863944,0.0030014653077164,0.00202536778327026,0.0137911117895185,0.00842703036877417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39473,0.0203337234306816,0.007729313774572,0.0051842684325205,0.0354831784288427,0.00852858142233839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37134,0.00501661976388078,0.0019106526887525,0.00127174049392589,0.00876149903383567,0.00865942629700311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39814,-0.0067437974229762,0.00256947811761952,-0.0117799745335105,-0.00170762031244193,0.00868389218297767
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37433,0.0250197135376462,0.00953395341826063,0.0063331648378554,0.0437062622374371,0.00869309209784143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39485,0.00911566802108861,0.00347427035628741,0.00230609812276528,0.0159252379194119,0.00870483529833856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37017,0.0167239220446185,0.00637517515641725,0.00422857873804066,0.0292192653511963,0.00871860138932965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39583,-0.00727829230987716,0.00277907248782429,-0.0127252743860128,-0.00183131023374155,0.00882817433569887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37384,0.00931963709083515,0.00356162496666329,0.00233885215617511,0.0163004220254952,0.00888879706873626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,39864,-0.00901621720883054,0.00344683770317064,-0.015772019107045,-0.00226041531061608,0.00891038173924714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39998,-0.0110868741611584,0.00424008532545509,-0.0193974413990504,-0.00277630692326639,0.00893689356515754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37408,0.014037628294102,0.00537021731813139,0.00351200235056449,0.0245632542376395,0.0089593867871492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39473,0.00958675380347946,0.00367679490156765,0.00238023579640687,0.0167932718105521,0.00913282846432605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39864,0.00821699856521649,0.0031543403220152,0.0020344915340667,0.0143995055963663,0.00919641660114772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40048,0.0164542663162562,0.00631736102006716,0.00407223871692453,0.0288362939155878,0.00920627537609377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37052,0.00986817156875253,0.0037917025985434,0.00243643447560747,0.0172999086618976,0.00926313960112366
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37364,0.00816156478423411,0.00313795889383038,0.00201116535232656,0.0143119642161417,0.00930768001462637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37433,0.0070318945863304,0.00270621090356849,0.00172772121533615,0.0123360679573246,0.0093752864559428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37364,0.0102731513346204,0.0039588671821136,0.00251377165767777,0.0180325310115631,0.00947007793887369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40005,0.00546317778768569,0.00210707673151309,0.00133330739392004,0.00959304818145134,0.0095290618864414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36834,0.00749509818227397,0.00289306484853969,0.00182469107913618,0.0131655052854118,0.00958847339613431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39909,-0.00811274902924134,0.00313375091417949,-0.0142549008210331,-0.00197059723744953,0.00963894405374691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39452,-0.0145760434939079,0.00563206484409056,-0.0256148905883254,-0.0035371963994904,0.00966115886322252
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37052,0.00949872291443282,0.0036816864706355,0.00228261743198723,0.0167148283968784,0.00989096313712092
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37120,0.00524515038452561,0.00203582464489321,0.00125493408053492,0.0092353666885163,0.00999348903927055
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39851,0.0182609848496619,0.00708829329363253,0.00436792999414213,0.0321540397051817,0.0099976686093465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,39864,0.0268553204710082,0.0104373287271431,0.00639815616580774,0.0473124847762087,0.0100908390521579
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40026,-0.0105879357681737,0.00411901958486655,-0.0186612141545122,-0.00251465738183531,0.0101640795459417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39485,0.0112412894911881,0.00437588987235321,0.00266454534137582,0.0198180336410004,0.0102109421715088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,39854,0.0208459572436451,0.00812060958752857,0.00492956245208906,0.036762352035201,0.0102659873151315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39581,0.0112033258141779,0.00437481704511898,0.00262868440574467,0.0197779672226111,0.0104503751087871
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39904,0.00617719763275618,0.00241685180782094,0.00144016808942713,0.0109142271760852,0.0106009148648469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37384,0.014552394175745,0.00571113569821756,0.00335856820723857,0.0257462201442514,0.0108429219848706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37406,0.0111330124218774,0.00437451743181536,0.00255895825551928,0.0197070665882355,0.0109397288411902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37052,0.0157131305366833,0.00618131353211398,0.00359775601373992,0.0278285050596267,0.0110321731653914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37408,-0.0117502303084541,0.00462623623776302,-0.0208176533344696,-0.00268280728243856,0.0110991278265876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39473,0.0125783594734811,0.00495611958995665,0.00286436507716606,0.0222923538697961,0.0111601834858852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37039,0.00639935358276398,0.00252560007314739,0.00144917743939508,0.0113495297261329,0.0112949482117524
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39862,0.00589618909776976,0.00232856497934791,0.00133220173824786,0.0104601764572917,0.0113472346933183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,39581,0.0123098506659413,0.00487182758643054,0.00276106859653741,0.0218586327353451,0.0115223362160666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39473,-0.00786751677316461,0.003117374617918,-0.0139775710242839,-0.00175746252204533,0.0116204324887999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37433,0.00738485042767038,0.00292845394883396,0.00164508068795582,0.0131246201673849,0.0116883690356298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39896,0.00711740710409697,0.00282264521750883,0.00158502247777965,0.0126497917304143,0.0116939142989004
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37035,0.00896948173781338,0.0035614241065436,0.00198909048898792,0.0159498729866388,0.0117970040900325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39485,0.0127281528901434,0.00505913857463232,0.00281224128386408,0.0226440644964228,0.0118837189968834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39797,-0.0425544154559691,0.0169353020968543,-0.0757476075658034,-0.00936122334613473,0.0119887379848832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39881,0.00756449947069771,0.00301432710103173,0.00165641835267551,0.0134725805887199,0.0120994874724437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37017,0.00941699463509772,0.00375410942272523,0.00205894016655627,0.0167750491036392,0.0121381554093593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39485,0.0112234946299896,0.00448541286925504,0.00243208540624975,0.0200149038537295,0.0123518191829197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39581,0.00979532763594261,0.00391735058424457,0.00211732049082326,0.017473334781062,0.0124119791417807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39449,0.0077990038720743,0.00312050025949814,0.00168282336345794,0.0139151843806907,0.0124547961530286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37039,-0.00586064279086889,0.00234587409110028,-0.0104585560094254,-0.00126272957231233,0.0124919556820844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37384,0.0100213297257648,0.00401789654646263,0.00214625249469807,0.0178964069568316,0.0126369383034457
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36987,-0.0098185281313607,0.00393684929023309,-0.0175347527402176,-0.00210230352250385,0.012643225105454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,36987,0.0251142456910055,0.0100918639052528,0.00533419243670995,0.044894298945301,0.0128383264833644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37035,-0.0116463900468245,0.00469435827482436,-0.0208473322654803,-0.00244544782816876,0.0131162715810237
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37035,0.00958265684577076,0.00386417122043216,0.00200888125372373,0.0171564324378178,0.0131552930631444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,39784,0.00942213581656529,0.00380180178089726,0.00197060432600667,0.0168736673071239,0.0132100232595215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37052,0.019358229087893,0.00781197383284298,0.00404676037552074,0.0346696978002652,0.013223784555965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37433,0.00537396643351468,0.00216939136802726,0.00112195935218125,0.00962597351484811,0.0132547045658739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,39888,-0.0100212000745887,0.00404869840557247,-0.0179566489495108,-0.0020857511996667,0.013327692495886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37039,0.0154896183793277,0.00626132895671492,0.00321741362416646,0.0277618231344889,0.0133789051576553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39864,0.0147442258208406,0.00597158761159186,0.00303991410212053,0.0264485375395606,0.0135571009547614
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39393,0.0144585937176251,0.00585862149910956,0.0029756955793704,0.0259414918558799,0.0136008629961826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37017,0.00834268508197336,0.00338117482757392,0.00171558241992847,0.0149697877440183,0.0136227464363724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37119,0.0117322686193934,0.00475834547251961,0.00240591149325497,0.0210586257455318,0.0136902282242438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,36987,0.0143310567725453,0.00581646985342859,0.00293077585982527,0.0257313376852654,0.013757113989594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39784,0.00791228728625168,0.00321355190632437,0.00161372554985592,0.0142108490226474,0.0138207180694594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36987,0.0171249174322883,0.00695526238045418,0.00349260316659806,0.0307572316979784,0.0138233430370221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37120,-0.00628371183972921,0.00256147971892343,-0.0113042120888191,-0.00126321159063929,0.0141736335320043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37364,0.012719387604994,0.00518563970650345,0.00255553378024719,0.0228832414297407,0.014187084313179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36987,0.0213296963706811,0.00870676097649098,0.00426444485675878,0.0383949478846034,0.014307104780269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39784,-0.00458861920440552,0.00187838616806817,-0.00827025609381912,-0.000906982314991911,0.014582506216698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39854,0.00902011263694374,0.00369784282284418,0.00177234070416915,0.0162678845697183,0.0147269293428717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36987,0.00705446794229606,0.0028930262760023,0.00138413644133155,0.0127247994432606,0.0147640169079097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39725,-0.0073830981059768,0.00303015528323736,-0.013322202461122,-0.00144399375083158,0.0148394027286874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37052,0.00779136249646156,0.00320229893150645,0.00151485659070893,0.0140678684022142,0.0149853113586501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39485,0.00719249601494116,0.00295964288495571,0.00139159596042796,0.0129933960694544,0.0151020712757896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37165,0.00754362636033055,0.00310876566827898,0.00145044565050376,0.0136368070701574,0.0152556555017284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37035,0.0119961636598624,0.00494609436110611,0.0023018187120944,0.0216905086076303,0.0153056713763191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,37052,0.00891681798635556,0.00368303184856518,0.00169807556316781,0.0161355604095433,0.0154889942909673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,39902,0.00844977783390391,0.00349195631974833,0.00160554344719718,0.0152940122206106,0.0155407965767898
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37364,0.00906001823393197,0.00374418413726712,0.00172141732488842,0.0163986191429755,0.0155439705431269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37449,-0.00419115297501914,0.00173275247607762,-0.00758734782813128,-0.000794958121907001,0.0155855599059921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37017,0.0104457331477466,0.00431981299041334,0.00197889968653645,0.0189125666089567,0.0156153463308563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37052,0.00572198609224549,0.00236698434733054,0.00108269677147763,0.0103612754130134,0.0156446046457962
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39864,-0.00614539412119533,0.00254282803176947,-0.0111293370634635,-0.00116145117892716,0.0156706343539965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,39583,0.0112564673153709,0.00467034290576142,0.00210259522007851,0.0204103394106633,0.0159551191868957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37035,0.015365329265953,0.00638701196603462,0.0028467858125251,0.0278838727193808,0.0161545499705647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37433,0.0292096708453906,0.0121566791008501,0.00538257980772439,0.0530367618830569,0.0162848775492713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36987,0.019545447339453,0.00814292807391201,0.00358530831458552,0.0355055863643206,0.0163956016894008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37378,-0.010856968832942,0.00452500224121721,-0.0197259732257277,-0.00198796444015624,0.0164386042727399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39904,0.0166847452779152,0.00695626653748072,0.00305046286445301,0.0303190276913774,0.0164728174984779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39862,0.00888827186415475,0.00370868989138208,0.00161923967704589,0.0161573040512636,0.0165590678309254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40054,0.013219385440326,0.00551875861709834,0.00240261855081323,0.0240361523298387,0.0166155709251431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39583,0.00620388455858648,0.00259319236327258,0.00112122752657222,0.0112865415906007,0.0167514675646293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37165,0.009978567154493,0.00418509567434223,0.00177577963278223,0.0181813546762038,0.0171250915510546
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,39850,0.0171461055128196,0.0072002233128701,0.00303366781959425,0.031258543206045,0.0172618985585368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,39914,0.00843125567392198,0.00354161864807638,0.00148968312369228,0.0153728282241517,0.0172950283306369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37366,0.00792300058132184,0.00332822853399703,0.00139967265468766,0.014446328507956,0.0173007964280955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,39583,0.00841911171832211,0.00354688287120646,0.00146722129075745,0.0153710021458868,0.0176244657092689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39473,0.0272815934849268,0.0114982204715761,0.0047450813606377,0.049818105609216,0.0176716163619798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37378,0.0106745381394009,0.00450188201579463,0.00185084938844341,0.0194982268903584,0.0177478279336302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39858,-0.00731542941016105,0.00308785006760041,-0.0133676155426579,-0.00126324327766424,0.0178431765303091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37408,0.0200768425420348,0.00848024633016779,0.00345555973490594,0.0366981253491637,0.0179234900539836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39581,-0.0107091885498983,0.00452653847983039,-0.0195812039703658,-0.00183717312943071,0.0179999597692909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37384,0.0511597147804329,0.0216305849722394,0.00876376823484362,0.0935556613260222,0.0180364941021698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37017,0.0255868243443258,0.0108579054476813,0.00430532966687054,0.0468683190217811,0.0184618655157114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37035,0.00933300365980118,0.00396282919801267,0.00156585843169634,0.017100148887906,0.0185304837562677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37384,-0.0057172175971772,0.0024301425995686,-0.0104802970923317,-0.000954138102022754,0.0186556012407728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,40005,-0.0161276301013695,0.00685902562502841,-0.0295713203264252,-0.00268393987631384,0.0187198741223029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37017,0.00778991899878062,0.00331561073651465,0.00129132195521191,0.0142885160423493,0.0188149963441443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,39799,0.00637478772209542,0.00271717556368331,0.00104912361727614,0.0117004518269147,0.0189827859734894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,37433,-0.00841007976998528,0.00358560961729342,-0.0154378746198804,-0.00138228492009018,0.0190154359193382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37433,-0.00756829120028205,0.00322897721389711,-0.0138970865395204,-0.00123949586104371,0.0190993525546524
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39485,0.0146675133939462,0.00627866406356415,0.00236133182936044,0.0269736949585319,0.0194992199982556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37165,0.0069713098651991,0.00298618375727242,0.00111838970094515,0.0128242300294531,0.0195832359211278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37120,-0.00878042777085696,0.00376117293353796,-0.0161523267205914,-0.00140852882112256,0.0195848288484313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37433,-0.00670319287716026,0.00287181500426445,-0.0123319502855186,-0.00107443546880193,0.0196033684893312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37017,0.0138738510912352,0.00594508276931423,0.00222148886337933,0.0255262133190911,0.0196280784490334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39862,0.0092862829688951,0.00398132383660207,0.00148288824915504,0.0170896776886352,0.0196887813605706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37165,-0.00650610274245737,0.00279177004358556,-0.0119779720278851,-0.00103423345702968,0.0197968288547715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37017,0.0135898106668606,0.00583584798270157,0.00215154862076554,0.0250280727129557,0.0198912002931577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37120,0.0145452325518021,0.00625086652088637,0.00229353417086477,0.0267969309327393,0.0199847935823243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37035,0.0139096297454152,0.0059836551142306,0.00218166572152325,0.0256375937693072,0.0201082545129669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,39583,0.0102658866963639,0.00441753719430815,0.0016075137955199,0.0189242595972079,0.0201438738633257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,40048,0.0108628937843294,0.00469543906412745,0.00165983321863962,0.0200659543500192,0.0207076823214967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39473,0.0121226116911649,0.00524310424478888,0.00184612737137874,0.0223990960109511,0.020784798976199
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39826,-0.00410449480126634,0.00177584210867395,-0.00758514533426729,-0.000623844268265393,0.0208292422578802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,39854,0.0049263563315053,0.00213145779086351,0.00074869906141281,0.00910401360159779,0.0208310639795011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37052,0.0125053580418293,0.00541553141044385,0.00189091647735932,0.0231197996062992,0.020949774482624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37052,0.0142180707084516,0.00618335962342581,0.00209868584653703,0.0263374555703662,0.021497288800019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37120,0.0109799743971533,0.004780033103554,0.00161110951418741,0.0203488392801191,0.0216314313964474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37364,0.0101394960203596,0.00441971846952963,0.00147684782008149,0.0188021442206376,0.0217971743393945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39485,0.017474066909755,0.0076228289103094,0.00253332224554855,0.0324148115739614,0.0218996288145119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37433,0.0179060418006528,0.00781676281378725,0.00258518668562976,0.0332268969156758,0.0219946707672185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37378,0.0301617767083242,0.0131898704667911,0.00430963059341371,0.0560139228232347,0.0222265132235495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37035,0.00561041090673569,0.0024568705672878,0.000794944594851589,0.0104258772186198,0.0224132572774399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,39581,-0.00450055505471448,0.00197093038165875,-0.00836357860276563,-0.000637531506663325,0.0224161365867258
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,37433,0.00693359888331399,0.00303660271487775,0.000981857562153607,0.0128853402044744,0.0224256841147151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39485,0.0292638211103641,0.0128201090038071,0.00413640746290218,0.054391234757826,0.0224643691893312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,38717,0.00811161366224345,0.00356476625150763,0.0011246718092885,0.0150985555151984,0.0228903290145404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,39805,0.00564452225604608,0.00248297982767346,0.000777881793806094,0.0105111627182861,0.0230222158252313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39716,0.00811695800624723,0.00357763614436471,0.0011047911632924,0.0151291248492021,0.023293579831432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,39960,-0.00683744350571624,0.00301826793240188,-0.0127532486532239,-0.000921638358208562,0.0235042286507793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40005,0.00605322990669108,0.00267463400615478,0.000810947254627705,0.0112955125587545,0.0236366248502526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37433,-0.00671977599387486,0.00297020502638732,-0.012541377845594,-0.000898174142155724,0.0236887703724697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39986,0.00823415690590275,0.0036412303070986,0.00109734550398949,0.015370968307816,0.023749822536492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37165,0.00849395638380625,0.00376507144516422,0.00111441635128439,0.0158734964163281,0.0240875442904929
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39838,0.0129331434935169,0.00573313475399719,0.00169619937568241,0.0241700876113514,0.0240929293404041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,37035,-0.00905092284825506,0.00401752625027871,-0.0169252742988013,-0.00117657139770879,0.0242843809485403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,39583,0.00690506059361378,0.00307071042077892,0.000886468168887104,0.0129236530183405,0.0245463298071042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37408,0.0131836355755581,0.00586858933173326,0.00168120048536089,0.0246860706657553,0.0246896784853102
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37165,0.0106054626936458,0.00472418839187189,0.00134605344557689,0.0198648719417147,0.0247891158623077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39817,0.00515909927137734,0.00229947629045532,0.000652125742084908,0.00966607280066977,0.0248719692739969
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39473,0.0104794662281153,0.00467095168893806,0.00132440091779673,0.0196345315384339,0.0248759846867575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40005,-0.00754993228001628,0.00336575052838509,-0.0141468033156511,-0.000953061244381504,0.0248997116954461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37165,0.0142895439078808,0.00637384674254486,0.00179680429249287,0.0267822835232687,0.0249840762658507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39527,0.0120356681804138,0.00537471757954534,0.0015012217245049,0.0225701146363226,0.0251496145539783
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39862,0.00746856993955269,0.00334585507009524,0.000910694002166028,0.0140264458769394,0.025616474758624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39311,-0.00814608502238114,0.00365355311105798,-0.0153070491200548,-0.000985120924707501,0.0257860867897111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37364,0.00799027550660353,0.00358574504377065,0.000962215220813052,0.015018335792394,0.0258739459263065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39862,0.0149445213837955,0.00671006672120952,0.00179279061022486,0.0280962521573662,0.0259491522814936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39485,0.00776079501046709,0.00348652412665578,0.000927207722221752,0.0145943822987124,0.0260323804344075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,36987,0.0117163180227393,0.00526697923821245,0.00139303871584291,0.0220395973296357,0.0261327467002527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37017,0.00811021722240436,0.00364796967523214,0.000960196658949355,0.0152602377858594,0.0262182951841265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39473,0.0150311603088145,0.00676115518181656,0.00177929615245407,0.028283024465175,0.0262189684453206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37017,0.00405584758729379,0.00182760082360897,0.000473749973020206,0.00763794520156738,0.0264887781599047
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39862,0.0196955179793282,0.00887973237207737,0.00229124253005656,0.0370997934285998,0.0265667336977044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37035,0.0150200544618539,0.0068169811296495,0.00165877144774084,0.0283813374759669,0.0275887865041517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,39583,-0.0098709400536458,0.00448618730013853,-0.0186638671619173,-0.00107801294537427,0.0278003903099878
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37449,0.00370285497193753,0.00168473079920477,0.000400782605496187,0.00700492733837887,0.0279736677246308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37261,0.0109801475130082,0.00499751017978208,0.00118502756063535,0.0207752674653811,0.028028675878526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39841,0.00482327014244211,0.00219865189074047,0.000513912436590799,0.00913262784829343,0.0282684707269842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,39583,-0.00567314302981688,0.00258627538748253,-0.0107422427892826,-0.000604043270351122,0.0282818447290996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37052,0.00779061511659813,0.00355291602778881,0.000826899702132059,0.0147543305310642,0.0283436386345288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39873,0.0112972297483505,0.00516758071392167,0.00116877154906404,0.021425687947637,0.0288173167065631
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39854,0.0087184533873818,0.00398931316143192,0.000899399590975252,0.0165375071837884,0.0288701583221912
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37102,0.00713072190541263,0.00327688232557473,0.000708032547286152,0.0135534112635391,0.0295677217636239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37089,-0.00966531820732966,0.00444522746271465,-0.0183779640342504,-0.000952672380408949,0.0296992611414546
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37408,0.0151873880142683,0.00699487512421601,0.00147743277080488,0.0288973432577317,0.0299321126159356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40048,0.0116222346729525,0.00535553751267094,0.00112538114811747,0.0221190881977876,0.0300111798225064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39581,-0.00719793910943321,0.00332194655977339,-0.0137089543665891,-0.00068692385227736,0.0302663339814224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37378,0.00828474332089085,0.00383177912842522,0.00077445622917742,0.0157950304126043,0.0306268767368744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37052,0.00623522083869797,0.00288754795931155,0.000575626838447343,0.0118948148389486,0.030841146404778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37120,0.0073184815405069,0.00339956659709154,0.000655331010207484,0.0139816320708063,0.0313548216076568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37314,0.00551740862754998,0.00256417971753155,0.000491616381188141,0.0105432008739118,0.0314367906562786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37052,0.00885217683755595,0.00412229856224208,0.00077247165556147,0.0169318820195504,0.0317805247982954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39485,0.00983972882066894,0.00458338292975979,0.000856298278339759,0.0188231593629981,0.0318224259300849
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37384,0.0107427892811698,0.00500448110035304,0.000934006324477854,0.0205515722378618,0.0318401625855183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37441,-0.0118180711967529,0.00551108118674228,-0.0226197903227677,-0.001016352070738,0.0320169642565056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37364,0.00997723782784767,0.00465846242060798,0.000846651483456032,0.0191078241722393,0.0322318579686754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37408,0.00531035372158129,0.00248069934390947,0.000448183007518722,0.0101725244356439,0.0323186169053792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39473,0.0068919205854489,0.00322535200420544,0.000570230657206228,0.0132136105136916,0.0326300510705883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39473,0.00655146860869695,0.00306947817946972,0.000535291376936307,0.0125676458404576,0.0328262645887946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,39792,-0.00621841572881669,0.00291861868383513,-0.0119389083491335,-0.000497923108499835,0.0331371896644734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39858,0.00475881528682552,0.00223584780186693,0.000376553595166331,0.0091410769784847,0.0333178064688453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37433,0.0141131798731431,0.00663260219503756,0.00111327957086951,0.0271130801754168,0.033367525472427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39473,0.0189264004079966,0.00891376257272418,0.00145542576545718,0.036397375050536,0.0337462060269508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37388,0.00455489211475112,0.00214899829079395,0.000342855464794985,0.00876692876470726,0.0340628506894377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37035,-0.00929666245132377,0.00439095490138826,-0.0179029340580448,-0.00069039084460277,0.0342589990797115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37426,-0.00722470838784485,0.00341263953221717,-0.0139134818709905,-0.000535934904699188,0.0342742555671521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37364,0.013127125255547,0.00624950352925901,0.000878098338199322,0.0253761521728946,0.0357027695972628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,39862,-0.00756796671288546,0.00360892659092539,-0.0146414628310992,-0.000494470594671692,0.0360080603020492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37052,0.0052239481003565,0.00249282235458028,0.000338016285379156,0.0101098799153338,0.0361370715742537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,39864,-0.00703555369624018,0.00335833223084437,-0.0136178848686951,-0.000453222523785223,0.0361907037195062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37035,-0.0115875803782306,0.00553486303362597,-0.0224359119241375,-0.000739248832323701,0.036318060236814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36958,-0.00575640940049741,0.00275668156287382,-0.0111595052637301,-0.00035331353726473,0.0368021073073941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,39583,0.0157548500265668,0.00755424756295996,0.00094852480316524,0.0305611752499683,0.0370344206298183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40005,0.0243001307751892,0.0116728245138175,0.00142139472810687,0.0471788668222714,0.0373792363617902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39310,0.0172724507762094,0.00831225981343334,0.000980421541880112,0.0335644800105388,0.0377305412713019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37052,0.00874547209950621,0.00421239955106641,0.000489168979416053,0.0170017752195964,0.0379016213831875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36987,0.0113368595902131,0.00546109386583604,0.000633115613174411,0.0220406035672517,0.0379196574354452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37120,0.00698250657552792,0.00337223895283227,0.000372918227976666,0.0135920949230792,0.038416924424064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39745,-0.00525630464086932,0.00254620963457412,-0.0102468755246346,-0.000265733757104051,0.0389993713169368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39485,0.00942286493672697,0.00457791472784427,0.000450152070152197,0.0183955778033017,0.0395748912004236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,37433,-0.0140185723770756,0.00681340193807885,-0.0273728401757102,-0.000664304578441089,0.0396572432166369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39473,0.00870141451723608,0.00422963985387077,0.000411320403649364,0.0169915086308228,0.0396790301417113
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37052,0.00404543769730146,0.00196897737282302,0.000186242046568331,0.00790463334803458,0.0399384490598456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36987,-0.00863363804073549,0.00420337201177276,-0.0168722471838101,-0.000395028897660885,0.0399974801196562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37052,0.00802794733891989,0.00392530910494756,0.000334341493222668,0.0157215531846171,0.0408573230381495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39581,0.00396632212177473,0.00194721115818352,0.000149788251735035,0.00778285599181443,0.0416743252836748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39485,0.00803998397374171,0.00394856569399397,0.000300795213513538,0.0157791727339699,0.0417492788741131
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39473,0.0109058376788244,0.00536853484351211,0.000383509385540628,0.0214281659721081,0.0422276363239731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40026,0.00531819369451063,0.00262559266634345,0.000172032068477462,0.0104643553205438,0.0428302663060468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39452,0.00939528539929517,0.00464132250109898,0.000298293297141171,0.0184922775014492,0.0429594934691732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37378,0.0110378173397522,0.00545704065740107,0.000342017651246066,0.0217336170282583,0.0431263596961197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40048,0.00793424569927789,0.00392435455712499,0.0002425107673129,0.0156259806312429,0.0432138140126228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,39583,0.0165009072780994,0.00818157309278044,0.000465024016249736,0.0325367905399491,0.0437293901589406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37378,-0.0310769504533677,0.0154133446290737,-0.0612871059263521,-0.000866794980383369,0.0437949761668111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37433,-0.0105991143316089,0.00525881071828638,-0.0209063833394502,-0.000291845323767576,0.0438723294505655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37364,0.00880977395442963,0.00437851632007245,0.000227881967087619,0.0173916659417716,0.0442349648740569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37035,-0.00685732875447127,0.00340883177458034,-0.0135386390326487,-0.0001760184762938,0.0442786428444589
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36987,0.0191574527097904,0.00953447367971126,0.000469884297556303,0.0378450211220244,0.0445275960822077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37408,0.00648264965103799,0.00322930152225687,0.000153218667414526,0.0128120806346615,0.0447219766783609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37035,0.00570334541201952,0.0028456877640066,0.000125797394566587,0.0112808934294725,0.0450683936246455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37364,0.0050033836029224,0.00250768424110371,8.8322490359131e-05,0.00991844471548568,0.046038868234396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37165,0.0131629845580827,0.00662675130224297,0.00017455200568646,0.0261514171104789,0.047016009940694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37052,-0.00812423004446992,0.00409105574553161,-0.0161426993057119,-0.000105760783227958,0.0470704569551591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37433,-0.00612477025746972,0.00308501158483333,-0.012171392963743,-7.81475511963982e-05,0.0471277085550762
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37060,0.00607343082092741,0.00307064697054121,5.49627586666308e-05,0.0120918988831882,0.0479608189896147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39243,-0.0110265012759023,0.00557870817495072,-0.0219607692988057,-9.22332529988967e-05,0.0481122651868529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37364,0.0150960185573509,0.00763885806815229,0.000123856743772421,0.0300681803709294,0.04815085891796
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37433,-0.0096014636634066,0.00485946986260651,-0.0191260245941154,-7.69027326978419e-05,0.048194783451142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39485,0.00917570277912341,0.00465497569433158,5.19504182335193e-05,0.0182994551400133,0.0487231746966361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37052,0.00567893553288798,0.00289601755788042,2.74111944235933e-06,0.0113551299463336,0.0499062699219876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,36987,0.00837316161441,0.00427372576788357,-3.34089064179047e-06,0.0167496641194618,0.0501083648724731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37433,0.00629503202465765,0.00321836143528151,-1.29563884940995e-05,0.0126030204378094,0.0504886725811114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40005,-0.0049794148257001,0.00254584921487416,-0.00996927928685346,1.04496354532647e-05,0.0504946949559141
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37165,0.0093279055691802,0.00478299722010493,-4.67689822254685e-05,0.0187025801205859,0.0511706563960569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37165,0.00936321538210571,0.00480565715762756,-5.58726468443144e-05,0.0187823034110557,0.0513912752433229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,39784,0.03279329498348,0.0168754045254985,-0.000282497886496938,0.065869087853457,0.0520023752762371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37364,0.00498199481283776,0.0025722835624354,-5.96809695356214e-05,0.0100236705952111,0.0527908188078375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37364,0.00766813010772691,0.00396840913788211,-0.000109951802522035,0.0154462120179758,0.0533442133491585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37039,-0.00688011819560538,0.00357162024498167,-0.0138804938757695,0.000120257484558696,0.0540846985784215
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36958,0.00572836068717659,0.00297709771842447,-0.000106750840935366,0.0115634722152885,0.0543583470156324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36987,0.0102374464748324,0.00532408182147665,-0.000197753895261806,0.0206726468449267,0.0545196570908234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,39745,0.00733437439529755,0.00381480351472757,-0.000142640493568482,0.0148113892841636,0.0545470719917591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,39881,0.00676538214484822,0.0035194706368638,-0.000132780303404831,0.0136635445931013,0.0545891718824566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37165,-0.00585581795980298,0.00305527314427057,-0.0118441533225733,0.000132517402967347,0.0553067764649289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39492,0.00653473531534422,0.00341188617700359,-0.000152561591582808,0.0132220322222712,0.0554743603704197
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39581,0.0153632445191857,0.00804327317964046,-0.000401570912909575,0.031128059951281,0.0561419024667927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37052,0.00512686104437029,0.00268735175819674,-0.000140348401695323,0.0103940704904359,0.056442063200081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,39854,-0.00580703947981602,0.00305412550933852,-0.0117931254781195,0.000179046518487485,0.0572707972908405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39583,0.00726029402276727,0.00382337921818603,-0.000233529244877345,0.0147541172904119,0.0575931882475201
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37017,0.00674132262943527,0.00355500989734097,-0.000226496769353019,0.0137091420282236,0.0579438573578525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39862,-0.00662593334993817,0.00351389705187676,-0.0135131715716166,0.00026130487174029,0.0593620218394073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,39864,0.0127745359892824,0.00678614903439854,-0.000526316118138774,0.0260753880967035,0.0597940731610844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,39581,-0.00399900348404921,0.00212479281890035,-0.0081635974090939,0.000165590440995489,0.0598453086898146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37433,0.00951943536953182,0.0050636996859351,-0.000405416014900975,0.0194442867539646,0.0601380923755339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37449,-0.00559808682421319,0.00298521708267849,-0.011449112306263,0.00025293865783665,0.0607770707410802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37035,0.00841847292887505,0.00449406138800757,-0.000389887391619787,0.0172268332493699,0.0610568400241665
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,36958,0.00508016249197604,0.00271549708842161,-0.00024221180133032,0.0104025367852824,0.0613945496634944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37364,-0.00636692717223255,0.00340612882006067,-0.0130429396595515,0.000309085315086363,0.0616088157698603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,39814,0.00679805693980681,0.00363865296923208,-0.000333702879888064,0.0139298167595017,0.0617400517102052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36987,0.00486571692965312,0.00261088098474901,-0.00025160980045494,0.00998304365976119,0.0623959493467417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37017,0.00870729166489247,0.00469688279168016,-0.000498598606800653,0.0179131819365856,0.0637837352737724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37052,-0.00606335252486003,0.00327794652071352,-0.0124881277054585,0.000361422655738477,0.0643732185532593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37017,0.00824674990311118,0.00447432959565583,-0.000522936104374252,0.0170164359105966,0.0653332029373386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40020,-0.00591557739103593,0.00321556112242176,-0.0122180771909826,0.000386922408910729,0.0658347544198967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37433,0.00821052546030972,0.00447815467726908,-0.000566657707137687,0.0169877086277571,0.0667558128929476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37378,0.00639205359815189,0.00349949042092741,-0.00046694762686583,0.0132510548231696,0.0677869462096427
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,39902,0.0248969383620402,0.0136395220687069,-0.00183652489262526,0.0516304016167057,0.0679664068902349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37165,0.00553183358085207,0.00303767531909961,-0.000422010044583161,0.0114856772062873,0.0686179552159333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40054,0.00549283180884507,0.0030169919934891,-0.00042047249839356,0.0114061361160837,0.0686812801184254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37017,0.00809947868644905,0.00444988329298329,-0.000622292567798208,0.0168212499406963,0.0687580668781326
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39784,0.0039635549870684,0.00217865995420171,-0.000306618523166948,0.00823372849730376,0.0688901180305369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36958,-0.0134087805581186,0.00737044183461582,-0.0278548465539657,0.00103728543772836,0.0688939614656389
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,39745,0.0086209215397353,0.00473927026393764,-0.000668048177582474,0.0179098912570531,0.0689241669091025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37017,-0.00730239489572288,0.00402187919190053,-0.0151852781118479,0.000580488320402166,0.0694441620472709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37441,0.00421798653724981,0.0023254927628959,-0.000339979278026151,0.00877595235252577,0.0697300679890982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,39861,0.00509012368147102,0.00280918047873972,-0.00041587005685883,0.0105961174198009,0.0700110588074939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39564,0.00686870419891532,0.0037929152157244,-0.000565409623904498,0.0143028180217351,0.0701707780837347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37017,0.006514982707071,0.00360049952027548,-0.00054199635266894,0.0135719617668109,0.070401395528448
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37017,0.0057088473639338,0.00316683992241588,-0.000498158884001331,0.0119158536118689,0.0714589587153043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39909,0.00441150556684808,0.00244957945892785,-0.000389670172650501,0.00921268130634665,0.0717336810110176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39784,0.00425053201045273,0.00236206489272651,-0.000379115179291228,0.00888017920019668,0.0719587991014465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37433,-0.00420441768671244,0.00233759602655657,-0.00878610589876331,0.000377270525338438,0.0721030029956732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37165,0.0116024391079993,0.00645787069803788,-0.00105498746015495,0.0242598656761535,0.0724161943047888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40048,-0.00508524789523549,0.00283610643119203,-0.0106440165003719,0.000473520709900883,0.0729854369150855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37017,0.00549718671946455,0.00306712418079545,-0.00051437667489454,0.0115087501138236,0.07310893198192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,37408,0.00523501458575814,0.00292247028926908,-0.000493027181209253,0.0109630563527255,0.0732678327297997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37052,0.006631702997681,0.00370591583327691,-0.000631892035541752,0.0138952980309038,0.0735587079173008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37017,0.0059675698918581,0.00333802744194872,-0.000574963894361397,0.0125101036780776,0.0738388099308321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37035,0.0118101439484735,0.00661318146584168,-0.00115169172457617,0.0247719796215232,0.0741466915828547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37364,0.00786447766611665,0.00440541195493424,-0.000770129765554458,0.0164990850977878,0.0742536659153439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37052,0.00579281425006508,0.00324692443226253,-0.00057115763716949,0.0121567861372996,0.0744315769250532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39485,0.0111513090323281,0.00625263119198481,-0.00110384810396214,0.0234064661686183,0.0745310812668308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37052,0.00968230735419126,0.00543618121033694,-0.000972607818069135,0.0203372225264517,0.074921371946206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37441,-0.00384113610304378,0.00216020911495669,-0.0080751459683589,0.000392873762271333,0.0754046104521064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39485,0.0103772513567509,0.00583802461113378,-0.00106527688107134,0.0218197795945731,0.0755008782408697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39401,-0.0190187416537499,0.0107120903472845,-0.0400144387344276,0.00197695542692784,0.0758437831740626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36958,0.0139393104489001,0.0078519835476052,-0.00145057730440614,0.0293291982022062,0.0758782225956186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,36987,-0.00609779921202444,0.00343660121952051,-0.0128335376022846,0.00063793917823577,0.0760252806470702
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37364,0.00700769980870473,0.00395534031393993,-0.000744767206617537,0.014760166824027,0.0764659351210558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,36958,0.0095521678271255,0.00539634324464798,-0.00102466493238455,0.0201290005866355,0.0767306358297582
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,39583,0.00852157745998756,0.00483954066116274,-0.000963922235891401,0.0180070771558665,0.0782876995405834
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37408,0.0121515527643277,0.00690859649660147,-0.00138929636901115,0.0256924018976666,0.0786165167613766
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37052,0.0101261036776567,0.00576513263024394,-0.00117355627762145,0.0214257636329348,0.0790366819086226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40048,-0.00649903973033176,0.00370457010102407,-0.0137599971283389,0.000761917667675423,0.0793928388723679
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37017,0.00826111595994702,0.00470942875338326,-0.000969364396684175,0.0174915963165782,0.0794254857920998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39473,0.00786278255343028,0.0044856693686324,-0.000929129409089223,0.0166546945159498,0.0796444359844647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37017,0.00628173003265816,0.00358585514053693,-0.000746546042794226,0.0133100061081105,0.0798301098104316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37039,0.00946569625787233,0.00540533931208087,-0.00112876879380617,0.0200601613095508,0.0799389949169935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37039,0.0117884308936345,0.00673467825470374,-0.0014115384855848,0.0249884002728538,0.0800713019417503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37017,-0.00579632950409327,0.00331184816617993,-0.0122875519098059,0.000694892901619382,0.0801106153253433
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39415,0.0108690794549565,0.0062212509696143,-0.00132457244548756,0.0230627313554005,0.0806416267816255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37441,-0.00404414224142345,0.00232060677766231,-0.00859253152564158,0.000504247042794679,0.0814070979815853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,39716,-0.00493667727265572,0.00283433367911353,-0.0104919712837182,0.0006186167384068,0.0815730371225584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37052,0.00423084488916086,0.00243255304364764,-0.000536959076388516,0.00899864885471023,0.0820121712154887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39784,0.00859190606495044,0.00495088650250066,-0.00111183147995085,0.0182956436098517,0.0826844052792422
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37017,0.0079420064193435,0.0045815932879371,-0.00103791642501322,0.0169219292637002,0.0830374570530182
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36958,0.00564844138239755,0.00326345015769433,-0.000747920926683336,0.0120448036914784,0.0835076114721472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37384,0.00602220995457681,0.00348305782289619,-0.000804583378299729,0.0128490032874533,0.0838317629206804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37035,0.00764386767862912,0.00442194211117097,-0.00102313885926598,0.0163108742165242,0.0839001463574009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39581,0.00498283211633308,0.00288636134649253,-0.000674436122792272,0.0106401003554584,0.0843064659129729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37364,0.00528088993892743,0.00306051494979273,-0.000717719362666322,0.0112794992405212,0.0844619640969888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,39864,0.00963831465429538,0.00559157055553917,-0.0013211636345614,0.0205977929431522,0.0847773069209497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37052,0.0170765031873725,0.00991116641642333,-0.00234938298881725,0.0365023893635622,0.0849199252461176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37052,0.00404039518661042,0.00235937956653646,-0.000583988763801047,0.00866477913702189,0.0868313675136159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39999,0.00468401935266797,0.00273956224949895,-0.00068552265634998,0.0100535613616859,0.0873277695478529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40054,0.00567616469453396,0.00332315066701979,-0.000837210612824833,0.0121895400018928,0.0876430371033649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37384,0.0055173692965978,0.00323574652616985,-0.000824693894695108,0.0118594324878907,0.0881930998420713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37039,0.00938787709357117,0.00550615462266857,-0.00140418596685922,0.0201799401540016,0.0882219395413947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,37145,-0.00495062583523716,0.00290386022628201,-0.0106421918787499,0.000740940208275577,0.0882470862884896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,37017,-0.0105644359846527,0.00619849575754176,-0.0227134876694346,0.0015846157001291,0.0883384339339251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36958,0.00838071701975739,0.00492081544506591,-0.0012640812525718,0.0180255152920866,0.0885701814475014
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39583,-0.00582151383806323,0.00341915293136963,-0.0125230535835477,0.000880025907421244,0.0886592074949071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37120,-0.00433737922025242,0.00255095782329275,-0.00933725655390622,0.000662498113401376,0.0890990195429027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,36958,-0.00627597094744028,0.00369263904344806,-0.0135135434725985,0.000961601577717917,0.0892318905558261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37364,0.00808544842390733,0.00476035221936774,-0.00124484192605344,0.0174157387738681,0.0894368580779414
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40005,0.00530213869809984,0.00313432413300327,-0.000841136602586581,0.0114454139987863,0.0907345042122479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40013,0.00919912085936362,0.00545532029225802,-0.0014933069134621,0.0198915486321893,0.0917638978631715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39485,0.00861739335689953,0.00511271476662439,-0.00140352758568427,0.0186383142994833,0.091915407226349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37378,0.00510647351117488,0.00304091960480409,-0.00085372891424113,0.0110666759365909,0.0931258476316794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39784,-0.00503783150586565,0.00300184471667685,-0.0109214471505523,0.00084578413882098,0.0933188622825517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36958,-0.00388870111302309,0.00232001247479024,-0.00843592556361196,0.00065852333756578,0.093731651069145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,37364,0.0166460150411205,0.00993489853655081,-0.00282638609051911,0.0361184161727601,0.0938574964821616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36958,0.00903984159130905,0.00539547880699363,-0.00153529687039848,0.0196149800530166,0.0938703288828058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39831,-0.0110521034092549,0.00659786749053216,-0.0239839236906979,0.00187971687218813,0.0939337267923432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39909,0.00386815671684711,0.00231444450449238,-0.00066815451195796,0.00840446794565218,0.094679747558911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36958,-0.0096147045609209,0.00576001256106417,-0.0209043291806067,0.00167492005876487,0.0950984979698604
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37052,0.00339627908656359,0.00203720715602992,-0.000596646939255059,0.00738920511238224,0.0955132787462733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37052,0.0135509325564033,0.00812841402146488,-0.00238075892566781,0.0294826240384745,0.0955169498461233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36958,-0.00850786815039589,0.00510478974214682,-0.0185132560450037,0.00149751974421188,0.0956090866538562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37378,0.00835365928268147,0.00501419431231935,-0.00147416156946445,0.0181814801348274,0.0957361248114459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40048,0.00342328285100942,0.00205498891441236,-0.000604495421238801,0.00745106112325764,0.0957646239109424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37165,0.0103450087140564,0.00623645815294956,-0.00187844926572473,0.0225684666938376,0.0971805781690907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40048,0.00403997793315887,0.00243969008791458,-0.000741814639153703,0.00882177050547145,0.097753557367333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,38828,0.00719972415113122,0.00434952555267981,-0.0013253459321212,0.0157247942343836,0.0978867438694925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36958,-0.00611496432529293,0.00369620373772748,-0.0133595236512388,0.00112959500065293,0.0980721575579101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,39678,0.00999469240578009,0.00604525086647554,-0.00185399929251196,0.0218433841040721,0.0982870038360887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37378,0.00727851424966668,0.00441690774332367,-0.00137862492724771,0.0159356534265811,0.0994014532929978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40048,0.00334810457999893,0.00205026620508799,-0.000670417181973523,0.00736662634197138,0.102486406913967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40008,0.00778710836188728,0.00477155246435314,-0.00156513446824488,0.0171393511920194,0.10270186636995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37033,0.00890595895684625,0.00545826941509174,-0.00179224909673356,0.0196041670104261,0.102778159305995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37017,0.00870105709224176,0.00533311813353787,-0.00175185444949247,0.019153968633976,0.102805833656563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37378,0.00686402783214142,0.00421194332934078,-0.0013913810933665,0.0151194367576493,0.103197063481721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37035,0.0123890214116102,0.00763375446261832,-0.00257313733512171,0.0273511801583421,0.10462907102652
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37364,0.00311115666267362,0.00193408875872016,-0.000679657304417894,0.00690197062976514,0.107729305142494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37165,0.0105596287368315,0.00656452476323503,-0.00230683979910916,0.0234260972727722,0.107729753321668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37408,0.00373714552090969,0.00232351533293087,-0.000816944531634808,0.00829123557345419,0.107770576615934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36958,0.00817605574511203,0.00508542702576454,-0.00179138122538648,0.0181434927156105,0.107915750064768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,39745,0.00607079258197181,0.0037960732382221,-0.0013695109649435,0.0135110961288871,0.109789489522143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39862,0.0215608421897552,0.0135145133961785,-0.00492760406675461,0.0480492884462651,0.110646077578627
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39242,0.00676695533205347,0.00425398482376125,-0.00157085492251859,0.0151047655866255,0.111690158599205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,36987,0.00688231493059844,0.00432689050252766,-0.00159839045435578,0.0153630203155527,0.11172563585491
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39401,0.0097014147273267,0.00611340615240633,-0.00228086133138971,0.0216836907860431,0.112553767878361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37120,-0.0055810560102089,0.00352485591524616,-0.0124897736040914,0.00132766158367358,0.113367150804662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37027,0.00996208880312053,0.00631975680740862,-0.00242463453940036,0.0223488121456414,0.114971369480774
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39473,0.0119703372265764,0.00760664483715262,-0.00293868665424275,0.0268793611073955,0.115584374412568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37068,0.00622669069039893,0.00396304219065479,-0.00154087200328446,0.0139942533840823,0.116162567552685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39784,0.00376569089716927,0.0024034013555456,-0.000944975759700102,0.00847635755403865,0.117177265362683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37017,0.00616173519846352,0.00393516079467125,-0.00155117995909212,0.0138746503560192,0.117415899735242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37052,0.0108186409032355,0.00691073667841044,-0.00272640298644892,0.02436368479292,0.117493682249826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36958,0.0203768423943886,0.0130345584074412,-0.00517089208419607,0.0459245768729733,0.118007699938765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,40048,-0.00704700859145305,0.00450961763020164,-0.0158858591466483,0.00179184196374217,0.118151639061558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,39854,-0.00672610081047865,0.00431625039640913,-0.0151859515874405,0.00173374996648324,0.119177113893285
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37052,0.00418367940160048,0.00269299647231426,-0.00109459368413546,0.00946195248733643,0.120318021998352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37017,0.0124730915858747,0.00804026536945021,-0.00328582853824775,0.0282320117099971,0.120847069044384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37165,0.00646801817863453,0.00418073013806085,-0.00172621289196475,0.0146622492492338,0.12186230755681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36987,-0.00756086017557681,0.00488867064934687,-0.0171426546482967,0.00202093429714305,0.121981755651968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,39854,0.00894848496560102,0.00583662341927052,-0.00249129693616921,0.0203882668673712,0.125255903680011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37017,0.003863076570186,0.00252427210904212,-0.00108449676353656,0.00881064990390856,0.125948597955461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37378,-0.0042384450790987,0.00277408437827552,-0.00967565046051872,0.00119876030232132,0.126567787044656
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39927,0.00573724658156613,0.00375838284674702,-0.00162918379805802,0.0131036769611903,0.126900097470876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37165,0.00582890760998601,0.00382377320644622,-0.00166568787464858,0.0133235030946206,0.127436000209206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39858,-0.00553339216898358,0.00363414809753331,-0.0126563224401489,0.00158953810218171,0.127875938241759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,39716,-0.0173316284715958,0.0113851074714324,-0.0396464391156033,0.00498318217241171,0.127952123875147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37052,0.00382076473029876,0.00251071387045133,-0.00110023445578585,0.00874176391638337,0.128087126598156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39581,0.00515362832531318,0.00338887670713572,-0.00148857002067283,0.0117958266712992,0.128343136458366
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37052,0.00514785568286098,0.00338933803149975,-0.00149524685887853,0.0117909582246005,0.128827221139522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,37449,-0.00299287125418257,0.0019748571498923,-0.00686359126797147,0.000877848759606335,0.129672261833586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37384,-0.0119033667904962,0.00787837638729534,-0.027344984509595,0.00353825092860269,0.130839626465698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37408,0.0123314946973068,0.00818181450432765,-0.0037048617311754,0.028367851125789,0.131786979528073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39924,0.0109816235637408,0.00729170357460924,-0.00331011544249331,0.0252733625699749,0.132075641710343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36958,0.00871582175098247,0.00578776945399444,-0.00262820637884663,0.0200598498808116,0.132116085889378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37052,0.00666618508267309,0.00444799836017331,-0.00205189170326659,0.0153842618686128,0.13397715862715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37441,0.00630844205988104,0.00423120836703795,-0.00198472633951333,0.0146016104592754,0.136002691156551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37017,-0.00758140489031329,0.00508855897610691,-0.0175549804834828,0.00239217070285627,0.136276524307317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37017,0.0148951080792306,0.00999962669955345,-0.00470416025189418,0.0344943764103553,0.136362248377411
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40048,0.0054053540161346,0.003643973480133,-0.00173683400492608,0.0125475420371953,0.137996106316671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40026,0.00537079596706793,0.00362770480292514,-0.00173950544666534,0.0124810973808012,0.138760891916596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37433,0.00394195944083295,0.00266653878342465,-0.00128445657467936,0.00916837545634525,0.139349181464606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36987,0.00838843327902856,0.00567483164111721,-0.00273423673756117,0.0195111032956183,0.139383096299371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37165,0.00909261436582982,0.0061641423591514,-0.00298910465810693,0.0211743333897666,0.140214208020322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39822,0.00727779860098927,0.00493474423636519,-0.0023943001022865,0.016949897304265,0.140283983891001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37017,0.00812032301473229,0.00552425990695132,-0.0027072264028923,0.0189478724323569,0.14160228866538
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37052,0.00594967859008085,0.00405267383544408,-0.00199356212738955,0.0138929193075512,0.142104379387698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,39583,0.0102992526937059,0.00701557713637186,-0.00345127849358292,0.0240497838809948,0.142109302990334
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,39827,-0.00351431024920579,0.00239506877516798,-0.00820864504853503,0.00118002455012345,0.142311226695374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,36987,0.00574784068220614,0.0039296426019272,-0.00195425881757117,0.0134499401819834,0.143576739479757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39854,0.00531219065698323,0.00363314793083211,-0.0018087792874477,0.0124331606014142,0.143721008368335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36958,0.0039606330058262,0.00271335318436543,-0.00135753923553005,0.00927880524718245,0.14440145305669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37165,0.0100637247697345,0.00689737902015283,-0.00345513810976501,0.0235825876492341,0.144570807414338
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,39858,0.00286472823635411,0.00196816176172983,-0.000992868816636364,0.00672232528934459,0.145540843177479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39485,0.00535161329858652,0.00367747186241404,-0.001856231551745,0.012559458148918,0.14562223195056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39877,0.00640835606314386,0.00441771051926683,-0.00225035655461912,0.0150670686809068,0.146909269424339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37035,-0.0090338447791345,0.00623407336856268,-0.0212526285815173,0.00318493902324834,0.1473312608848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,37449,0.00290554489099006,0.00201005221291222,-0.00103415744631789,0.006845247228298,0.148338540121267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37052,0.00754869757909224,0.00522967717541669,-0.00270146968472446,0.0177988648429089,0.148921796279551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37017,0.0070819850053007,0.00491035241407997,-0.00254230572629604,0.0167062757368974,0.149253984022306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,36958,0.00536923504275505,0.00373316642413424,-0.00194777114854807,0.0126862412340582,0.150386384433038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37052,0.00696666293894862,0.00485546505154134,-0.00255004856207241,0.0164833744399696,0.151365356660676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36987,0.00973456590162267,0.00680938038556072,-0.00361181965407634,0.0230809514573217,0.152860895273134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37408,0.00446450143814996,0.00312418598747954,-0.00165890309730993,0.0105879059736099,0.153023640014527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37052,0.00383012025800564,0.00268860212003192,-0.00143953989725693,0.00909978041326821,0.154303219612612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36987,0.00631081282832292,0.00443343525170755,-0.00237872026502388,0.0150003459216697,0.154626937326317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37408,0.00750324746071562,0.00528087623053398,-0.00284726995113097,0.0178537648725622,0.155388095393856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39583,-0.00554514993239664,0.00390401502080646,-0.0131970193731773,0.00210671950838403,0.155519513805283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37017,-0.0078847822851223,0.00561015119918891,-0.0188806786355326,0.00311111406528796,0.159911369329345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,39853,-0.00746695728686664,0.00532240206371669,-0.0178988653317513,0.00296495075801807,0.1606571398896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39908,-0.0062210161907256,0.00443504210480046,-0.0149136987161345,0.00247166633468331,0.160726830574775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39862,0.00898270118233749,0.00643108944523471,-0.00362223413032255,0.0215876364949975,0.162504531529211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39864,0.00323102366091285,0.00231534319961751,-0.00130704901033748,0.00776909633216317,0.162889392649648
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36987,0.00950895543616558,0.00681430797198535,-0.00384708818892571,0.0228649990612569,0.162906910387861
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36927,0.00665561617309034,0.00477128264566999,-0.00269609781242285,0.0160073301586035,0.163059971849997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37052,0.00856655233617484,0.00614899101516758,-0.00348547005355362,0.0206185747259033,0.163593705688204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37364,0.0122828942676308,0.00883103989007185,-0.00502594391691001,0.0295917324521717,0.164285508146676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40026,0.00754998911803447,0.00543081244125563,-0.00309440326682655,0.0181943815028955,0.164483175787052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36987,0.00955823609672226,0.00687845409035784,-0.00392353392037911,0.0230400061138236,0.164676756611906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,39583,-0.00416459276835566,0.00300161002873904,-0.0100477484246842,0.00171856288797285,0.165323344514792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37017,0.00949642960753304,0.00685669561234309,-0.00394269379265942,0.0229355530077255,0.166080133645415
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39862,-0.00679896730354735,0.00491335542020546,-0.01642914392715,0.00283120932005535,0.166447352711002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37017,0.00444001937516948,0.00320913248270481,-0.00184988029093195,0.0107299190412709,0.166517456509796
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37384,-0.00884790893623634,0.00640724271507295,-0.0214061046577793,0.00371028678530665,0.167325450637251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37408,-0.00457083592725573,0.00331145590620149,-0.0110612895034107,0.0019196176488992,0.167513970238489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37052,0.0131070462840753,0.00949881643766578,-0.00551063393374959,0.0317247265019002,0.167652833993352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37433,-0.00362231555409304,0.0026260907642481,-0.00876945345201932,0.00152482234383323,0.167807567633204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37039,-0.00260625474619689,0.00189024129582591,-0.00631112768601567,0.0010986181936219,0.167981451575318
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,36987,0.0105350530530437,0.00766065287492624,-0.00447982658181172,0.0255499326878992,0.169087931589639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39909,0.00977408748021259,0.00711569556577466,-0.00417267582870575,0.0237208507891309,0.169586477842268
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39941,-0.00297490924673626,0.0021739346924646,-0.00723582124396688,0.00128600275049437,0.171192061226904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36938,0.005852742997181,0.00429779744994523,-0.00257094000471165,0.0142764259990736,0.173284290216928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,39881,0.00392962477680481,0.00288678032970182,-0.00172846466941075,0.00958771422302037,0.173454384153331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37039,0.00987127829662788,0.00726261364057546,-0.00436344443890001,0.0241060010321558,0.174109364726636
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37017,0.0101944334346879,0.00751080073968684,-0.00452673601509831,0.0249156028844741,0.174708191372345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36987,0.00597226485364213,0.00440088553057118,-0.00265347078627739,0.0145980004935617,0.174785542106905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37017,-0.0119702305929235,0.00882564928461997,-0.0292685031907786,0.00532804200493166,0.175026920340401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37408,0.00441312364524231,0.00326352461955661,-0.00198338460908866,0.0108096318995733,0.17631572193525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37035,-0.00352259365653679,0.00262173507888061,-0.00866119441114278,0.00161600709806921,0.17909715712221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37039,0.00567953124303692,0.00423050480144102,-0.00261225816778748,0.0139713206538613,0.179451038029033
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39862,0.0111966536080685,0.00834020654546084,-0.0051501512210348,0.0275434584371717,0.179455837021413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36967,-0.0118907522301992,0.00886976533105201,-0.0292754922790611,0.00549398781866276,0.180075612391106
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36987,0.00685314680494298,0.005114885977869,-0.00317202971168026,0.0168783233215662,0.180319417988317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,36927,0.00491174714454542,0.00366853029016419,-0.00227857222417639,0.0121020665132672,0.180630786266625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37433,0.00407728259639124,0.00304728642251128,-0.00189539879173087,0.0100499639845134,0.180917422787793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39485,0.00593495733322385,0.0044412722216977,-0.00276993622130365,0.0146398508877513,0.181464423807199
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37165,0.00899383268655751,0.00673266793530145,-0.00420219646663334,0.0221898618397484,0.181621241376694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39473,-0.00632182573657165,0.0047361179241246,-0.0156046168678559,0.00296096539471257,0.181957438631856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,39581,-0.00487862236767107,0.00366176854153952,-0.0120556887090885,0.00229844397374639,0.182776620677395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37378,-0.00398272423131407,0.00299182698341102,-0.00984670511879967,0.00188125665617152,0.183145204457042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37165,0.00926687346209371,0.00696128802412659,-0.0043772510651944,0.0229109979893818,0.183145696816239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,40048,-0.00204171253016574,0.00153451372411199,-0.00504935942942525,0.000965934369093771,0.183363312188812
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37017,0.00461372179226527,0.00347836491434667,-0.0022038734398542,0.0114313170243847,0.184728494273053
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37378,0.00734295733022656,0.00555775337374801,-0.00355023928231954,0.0182361539427727,0.186453835429327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39877,-0.00764889729029632,0.00579726142147057,-0.0190115296763786,0.003713735095786,0.187054824936732
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37017,0.00378274049224435,0.00286934011308022,-0.00184116612939288,0.00940664711388157,0.187415762216586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37039,-0.00743899321523604,0.00565942561890248,-0.0185314674282849,0.00365348099781283,0.188719993767087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39451,0.0103472787625747,0.00788080059523241,-0.00509909040408079,0.0257936479292303,0.189211355275433
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40026,0.00542736144425825,0.00415515312299725,-0.00271673867681637,0.0135714615653329,0.191511283570998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36987,0.00690784671317442,0.00529477400669873,-0.00346991033995509,0.0172856037663039,0.192033651575513
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37035,-0.00570281888201302,0.00438411225123262,-0.0142956788944289,0.00289004113040291,0.193352353675265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37017,0.0057553912751054,0.0044380815197255,-0.00294324850355658,0.0144540310537674,0.194715993522794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39485,0.00516911994705544,0.00398621572755077,-0.00264386287894408,0.012982102773055,0.194736826072678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37035,0.00710198319027193,0.00547866751310652,-0.00363620513541686,0.0178401715159607,0.19489570316145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39430,0.0106047908166413,0.00819528464580817,-0.00545796708914273,0.0266675487224253,0.195680716256547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39473,0.00366922455975414,0.00284250436544174,-0.00190208399651166,0.00924053311601994,0.196777518197724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,39854,-0.00223652953269151,0.00173320131595194,-0.00563360411195731,0.00116054504657428,0.196929154139741
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37052,0.00562859489594945,0.00436733538619002,-0.00293138246098298,0.0141885722528819,0.1974923718633
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36987,0.00574170315824415,0.00445522119354655,-0.0029905303811071,0.0144739366975954,0.197504849197913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37433,0.00384650641842695,0.00298854536885845,-0.0020110425045356,0.00970405534138951,0.19808725261289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37035,0.0120917790347078,0.00940634342859198,-0.00634465408533247,0.0305282121547481,0.198643012550243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37017,-0.00601745132188385,0.00468939493622273,-0.0152086653968804,0.0031737627531127,0.199443143427395
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37426,0.00650041746048124,0.00509241283330686,-0.0034807116928002,0.0164815466137627,0.201803974559036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,39583,-0.00767907806960467,0.00602086581544638,-0.0194799750678796,0.00412181892867024,0.202182675691162
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37364,-0.00452956827315257,0.00355171151063166,-0.0114909228339906,0.00243178628768549,0.202217985555585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37165,0.00730995100220754,0.005737362994511,-0.00393528046703402,0.0185551824714491,0.202651664784163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39862,-0.00412150838753359,0.00323616134981002,-0.0104643846331612,0.00222136785809405,0.202831020211132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40048,0.00662135820391076,0.00520122120410273,-0.0035730353561306,0.0168157517639521,0.203022432412805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37433,0.0103373047570976,0.00815494118855479,-0.00564637997246975,0.026320989486665,0.204958139230576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,39858,-0.00605475699869689,0.00477963475078289,-0.0154228411102314,0.00331332711283759,0.205251562591159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36958,0.00626802653879323,0.0049520793794713,-0.00343804904497051,0.015974102122557,0.205630027756721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39583,0.00345053493832722,0.00273159797686565,-0.00190339709632945,0.0088044669729839,0.20653862533221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36987,0.0038760267349216,0.00306966812912796,-0.0021405227981692,0.0098925762680124,0.206724504501095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37035,-0.0105521779840497,0.00840892763641356,-0.0270336761514202,0.00592932018332092,0.209545323936703
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37035,0.00567416862991034,0.00452405454733963,-0.00319297828287534,0.014541315542696,0.209783586095972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39784,0.00525159413937129,0.00419442385633427,-0.00296947661904387,0.0134726648977865,0.210573009867324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37017,0.00380486662879503,0.00303970213937009,-0.00215294956437035,0.00976268282196041,0.210692883565752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37052,0.00621029921135271,0.00498474832832718,-0.00355980751216858,0.015980405934874,0.212837874154342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,36958,0.00687702729261395,0.00552244172190598,-0.00394695848232177,0.0177010130675497,0.213048389617831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37052,0.00386975285986499,0.00311089489941042,-0.00222760114297943,0.0099671068627094,0.213545374659081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37378,-0.00935923314642259,0.00755602434818941,-0.0241690408688738,0.00545057457602864,0.215498436123309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37052,0.00726946989940608,0.00587123293298009,-0.00423814664923489,0.0187770864480471,0.21568230102349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37052,0.00480947940010695,0.00388623974038725,-0.00280755049105207,0.012426509291266,0.21589893688288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37039,-0.0031306344583699,0.00253518895570492,-0.00809960481155153,0.00183833589481174,0.216900072678005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37165,0.00411784904978511,0.00333806173919641,-0.00242475195903985,0.0106604500586101,0.217371987804604
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39473,0.00671276184372523,0.00544678265959502,-0.003962932169081,0.0173884558565315,0.21780818994511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39485,0.0033837804863535,0.00276321953143325,-0.00203212979525567,0.00879969076796267,0.220752363036718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,39727,0.00317612372600892,0.00259791872514006,-0.0019157969752656,0.00826804442728344,0.221512312180638
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37433,0.00859981247041171,0.00711464872648283,-0.00534489903349463,0.0225445239743181,0.226780998540159
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,39864,0.00721218912573532,0.00597428201958892,-0.00449740363265895,0.0189217818841296,0.227370660250344
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37135,-0.00705758702521127,0.00585086207417632,-0.0185252766905969,0.00441010264017432,0.227743618436804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37165,0.00434505198324859,0.00360312623954145,-0.00271707544625264,0.0114071794127498,0.227872994144799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39583,-0.00638906086507015,0.00530739401770157,-0.0167915531397652,0.00401343140962492,0.228683559744984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37052,0.0064041264498982,0.00532167849508073,-0.00402636340046003,0.0168346163002564,0.228841814417151
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37165,0.00681137995310714,0.00566920617748025,-0.00430026415475415,0.0179230240609684,0.229590404413249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40026,0.00286235178398798,0.00238388893218618,-0.00181007052309693,0.00753477409107289,0.229882526784667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37408,-0.00452932149726088,0.00377513641172086,-0.0119285888642338,0.002869945869712,0.230246974626311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39452,0.00385382400779224,0.00324349659436669,-0.00250342931716647,0.0102110773327509,0.234784700956641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39485,-0.00541379617880395,0.00456462220724029,-0.0143604557049949,0.00353286334738702,0.235626990269343
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39485,0.00507381289842137,0.00428867197239268,-0.00333198416746828,0.013479609964311,0.236798136250015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,36958,0.00781343949954381,0.00663066177211907,-0.00518265757380956,0.0208095365728972,0.238666537962243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37017,0.0050962656146882,0.00433040457471738,-0.00339132735175787,0.0135838585811343,0.239273999303386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39881,0.00284391670932769,0.00241900741856965,-0.00189733783106883,0.0075851712497242,0.239750478849204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37035,0.00759101107114427,0.00645939596295181,-0.00506940501624128,0.0202514271585298,0.239940348332181
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39060,0.00308306905059852,0.00262801830424908,-0.00206784682572968,0.00823398492692673,0.240752611489996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37052,0.00507813121405751,0.00433202354323533,-0.00341263493068375,0.0135688973587988,0.241125593695786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37017,0.00500977463056722,0.00428721936550288,-0.00339317532581842,0.0134127245869529,0.242611379385886
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,39854,0.0200007132193038,0.0171526140326856,-0.01361841028476,0.0536198367233676,0.243613795109337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36958,0.00438706054177907,0.0037726980015249,-0.00300742754120973,0.0117815486247679,0.244913846267405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40007,0.0125514638912753,0.0107968344308952,-0.00861033159327937,0.03371325937583,0.245044196490214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37017,0.0075416341085163,0.0064935206474689,-0.00518566636052274,0.0202689345775553,0.245496630962445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40026,-0.00621546350852046,0.00535423100975028,-0.016709756287631,0.00427882927059009,0.245719709295922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37052,0.00623165895967821,0.00537602226623855,-0.00430534468214934,0.0167686626015058,0.246412788340254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37035,-0.0069919613536959,0.00604370337459513,-0.0188376199679024,0.00485369726051056,0.247334131702959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39485,0.00550275452643357,0.00477310891708898,-0.00385253895106083,0.014858048003928,0.248983065133275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39822,-0.00233633680236109,0.00203475586143184,-0.00632445829076749,0.00165178468604532,0.250897106606017
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39881,0.00488957689402747,0.00425953855309697,-0.0034591186700426,0.0132382724580975,0.251021891053948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37364,0.00391188927699571,0.00341022657782876,-0.00277215481554866,0.0105959333695401,0.251358390972089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37120,-0.0042676138475681,0.00374414813890739,-0.0116061441998266,0.00307091650469038,0.254386460341767
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39583,0.00588234325415554,0.00516614628822851,-0.00424330347077235,0.0160079899790834,0.254873719183099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39473,0.00969091056828504,0.00852028453875531,-0.00700884712767537,0.0263906682642454,0.255391556756083
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39485,-0.00436610224892442,0.0038710905043226,-0.0119534396373967,0.00322123513954788,0.259390463103261
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37035,0.00360970521065535,0.0032005891439242,-0.00266344951143608,0.00988285993274679,0.259414270923544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37017,0.00519161244645451,0.00460414511906334,-0.00383251198690963,0.0142157368798187,0.259511430588775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,39864,0.00357061989534464,0.00316892735999865,-0.00264047773025272,0.009781717520942,0.259860953822677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36987,0.00492059570866484,0.00436915387663576,-0.00364294588954125,0.0134841373068709,0.260096172112103
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37035,0.00615517654379838,0.00546628918329067,-0.00455875025545133,0.0168691033430481,0.260175582048038
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37017,0.00631151684718421,0.00560619792225997,-0.00467663108044534,0.0172996647748138,0.260266246499784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40026,0.00609295511330855,0.0054489468933099,-0.00458698079757885,0.016772891024196,0.26350269074292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,39927,0.00476515900849419,0.00426486135023696,-0.00359396923797024,0.0131242872549586,0.263879833817495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37017,0.00640909329115361,0.00575333823244891,-0.00486744964444627,0.0176856362267535,0.265308894328743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,36987,-0.00646813094295828,0.00581547797776436,-0.0178664677793764,0.00493020589345986,0.266060980371847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39858,0.0295883303226681,0.0266460257338103,-0.0226378801156001,0.0818145407609362,0.266833958085576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37052,0.00278497166676327,0.00251204446133365,-0.00213863547745068,0.00770857881097723,0.267602514291378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37017,0.007183745797705,0.00649026968647957,-0.00553718278779496,0.019904674383205,0.26837963576218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40048,0.00301650466588494,0.00272625417020855,-0.00232695350772383,0.0083599628394937,0.268541771659363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36987,0.00750641127341437,0.00679874761601409,-0.00581913405397324,0.020831956600802,0.269575483747946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,39862,0.00334796955087034,0.0030476614242688,-0.00262544684069651,0.00932138594243718,0.27198649636839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39485,0.00638153257634509,0.00581519951810734,-0.0050162584791453,0.0177793236318355,0.272488547155977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37408,-0.0080019758316397,0.00730182290604252,-0.022313548727483,0.00630959706420363,0.273147527076944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37052,0.00946672774636079,0.00865150859815466,-0.00749022910602234,0.0264236845987439,0.273874729695863
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37364,-0.00527709667146587,0.00482894740889196,-0.0147418335928941,0.00418764024996237,0.27449902956452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37364,0.00446499403317083,0.00410080510250579,-0.00357258396774051,0.0125025720340822,0.276257495397059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37017,0.00457527042824531,0.00420672967845745,-0.00366991974153129,0.0128204605980219,0.276788375129423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39862,0.00849051785498213,0.00781365607834368,-0.00682424805857147,0.0238052837685357,0.277218723471489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37433,-0.0076840299205493,0.0070852791409871,-0.021571177036884,0.00620311719578542,0.278159634531785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36987,-0.00838341399394231,0.00773266901398403,-0.023539445261351,0.00677261727346637,0.278315864294341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37035,-0.00410893419490371,0.00380375410802607,-0.0115642922466348,0.00334642385682738,0.28005897306881
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37384,0.00448797810600775,0.004168224206758,-0.00368174133923792,0.0126576975512534,0.281628039619412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37433,0.00775279591966698,0.00720084214484885,-0.00636085468423677,0.0218664465235707,0.281655221015052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,36987,0.00462651558368568,0.00429738714471979,-0.00379636321996511,0.0130493943873365,0.281684136635117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39745,-0.00684091806976878,0.00638715648941585,-0.0193597447890239,0.00567790864948629,0.284166451094406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36987,-0.0063230005588685,0.00590825235846731,-0.0179031751814644,0.00525717406372743,0.284549818007716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37039,-0.00499318788081202,0.00468500809744877,-0.0141758037518116,0.00418942799018757,0.286542633152583
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,36958,0.00691474347840862,0.00648806105949478,-0.00580185619820115,0.0196313431550184,0.286549873862452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39473,0.00386138014770689,0.00363092720678892,-0.0032552371775994,0.0109779974730132,0.287585561312117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39862,-0.00597436519889849,0.00561986107273386,-0.0169892929014569,0.00504056250365988,0.287761450304449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36987,0.00428535481342759,0.00403285397999271,-0.00361903898735812,0.0121897486142133,0.287977965228123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37017,0.00444300896913898,0.00418498482929852,-0.00375956129628612,0.0126455792345641,0.288411941311076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37384,-0.00243129909640913,0.00229418258856909,-0.00692789697000455,0.00206529877718629,0.28926952046939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37120,0.00356660862254113,0.0033666621996167,-0.0030320492887076,0.0101652665337899,0.289441450859193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39980,0.00676650608002755,0.00639875530437324,-0.00577505431654399,0.0193080664765991,0.290311965523269
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36987,0.0026979023094907,0.00255236155685497,-0.00230472634194505,0.00770053096092645,0.290521000029425
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39716,0.00315767877110328,0.00298772908671215,-0.00269827023885254,0.00901362778105909,0.290581289703819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,39581,0.0112218960799974,0.0106271028531413,-0.00960722551215957,0.0320510176721543,0.290998393907211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39583,0.00522315311020731,0.00495784535082092,-0.00449422377740169,0.0149405299978163,0.292122259725218
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37165,0.00557684506650577,0.00529614652510249,-0.00480360212269511,0.0159572922557066,0.292359874523883
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39583,-0.00589147347459503,0.00560063318522493,-0.0168687145176359,0.00508576756844583,0.292847881570346
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37408,-0.00589121693930841,0.00561202373068758,-0.0168907834514561,0.00510834957283926,0.29385220121701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36958,-0.00460701934905066,0.0043952718351327,-0.0132217521459107,0.00400771344780942,0.294576772470855
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39473,-0.00330328281522637,0.00316085331031286,-0.00949855530343957,0.00289198967298683,0.296011206413374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37165,0.00558866841361094,0.00536506316569832,-0.00492685539115777,0.0161041922183797,0.29757990695506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,39862,0.00887272416528877,0.00853103480766367,-0.00784810405773202,0.0255935523883096,0.298331219360453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,39842,0.00272178634989764,0.0026242474326525,-0.00242173861810126,0.00786531131789654,0.299673102556997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37052,0.00683743875757569,0.00659881242297635,-0.00609623359145796,0.0197711111066093,0.300145558432065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,37017,0.00448587785639671,0.00435993713823124,-0.00405959893453653,0.0130313546473299,0.303552207720772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37052,0.00587500731414647,0.00571461888364954,-0.00532564569780663,0.0170756603260996,0.303937472449576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40048,0.00267044727717819,0.00260158600276834,-0.00242866128824776,0.00776955584260415,0.304685925201516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37052,-0.00403598379966901,0.00394644540888921,-0.0117710168010919,0.00369904920175384,0.306473967838767
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,39881,0.00275039869812872,0.00269730580966596,-0.00253632068881657,0.00803711808507401,0.307893904302554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36958,0.00607643198749194,0.0059655908821077,-0.00561612614143915,0.017768990116423,0.308421182717746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37035,0.00489962176700051,0.00482776521665363,-0.0045627980576406,0.0143620415916416,0.310179753629012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,36987,-0.00489031850609053,0.00481912973491335,-0.0143358127865207,0.00455517577433963,0.31023316866591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37039,-0.00779767537167475,0.00768541831752086,-0.0228610952740156,0.00726574453066614,0.310312066352454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39862,0.00605797148950906,0.00597140160682082,-0.00564597565985975,0.0177619186388779,0.310360801271734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39994,0.00277169602548005,0.00273250081683582,-0.00258400557551815,0.00812739762647826,0.310433808587115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39581,0.00247119735223085,0.00243973766656296,-0.00231068847423255,0.00725308317869426,0.311126048620374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37165,0.00593382266434373,0.00586280129987338,-0.00555726788340809,0.0174249132120955,0.311502004079593
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39520,0.0042610364068228,0.00423995274100578,-0.00404927096554854,0.0125713437791941,0.314925562922854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39854,-0.00389642366036368,0.00388051675912629,-0.0115022365082512,0.00370938918752385,0.315346005539948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39583,0.0110232311359396,0.0109829789851965,-0.0105034076750456,0.0325498699469248,0.315555578817474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37039,-0.00471781871798309,0.00470376914698667,-0.013937206246077,0.00450156881011078,0.315885608646064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40026,-0.00387768416876349,0.00389133630635373,-0.0115047033292168,0.00374933499168982,0.31902623317418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36987,-0.00342266346337421,0.00343665568726119,-0.0101585086104062,0.00331318168365773,0.319303227212489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39440,0.00254465596537454,0.00255914797877706,-0.0024712740730285,0.00756058600377758,0.320074186575997
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37408,0.0103906407266694,0.0104706137909049,-0.0101317623035042,0.0309130437568429,0.32103862274489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,36987,0.00390864150437317,0.00394024101868706,-0.00381423089225347,0.0116315139009998,0.321225415190585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37433,-0.00360126536037327,0.00364223403051885,-0.0107400440601902,0.00353751333944368,0.322802229981497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,39581,0.00635371031837197,0.00646634324751979,-0.00632032244676681,0.0190277430835108,0.325828492607459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,39862,0.00525240010310811,0.00535086845825819,-0.00523530207507795,0.0157401022812942,0.326312927637384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,39867,0.00241548742107754,0.00246939595889118,-0.00242452865834918,0.00725550350050426,0.32800535942529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36987,0.00287326410347962,0.0029384045854182,-0.00288600888394005,0.00863253709089929,0.32817576587157
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37052,0.00275559705404396,0.00283362158840603,-0.00279830125923187,0.00830949536731978,0.330837233008458
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36958,0.00465197300342961,0.00478916132397156,-0.00473478319155466,0.0140387291984139,0.331389756570497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39485,0.00475142290040507,0.0048930295443088,-0.00483891500644017,0.0143417608072503,0.331533673693406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39854,-0.00291153819778331,0.00301163850775035,-0.00881434967297399,0.00299127327740737,0.333677554569349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40007,0.00373445728195297,0.00386695995561029,-0.0038447842310432,0.0113136987949491,0.334191431576708
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39425,0.00761596078371895,0.00788809509844519,-0.00784470560923362,0.0230766271766715,0.334309121245116
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37017,0.00872397474680574,0.00907608686892131,-0.00906515551628003,0.0265131050098915,0.336467062279423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37017,0.00553107703395558,0.00576955761824437,-0.00577725589780339,0.0168394099657145,0.337744795186104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36987,0.00600673951921102,0.00628647781712435,-0.0063147570023527,0.0183282360407747,0.339341699452536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39485,0.00492928009078853,0.00516606482878943,-0.00519620697363875,0.0150547671552158,0.340014708351911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39583,0.00568180614006694,0.00596185604206401,-0.00600343170237852,0.0173670439825124,0.340591350537188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37039,-0.00228175888031126,0.00239808289632463,-0.00698200135710753,0.00241848359648501,0.34137166371255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40005,-0.0118777661436022,0.0125384139783487,-0.0364530575411656,0.0126975252539613,0.34349496611065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39854,0.00229133091464124,0.00241936540724227,-0.0024506252835536,0.00703328711283609,0.343612676328298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37441,-0.005324019304194,0.00562932860928347,-0.0163575033783896,0.0057094647700016,0.344285528701056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,36958,0.00357694986243354,0.00379184115087194,-0.00385505879327546,0.0110089585181425,0.34553056642402
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36958,0.0047534842220792,0.00505625841304576,-0.00515678226749049,0.0146637507116489,0.347173899418859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36958,0.00307601069444809,0.00327741045071542,-0.00334771378895413,0.00949973517785031,0.347979592586172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37165,0.00744745535799374,0.00795408779686699,-0.00814255672386557,0.023037467439853,0.349132962573764
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37052,-0.00183807309223442,0.00197422781678236,-0.00570755961312784,0.002031413428659,0.351853048074236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37378,0.00227809742726504,0.00245450211987233,-0.00253272672768472,0.0070889215822148,0.353356631749306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37035,0.00368294993518695,0.00397060340189109,-0.00409943273251959,0.0114653326028935,0.353655846588428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,36987,0.00757671043014943,0.00819675235307908,-0.00848892418188557,0.0236423450421844,0.355318417297525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37039,-0.0034566681081449,0.00374070221518876,-0.0107884444499149,0.00387510823362507,0.355467150096995
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39862,-0.00423513010509492,0.00458821456074567,-0.0132280306441564,0.00475777043396659,0.355997490891772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39958,0.00246803735405985,0.00269383545929596,-0.00281188014616024,0.00774795485427994,0.359586376774016
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37035,0.00560510476800054,0.00611893390707702,-0.00638800568987043,0.0175982152258715,0.359669834082105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37035,-0.00245104418562591,0.00267874605977609,-0.00770138646278705,0.00279929809153523,0.360210033588293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,39800,0.00383341066186445,0.00420494368283738,-0.00440827895649681,0.0120751002802257,0.361970065874388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37364,0.00887313950731665,0.0098325759214145,-0.0103987092986558,0.0281449883132891,0.366848473684445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36987,0.00468642925403936,0.00523161114385898,-0.00556752858792424,0.014940387096003,0.370380917719971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37017,-0.00418548407484922,0.00467279765464435,-0.0133441674779521,0.0049731993282537,0.370422627285288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39583,-0.00488729643949489,0.00548863297383106,-0.0156450170682038,0.005870424189214,0.373243483143927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39635,0.013808284002915,0.0155109651648187,-0.0165932077201297,0.0442097757259596,0.3733574467213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37165,0.0133121063997576,0.0149582848364589,-0.0160061318797018,0.0426303446792169,0.373509514217586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37052,0.00247702129350944,0.00278365575065673,-0.00297894397777775,0.00793298656479663,0.373565511980172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37165,0.00183194625633743,0.00205919199798814,-0.00220407005971932,0.00586796257239419,0.373673561315021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39927,0.00210263814590757,0.00236421157732685,-0.00253121654565307,0.0067364928374682,0.373822282701846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39864,0.0024727060625146,0.00278540631654249,-0.00298669031790869,0.00793210244293788,0.374696001208095
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37408,-0.0126121226471389,0.0142235188348512,-0.0404902195634471,0.0152659742691694,0.375251312681934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40054,0.00305448126707392,0.00345574921627443,-0.00371878719682397,0.0098277497309718,0.376771984044618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37052,0.00480050489281346,0.00544001690195048,-0.00586192823500948,0.0154629380206364,0.37755336432718
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37017,0.00677603104605058,0.00770398864318809,-0.00832378669459809,0.0218758487866992,0.379120054876624
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37433,0.00470877712402324,0.00536409261017112,-0.00580484439191217,0.0152223986399586,0.38004993000039
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40034,0.00415487101033574,0.00473465444615016,-0.00512505170411856,0.01343479372479,0.380203874567515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39784,-0.00352098569858603,0.00401994117792348,-0.0114000704073161,0.00435809901014398,0.381108536313321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37143,0.00415833668414312,0.00475276751010369,-0.00515708763566011,0.0134737610039463,0.381628065142616
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36987,0.00267670706998383,0.00307719295166347,-0.00335459111527656,0.00870800525524423,0.384396373016478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,39709,0.00253638471008322,0.00291775768985777,-0.00318242036203802,0.00825518978220445,0.384700359311041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39312,-0.00273635052772099,0.00315538291132841,-0.00892090103392468,0.0034481999784827,0.385845474297401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37364,0.00480236262606443,0.00553969942073746,-0.006055448238581,0.0156601734907099,0.386012483608233
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39485,0.00412184646053261,0.0047554029524907,-0.00519874332634916,0.0134424362474144,0.38608067914281
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36987,0.0064937304585772,0.00749965279436311,-0.0082055890183745,0.0211930499355289,0.386576835309259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,39842,0.0140436929177149,0.016358628569139,-0.0180192190777976,0.0461066049132273,0.390635706156515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37165,0.00510938486319281,0.00595371794923106,-0.00655990231730008,0.0167786720436857,0.390806386221879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37433,-0.00231227089870385,0.00269793178116156,-0.00760021718978052,0.00297567539237281,0.391430649875016
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37231,0.00264332184461811,0.00309801592005703,-0.00342878935869368,0.00871543304792989,0.393546745838409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36958,0.00489399994632257,0.00574638199528914,-0.00636890876444414,0.0161569086570893,0.394414895408401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37017,-0.0030082368753833,0.00353409246933289,-0.00993505811527578,0.00391858436450917,0.394671025177065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39581,0.00600927720341006,0.00711323935446602,-0.00793267193134334,0.0199512263381635,0.398234381686587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37035,0.00464251188690011,0.0055069139633349,-0.00615103948123629,0.0154360632550365,0.399225120954649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39485,0.00463081409521462,0.0055022420079856,-0.00615358024043716,0.0154152084308664,0.400011823245143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39581,-0.00454252563682015,0.00544693287168145,-0.0152185140653158,0.00613346279167549,0.404316040538337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37052,0.00531538806414479,0.00638563011638632,-0.00720044696397241,0.017831223092262,0.405199193250025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37039,-0.00319031295298147,0.0038391915273634,-0.0107151283466137,0.00433450244065079,0.405996807052417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36987,0.00550895560300072,0.0066454275444159,-0.00751608238405445,0.0185339935900559,0.407128321440053
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,36958,0.003497025807744,0.004237428897947,-0.00480833483223212,0.0118023864477201,0.409232966534675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,39927,-0.00571444352401309,0.0069337154813659,-0.0193045258674903,0.00787563881946407,0.409864771657772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36958,-0.00429757388688198,0.00521452419574964,-0.0145180413105513,0.00592289353678731,0.40986675013907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37408,-0.00262106333277652,0.00318883525309408,-0.00887118042884091,0.00362905376328787,0.411119783981154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37418,0.00341545036148085,0.00419507895136845,-0.00480690438320132,0.011637805106163,0.415569660145275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37017,-0.0029791502059462,0.0036660117783218,-0.0101645332914569,0.00420623287956452,0.416438819864271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,36987,0.00344772032130781,0.00424415985962604,-0.00487083300355922,0.0117662736461748,0.416608659575177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37364,0.00266895130607739,0.00329431419788798,-0.00378790452178305,0.00912580713393783,0.417857316350307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37441,0.00253892181336815,0.0031501047904999,-0.00363528357601166,0.00871312720274795,0.420268428215803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,39486,0.00308301900378188,0.00382820812949943,-0.00442026893003701,0.0105863069376008,0.420634272062691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36958,-0.00585659421178681,0.00727996753762635,-0.0201253305855345,0.00841214216196084,0.421133946632013
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37017,0.00717856902082116,0.00893423431585836,-0.0103325302382612,0.0246896682799035,0.421706019318167
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37379,0.00135331181803906,0.00168812180496596,-0.00195540691969423,0.00466203055577235,0.422759605708377
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39119,-0.0020342882048685,0.00254316086707471,-0.00701888350433493,0.00295030709459793,0.423778039699368
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,39854,-0.00332608363288301,0.00415970283174741,-0.0114791011831079,0.00482693391734192,0.423956517607342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,36958,0.0035381068324133,0.00442859109889677,-0.00514193172142437,0.012218145386251,0.424349083653874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36958,-0.00286924329298863,0.00359520196118946,-0.00991583913691998,0.00417735255094272,0.424841035512848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,39904,-0.00192278142397047,0.00241311269992896,-0.00665248231583123,0.0028069194678903,0.425575802452362
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37165,-0.00426899806998085,0.00540336978108615,-0.0148596028409097,0.006321606700948,0.429505540227275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,39811,0.00426031112668878,0.0053938424418138,-0.00631162005926625,0.0148322423126438,0.429628775333987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39473,-0.0023108712250561,0.00292854159766843,-0.00805081275648623,0.00342907030637403,0.430073715997245
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36987,0.00548652949773978,0.00695923740718632,-0.00815357582034542,0.019126634815825,0.430488205763758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37035,-0.00240860447856683,0.00306287612681389,-0.00841184168712206,0.0035946327299884,0.431655225762073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37035,-0.00487074766218978,0.00619610069546194,-0.0170151050252952,0.00727360970091563,0.431823712761364
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37017,0.00333917713853899,0.00425814015480874,-0.00500677756488614,0.0116851318419641,0.432944649460651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,39927,0.00307827915881429,0.00394036217029475,-0.00464483069496343,0.010801389012592,0.434686201438941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,36814,0.0027584987316808,0.00354085784265182,-0.00418158263991676,0.00969858010327835,0.43596558598176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39473,0.011599367119341,0.0148919303699865,-0.0175888164058324,0.0407875506445145,0.436048745437767
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36987,0.00418571710990386,0.00537690991754892,-0.00635302632849202,0.0147244605482997,0.436311053699793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37035,0.00550959025538616,0.00708743812278929,-0.00838178846528084,0.0194009689760532,0.436952094290914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39973,0.00725406978247425,0.00933686158415034,-0.0110461789224604,0.0255543184874089,0.437212618806833
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39473,0.00548390576124778,0.00706449284636724,-0.00836250021763201,0.0193303117401276,0.437605360831031
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,36958,0.00236398879468632,0.00305289637396706,-0.00361968809828912,0.00834766568766175,0.438741985984986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37039,-0.00232972530229623,0.00301236870802229,-0.00823396797001992,0.00357451736542746,0.439307546330306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37052,0.00326148483689464,0.0042181127036844,-0.00500601606232678,0.0115289857361161,0.439412255622047
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36987,0.00523051817959215,0.0067764144649346,-0.00805125417167966,0.018512290530864,0.440204697341647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39583,0.00454064918255312,0.00591341944358547,-0.0070496529268744,0.0161309512919806,0.44258481599739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37035,0.00536807072465258,0.00699303947513859,-0.00833828664661905,0.0190744280959242,0.442720465066037
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,39745,0.000846052137868941,0.00111233564163803,-0.00133412571974159,0.00302622999547947,0.446902126583275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37433,0.00203454687043299,0.0026764209667605,-0.00321123822441759,0.00728033196528357,0.4471635114053
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37017,0.00429902134084941,0.00565839246921491,-0.00679142789881181,0.0153894705805106,0.447411555474865
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37017,0.0023767150008267,0.00313215602564699,-0.0037623108094414,0.0085157408110948,0.447979111591194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37035,0.00241912729123935,0.00319014924802254,-0.00383356523488483,0.00867181981736352,0.448278007933075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,39854,-0.00163832309317543,0.00216061541176398,-0.00587312930023283,0.00259648311388197,0.448302407000727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40048,0.00209299482582382,0.00276189488550987,-0.00332031914977552,0.00750630880142316,0.448575058833522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,39864,0.00350308277063818,0.0046404829115727,-0.00559226373604432,0.0125984292773207,0.450322393218959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37052,-0.00223241742860981,0.00295994678345484,-0.0080339131241813,0.00356907826696169,0.450737414318492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39583,0.00267055558283036,0.00354420396503029,-0.00427608418862901,0.00961719535428973,0.451161150771449
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37131,0.00346066529711155,0.00459873745776304,-0.005552860120104,0.0124741907143271,0.451748697524978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,37433,-0.00252875539811752,0.0033610485048766,-0.00911641046767566,0.00405889967144062,0.451841033328307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39485,0.00320619198091486,0.00426355431315021,-0.00515037447285955,0.0115627584346893,0.45206250781415
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39838,0.00444625141708588,0.00591919933853839,-0.00715537928644936,0.0160478821206211,0.452568892296691
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39581,0.00333893011633256,0.00444906779768868,-0.00538124276713726,0.0120591029998024,0.452977747132957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37017,-0.00279807053103986,0.00373015706264465,-0.0101091783738234,0.00451303731174365,0.453195022436989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37364,-0.00361782188601564,0.00483748507942306,-0.0130992926416848,0.00586364886965356,0.454550111309063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37011,0.0026981799217687,0.00361428858110859,-0.00438582569720414,0.00978218554074154,0.455359814595825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37035,0.00234029175127215,0.00314839560588714,-0.00383056363626664,0.00851114713881095,0.457296158389888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,39581,-0.00349108325538306,0.00470412375779253,-0.0127111658206564,0.0057289993098903,0.458018130874772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37035,-0.00325815967115428,0.00439160752327563,-0.0118657104167745,0.00534939107446595,0.458157556797747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36938,-0.00416940168586106,0.00563622048121452,-0.0152163938290415,0.0068775904573194,0.459464164616222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,39583,0.00210361709451133,0.00284610751689332,-0.00347475363859958,0.00768198782762224,0.459844717570492
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37384,0.00150568234841166,0.00203986387182103,-0.00249245084035756,0.00550381553718088,0.460448969141246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,39843,-0.00341370440942028,0.00464353415830689,-0.0125150313597018,0.00568762254086121,0.462257585521498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39485,-0.00213259711054946,0.00290873983329962,-0.00783372718381672,0.00356853296271779,0.46346651955862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39663,0.00251168714075972,0.00344147920647934,-0.00423361210393978,0.00925698638545922,0.465506277167956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37017,0.00576036375001979,0.00789526236465841,-0.0097143504847107,0.0212350779847503,0.465649234073397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,39893,0.00237135435728887,0.0032537026053138,-0.00400590274912618,0.00874861146370392,0.466124146461571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39697,-0.00411846718149804,0.0056967234423656,-0.0152840451285346,0.00704711076553853,0.469719018138827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40048,0.00153805969310588,0.00212783922187747,-0.00263250518177396,0.00570862456798572,0.469796604792521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,36958,0.00236344967712286,0.00327692082310322,-0.00405931513615946,0.00878621449040518,0.470774118628666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,39801,-0.00261524931532649,0.00363188705238786,-0.00973374793800669,0.00450324930735371,0.471486283682939
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36958,-0.00241889290414235,0.00336286629693297,-0.00901011084613098,0.00417232503784627,0.471972010457956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37017,0.00272733058690764,0.00379646725589783,-0.0047137452346521,0.0101684064084674,0.472531803467878
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,36958,0.00344471011160027,0.00480877713763226,-0.00598049307815895,0.0128699133013595,0.473795399227712
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,39709,-0.00304443303023308,0.0042849358645761,-0.0114429073248022,0.00535404126433608,0.477406596453062
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36958,0.00279869200460828,0.00393938050069687,-0.00492249377675758,0.0105198777859741,0.477444207307003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39473,0.00401003557571167,0.00565276146902871,-0.00706937690358459,0.0150894480550079,0.47809054772643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37052,0.0026489660939055,0.00376730208338044,-0.00473494598952016,0.0100328781773312,0.481976729064761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36987,0.005818567983627,0.00831062429418496,-0.0104702556329755,0.0221073916002295,0.483854727994495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,36958,0.003784968381962,0.00541095811468348,-0.00682050952281762,0.0143904462867416,0.484251667710548
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37035,0.00352139773621021,0.00503836708153069,-0.00635380174358995,0.0133965972160104,0.484616571167337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39485,0.00221001893964631,0.00317024878838942,-0.00400366868559694,0.00842370656488957,0.485742984368429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37378,-0.00498541897291991,0.00717963203639621,-0.0190574977642565,0.00908665981841665,0.487453588658707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37384,0.00234152205646148,0.00337577273590585,-0.00427499250591399,0.00895803661883694,0.487929009594147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,39581,0.00679724398151883,0.00980628417312102,-0.0124230729977984,0.026017560960836,0.4882245034869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36958,0.00425661384893063,0.00614555459878035,-0.00778867316467885,0.0163019008625401,0.488552182014198
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36958,0.00185514161170844,0.00268361303007307,-0.00340473992723477,0.00711502315065166,0.489398666275629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40048,0.00183261229774366,0.00265564244842612,-0.00337244690117152,0.00703767149665885,0.490152219958697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,39583,0.00328554411383566,0.00477787425702471,-0.00607908942993276,0.0126501776576041,0.491678231436374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37165,0.00334666133282756,0.00489612890116349,-0.00624975131345288,0.012943073979108,0.494282568477278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37302,0.00187668621001948,0.00275442684053999,-0.0035219903974389,0.00727536281747785,0.495671555001397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37035,-0.00139818073919271,0.0020568693230692,-0.00542964461240834,0.00263328313402291,0.496667380775383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36987,0.00345591694098527,0.00509036843046749,-0.00652120518273102,0.0134330390647016,0.497205002261221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37364,0.00412241607994689,0.0061096676567031,-0.00785253252719119,0.016097364687085,0.499854709534773
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37052,0.00534637956644154,0.00795484175441364,-0.0102451102722092,0.0209378694050923,0.5015373745247
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39854,0.00182671347344415,0.00271875649083788,-0.00350204924859808,0.00715547619548639,0.501661517534779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37017,0.00230432462058862,0.00343275783613677,-0.00442388073823945,0.00903252997941669,0.502057123173958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37165,0.00315516353400018,0.00470768496723952,-0.00607189900178928,0.0123822260697896,0.502732042995725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37052,0.00304166794080767,0.00455378065745615,-0.00588374214780639,0.0119670780294217,0.504181378901464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39473,0.00531843342619456,0.00797239951568453,-0.0103074696245471,0.0209443364769362,0.504714456922439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39485,0.00473299232742755,0.00710322212550513,-0.00918932303856251,0.0186553076934176,0.505218818803853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,35636,-0.00608336791490637,0.00915548583810163,-0.0240281201575856,0.0118613843277728,0.506414976632682
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39784,-0.00635981746487755,0.00957917265328824,-0.0251349958653225,0.0124153609355674,0.506750247996379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36987,-0.00396609535600625,0.00598473181424245,-0.0156961697119214,0.00776397899990894,0.507532891181015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39485,0.00441271897205899,0.00667514445107062,-0.00867056415203943,0.0174960020961574,0.508578973431183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37017,-0.00219840743556711,0.00333157416018395,-0.00872829278952766,0.00433147791839344,0.509348500977361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,36958,0.0026630105900026,0.00406393807837581,-0.00530230804361398,0.0106283292236192,0.512300073134435
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37039,0.00357190108312227,0.00546452753516884,-0.00713857288580864,0.0142823750520532,0.513347234468957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40026,0.00121036515136458,0.00185467567306323,-0.00242479916783936,0.00484552947056852,0.514022141410789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,36987,0.00547083279455467,0.0085443002999987,-0.0112759957934428,0.0222176613825521,0.521995046773954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39670,0.0034154144855897,0.00534513197488184,-0.00706104418517871,0.0138918731563581,0.522847383501553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37433,-0.00228916654705289,0.00358861035001492,-0.00932284283308213,0.00474450973897634,0.523550989249412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37441,-0.00296966404273062,0.00466466919582905,-0.0121124156665555,0.00617308758109432,0.524377210617122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37035,-0.00236497930713423,0.00371642835309578,-0.00964917887920196,0.00491922026493351,0.524554095186768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,39581,-0.00279757693790011,0.00441189202415279,-0.0114448853052396,0.00584973142943936,0.526025350070058
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39750,0.00344884784061919,0.00544776847624516,-0.00722877837282132,0.0141264740540597,0.526693560457009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37039,-0.00173794392928658,0.00274534209207918,-0.00711881442976177,0.00364292657118861,0.526710759028798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,36699,-0.00401201623324436,0.00635107374930399,-0.0164601207818802,0.00843608831539146,0.527589755733623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37035,0.00386379273135279,0.00616723103263029,-0.00822398009260258,0.0159515655553082,0.530995500374071
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37165,0.00200542600283126,0.0032130678118498,-0.00429218690839434,0.00830303891405686,0.532541880393966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,36864,0.00244897331570169,0.0039442417212165,-0.00528174045788265,0.010179687089286,0.534677365857027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36958,0.00344597597052888,0.00556089196368232,-0.00745337227828847,0.0143453242193462,0.535478976077379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36958,0.00233800785346695,0.00377742791051309,-0.00506575085113872,0.00974176655807261,0.53596549539361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37165,-0.00246383309988006,0.00401678922823551,-0.0103367399872217,0.00540907378746154,0.539633136676937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39862,0.00275729429804496,0.00450000316537918,-0.00606271190609824,0.0115773005021882,0.540062508572748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39852,-0.00237222961533353,0.00387727017409892,-0.00997167915656743,0.00522721992590036,0.540659038280592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39583,0.00331211766647723,0.00541749464545917,-0.00730617183862274,0.0139304071715772,0.540960569746321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,36958,0.00329033619218463,0.00542125879772364,-0.0073353310513537,0.013916003435723,0.543906469213434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37035,0.00281229488262001,0.00464389534069548,-0.00628973998514314,0.0119143297503832,0.544797718690916
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40048,0.00148982707248803,0.00247141807427322,-0.00335415235308748,0.00633380649806354,0.546635046584908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37408,0.00214844762998596,0.00357172527235584,-0.00485213390383149,0.00914902916380341,0.547506845857134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37408,0.00162887406512213,0.00271576966219092,-0.00369403447277208,0.00695178260301633,0.548660504947347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39485,0.0029715341494761,0.00495949585376608,-0.00674907772390542,0.0126921460228576,0.549074529290417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37426,-0.00589761771773123,0.00986031089862623,-0.0252238270790387,0.0134285916435762,0.549771978270646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39485,0.00212173225658538,0.00358983970153336,-0.00491435355842001,0.00915781807159077,0.554503401339621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37052,0.00179250871191001,0.00304316651925108,-0.00417209766582211,0.00775711508964214,0.555852924125045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37035,0.00223884421545685,0.00380620804514353,-0.00522132355302448,0.00969901198393817,0.556402383961976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37408,-0.00169718765075324,0.00288545442671577,-0.00735267832711615,0.00395830302560967,0.556416384810342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36958,0.00226542037193441,0.00386169487168575,-0.00530350157656966,0.00983434232043849,0.557456371687552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37364,0.00440713066524008,0.00757608174058522,-0.010441989546307,0.0192562508767871,0.560767462589852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37017,0.0026653510603109,0.00460430700471774,-0.00635909066893587,0.0116897927895577,0.562678616275246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37017,-0.00259361876290896,0.00450191157635548,-0.0114173654525657,0.00623012792674778,0.564547311369189
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37035,0.00162114019129199,0.00282775030339424,-0.00392125040336072,0.0071635307859447,0.56645353860627
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36958,0.00260045357526666,0.00453781084914425,-0.00629365568905607,0.0114945628395894,0.566611566063647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39927,-0.00221195416193268,0.00386461111117345,-0.00978659193983264,0.00536268361596728,0.567085180218933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37052,0.00242200082719778,0.00423788189366991,-0.00588424768439524,0.0107282493387908,0.567662289834098
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37157,0.00504732415828101,0.00886886450299619,-0.0123356502675915,0.0224302985841535,0.569293807266568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36958,-0.0013466923276939,0.00237707145206722,-0.00600575237374565,0.00331236771835785,0.57104038248382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40026,0.00287197660336765,0.00507609195104132,-0.00707716362067335,0.0128211168274086,0.571547808208895
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37364,-0.00392522488018544,0.00693962484154809,-0.0175268895696197,0.00967643980924882,0.571658168224019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37441,0.00315532338080884,0.00560556070447153,-0.00783157559995535,0.014142222361573,0.573517950142552
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39862,0.00176319787140791,0.00313631049502762,-0.00438397069884623,0.00791036644166204,0.573995431592581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36987,0.00306006929624759,0.00555289589648052,-0.00782360666085424,0.0139437452533494,0.581590753616312
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37408,0.00288730561940792,0.00524923692866703,-0.00740119876077946,0.0131758099995953,0.582299001737047
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,36958,-0.00219084694249897,0.00398344229277703,-0.00999839383634194,0.005616699951344,0.582336726990161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,37017,0.00186874762979472,0.00340246399701406,-0.00480008180435285,0.00853757706394229,0.582854453677858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37093,-0.0013875310026064,0.00255947342779313,-0.00640409892108094,0.00362903691586813,0.587747858399646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39986,-0.00303726292720455,0.00563238202106641,-0.0140767316884947,0.00800220583408561,0.589721695920806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37039,0.00157929244178605,0.00296297737856195,-0.00422814322019537,0.00738672810376747,0.594036610460702
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37035,0.00408367417639674,0.00770085624181757,-0.0110100040575657,0.0191773524103592,0.595920975433556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36958,-0.00286698208824608,0.00540826724918159,-0.013467185896642,0.00773322172014984,0.596043942409951
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37017,-0.00158161177418211,0.00299653648809513,-0.00745482329084856,0.00429159974248435,0.59763783483132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,39840,0.00593373962611757,0.0112956678476182,-0.0162057693552141,0.0280732486074492,0.599374235303372
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,36958,0.00169698590470736,0.00323140785422083,-0.00463657348956546,0.00803054529898019,0.599485212561658
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37384,0.00179986304859326,0.00344077499097885,-0.00494405593372529,0.00854378203091181,0.600914519531345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39581,0.00268090120636428,0.00514139602369493,-0.00739623500007778,0.0127580374128063,0.602071476387479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36426,0.0024382074223902,0.00468493340895045,-0.00674426205915269,0.0116206769039331,0.602768979597214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37035,-0.00181594567094059,0.00348977689240946,-0.00865590838006313,0.00502401703818196,0.6028203560262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39745,-0.003276142458586,0.00634181429986053,-0.0157060984863126,0.00915381356914064,0.60544687993385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39473,0.00217085978351786,0.00421103967048657,-0.00608277797063582,0.0104244975376715,0.606199549370291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,39988,-0.00197241051503757,0.00383265170457125,-0.00948440785599723,0.00553958682592209,0.60681628446203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37245,0.00282196305934064,0.00550931257465417,-0.00797628958698153,0.0136202157056628,0.60850766139911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,39583,0.00668422059803875,0.0130782823000636,-0.0189492127100859,0.0323176539061634,0.609293003278495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36958,0.00341240887725698,0.00670076479835725,-0.00972109012752324,0.0165459078820372,0.61058093473438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,39927,0.00138375837815327,0.0027228090322083,-0.003952947324975,0.00672046408128153,0.611313158796654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37035,0.00357588035485445,0.0070550454214037,-0.0102520086710968,0.0174037693808057,0.612265511222231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37364,-0.00272260600885347,0.00539960359132852,-0.0133058290478574,0.00786061703015043,0.614112686463505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37364,0.00178501229463759,0.00354089347480984,-0.0051551389159897,0.00872516350526488,0.614189826829066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37017,-0.00217829116158047,0.004327059875056,-0.0106593285166902,0.0063027461935293,0.614683503473206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36987,0.00157453989741331,0.00313240695914203,-0.00456497774250506,0.00771405753733168,0.615210823278228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,36987,0.00291673387372235,0.00582449028084991,-0.00849926707674347,0.0143327348241882,0.616540928881466
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40054,0.00226098793377521,0.00451503732650402,-0.00658848522617266,0.0111104610937231,0.616540946397888
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37378,-0.00203882532623254,0.00409416415187953,-0.0100633870639164,0.00598573641145133,0.618503922354476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39581,-0.00279257898054135,0.00562781265526005,-0.0138230917848511,0.00823793382376835,0.619752935098442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37433,0.00114346662692844,0.0023073104861469,-0.00337886192591948,0.00566579517977636,0.620195824338994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37017,0.00209445595155799,0.00422865711428697,-0.00619371199244447,0.0103826238955605,0.620396295045246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37441,-0.00213213882528645,0.00431023198305159,-0.0105801935120676,0.00631591586149468,0.620841677693521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,39583,0.00221892616282842,0.00449986473666124,-0.00660080872102762,0.0110386610466844,0.621942087693018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36958,-0.00115650142194824,0.00234804760572539,-0.00575867472917,0.00344567188527352,0.622347697401715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37017,-0.00208370985480564,0.00423201652454928,-0.0103784622429222,0.00621104253331094,0.622467375105065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,36958,0.00316450130184729,0.0064623124405219,-0.00950163108157563,0.0158306336852702,0.624364598878661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37017,-0.0051384600603031,0.0104988008123293,-0.0257161096524685,0.0154391895318624,0.624543304644511
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37052,0.00161146094490368,0.00330020812922267,-0.00485694698837274,0.00807986887818011,0.625352062266518
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37165,0.00184288675703061,0.00379797341624865,-0.00560114113881674,0.00928691465287797,0.627521918237642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37052,-0.00200371126640744,0.00413191821612159,-0.0101022709700058,0.00609484843719087,0.627730590922653
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37039,0.00263801975377331,0.0054507217832031,-0.00804539494130477,0.0133214344488514,0.628410783770277
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37344,0.00178936315738554,0.00371111846850653,-0.00548442904088727,0.00906315535565834,0.629698148787126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39864,0.00116704450710584,0.00243182092770377,-0.00359932451119355,0.00593341352540523,0.631301070108637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36996,0.00174203893733645,0.00363704669674551,-0.00538657258828475,0.00887065046295764,0.631967419222333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36958,0.00360113639318704,0.00755806048300577,-0.0112126621535043,0.0184149349398784,0.633752488133748
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37364,-0.00190594251910224,0.00401599840125873,-0.00977729938556935,0.00596541434736486,0.63508871353028
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37165,-0.00227136286664461,0.00479752813173505,-0.0116745180048453,0.00713179227155609,0.635903921316744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37384,0.00297058425690891,0.00630613641225309,-0.00938944311110713,0.015330611624925,0.637603715755543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37035,-0.00213509003387229,0.00454216094646259,-0.011037725488939,0.00676754542119438,0.638319639006337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37017,0.00205963257801109,0.00441948112370341,-0.00660255042444759,0.0107218155804698,0.641198212871486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36958,-0.00333905874290608,0.00722068773335675,-0.0174916067002853,0.0108134892144732,0.643781057134651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39473,0.00424118844668725,0.00920199526921708,-0.0137947222809782,0.0222770991743527,0.644877642743713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37052,0.00172430873002974,0.00374742803789155,-0.0056206502242377,0.00906926768429718,0.645429601541504
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36958,0.00139662053017562,0.00304125198435405,-0.00456423335915832,0.00735747441950956,0.646079845622111
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37039,0.00169869996566817,0.00372047497391585,-0.00559343098320689,0.00899083091454323,0.647979418602784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37364,0.00206383493222634,0.00458323699985814,-0.00691930958749562,0.0110469794519483,0.652500846960105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39842,-0.00280009857290015,0.00621918174159679,-0.0149896947864299,0.00938949764062956,0.652546496599309
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37157,0.00403003733901804,0.00897334414339978,-0.0135577171820455,0.0216177918600816,0.653358119062136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37433,0.00117985856693049,0.00263795175565233,-0.00399052687414807,0.00635024400800905,0.654692219614423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37433,-0.0010304992322445,0.00230529929706155,-0.00554888585448514,0.00348788738999613,0.654872656589696
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37364,0.00206074073866635,0.00461509208560819,-0.00698483974912571,0.0111063212264584,0.655227292282979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37052,0.00128889411220182,0.00290157209695079,-0.00439818719782173,0.00697597542222538,0.656901345363252
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37165,0.00217580420605988,0.0049015722829193,-0.00743127746846194,0.0117828858805817,0.657122653654562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36958,-0.00194806365056526,0.00441715067172316,-0.0106056789671427,0.00670955166601214,0.65920385322022
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37165,-0.00310745044799085,0.00710798282824711,-0.0170390967913552,0.0108241958953735,0.661989692173271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,36987,-0.00189127345300775,0.00440841088994854,-0.0105317587973069,0.00674921189129139,0.66791950484655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,39771,-0.00129655601179183,0.00304237139649286,-0.00725960394891783,0.00466649192533418,0.669992472645232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39745,-0.00231486543608883,0.00545047173247116,-0.0129977900317323,0.00836805915955465,0.671054435590482
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36958,0.00331114939253678,0.00782715983327484,-0.0120300838806819,0.0186523826657555,0.672277897722921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36987,0.00129517244148737,0.00306208334607278,-0.00470651091681528,0.00729685579979002,0.672323351542145
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37441,-0.00234079400331918,0.0055425192665083,-0.0132041317656754,0.00852254375903708,0.672787973511789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39832,0.00324593662202408,0.00772371731676286,-0.0118925493188311,0.0183844225628793,0.674304284540399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37165,0.0032713027831075,0.00785140320789539,-0.0121174475043675,0.0186600530705825,0.676939695910755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37091,0.00535496637229245,0.0128695875194636,-0.0198694251658562,0.0305793579104411,0.67734750154426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36987,0.00121510949389623,0.00292101657144942,-0.00451008298614462,0.00694030197393709,0.67742517059933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37052,-0.00172000442169399,0.00415044809656772,-0.00985488269096671,0.00641487384757873,0.678577565662393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37120,0.000791536699993035,0.00191084711514921,-0.00295372364569942,0.00453679704568549,0.67870988261075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37017,0.00171413900987054,0.0041444463717423,-0.00640897587874437,0.00983725389848546,0.679174522996537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36998,0.00309385776040841,0.00754014933606555,-0.0116848349382801,0.0178725504590969,0.681579500636352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36958,-0.00244741599956063,0.00601945396633072,-0.0142455457735688,0.00935071377444758,0.684319909516231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39862,-0.00192423639907575,0.00474715211377397,-0.0112286545420727,0.00738018174392122,0.685229038507964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37165,-0.00148174960962398,0.00365999048751999,-0.00865533096516316,0.0056918317459152,0.68559378748338
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37441,-0.000806576240593075,0.00202912352534991,-0.0047836583502789,0.00317050586909275,0.69100516475108
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37364,-0.00159478768160364,0.00401692535969023,-0.00946796138659648,0.0062783860233892,0.69136119394977
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37052,0.00365768991836765,0.00922856782170952,-0.014430303012183,0.0217456828489183,0.691857487965527
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36958,0.0017936987869487,0.00453574554480009,-0.00709636248085948,0.0106837600547569,0.69251103922097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37017,-0.00200954141337984,0.00510131132754495,-0.0120081116153679,0.00798902878860826,0.693641732631897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37017,-0.00109171915704211,0.00278714410827041,-0.00655452160925212,0.00437108329516789,0.695287609840314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37408,0.00156931883826698,0.00401796604074167,-0.00630589460158669,0.00944453227812065,0.696117226442059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37347,0.00176380710868274,0.00455827475894965,-0.00717041141885856,0.0106980256362241,0.69880214058572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37035,-0.00205947138195839,0.00538275310068717,-0.0126096674593052,0.00849072469538846,0.702018402842805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37035,0.00228952155103553,0.00600252519413718,-0.00947542782947334,0.0140544709315444,0.702893028507021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,36927,-0.00120753447830795,0.00319945698302413,-0.00747847016503524,0.00506340120841934,0.705868698449541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37052,0.000996888536241775,0.00264235029483159,-0.00418211804162814,0.00617589511411169,0.705976490830582
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39452,0.00239626191347586,0.00637422408536565,-0.0100972172938408,0.0148897411207925,0.70697406849621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,36987,-0.00248051850061577,0.00670332846541634,-0.0156190422928318,0.0106580052916003,0.711356563014533
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39784,0.00217110017961099,0.00589002973450655,-0.00937335810002185,0.0137155584592438,0.712426338133927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36987,0.00240634192678187,0.00654505564856959,-0.0104219671444145,0.0152346509979783,0.713134205079163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39862,0.000924778101618281,0.00251796778734232,-0.00401043876157266,0.00585999496480922,0.713421279914935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37017,-0.00168655745072615,0.00460128041724132,-0.0107050670685191,0.00733195216706683,0.713967395506059
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37384,-0.00190329142293976,0.00520136299965079,-0.0120979629022553,0.00829138005637578,0.714429250988494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,39555,-0.00179520968815872,0.00490864721525583,-0.0114161582300601,0.0078257388537427,0.714576026120423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37017,-0.00141838380902973,0.00389033704347486,-0.00904344441424046,0.00620667679618101,0.715422222027383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,39583,0.0020485517180764,0.00564024295107156,-0.00900632446602386,0.0131034279021767,0.716458320477738
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36987,-0.00172864313672052,0.00477781581280971,-0.0110931621298276,0.00763587585638652,0.717502720804905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37052,-0.0025069069829954,0.0069476651812492,-0.0161243307382438,0.011110516772253,0.718234361589486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39864,0.00143835524137906,0.00399883631804096,-0.00639936394198121,0.00927607442473933,0.719081134881362
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36958,0.00301382341093585,0.00839323588898092,-0.0134369189314667,0.0194645657533384,0.719542789620799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37182,0.00136570491426478,0.0038035997494241,-0.00608935059460646,0.00882076042313602,0.719558965124435
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,36899,0.00111374159868014,0.00310775211126525,-0.00497745253939976,0.00720493573676003,0.72006827441078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37035,0.00117897802210315,0.00330515324163711,-0.00529912233150559,0.00765707837571189,0.721315353765025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40026,0.000995924879695242,0.00280803156329366,-0.00450781698436033,0.00649966674375081,0.722841367845979
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36958,-0.00204314978391573,0.00576727547907253,-0.0133470097228979,0.00926071015506644,0.723145226553209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37433,-0.00141721864792145,0.00402227335578206,-0.00930087442525428,0.00646643712941138,0.724586740457135
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37408,-0.000946997421757488,0.00269444437287382,-0.00622810839259017,0.00433411354907519,0.725246513978124
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37408,0.00103426527152282,0.00303129167936863,-0.00490706642003969,0.00697559696308533,0.732961157719992
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37052,0.000914543010482516,0.00268619402906122,-0.00435039728647747,0.0061794833074425,0.733515171991854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37079,-0.00253916145680658,0.0074905845770048,-0.017220707227736,0.0121423843141228,0.734629869773502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37052,0.000796089238045243,0.0023589630938299,-0.00382747842586136,0.00541965690195185,0.735764809681534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,36650,-0.00376438452065613,0.0111627206425256,-0.0256433169800064,0.0181145479386941,0.735950391830232
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36987,0.00188099215966869,0.0055857093763938,-0.00906699821806316,0.0128289825374005,0.736310140136707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37384,0.00153004899302659,0.00459682428159593,-0.00747972659890143,0.0105398245849546,0.73925332464223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37017,0.000942503615554363,0.00284671509759386,-0.00463705797572961,0.00652206520683834,0.740585833472317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37052,0.00169284962571698,0.00511509047722952,-0.00833272770965289,0.0117184269610868,0.740685969231929
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37165,-0.00249422305753803,0.00760096517415335,-0.0173921147988786,0.0124036686838025,0.742806762853558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39839,0.00246102865137971,0.00751698122355323,-0.0122722545467846,0.017194311849544,0.743372774244446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37364,0.00136584778322261,0.00417604511505122,-0.00681920064227778,0.009550896208723,0.743622056207789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,39785,0.00219386386903466,0.00680999556744008,-0.0111537274431479,0.0155414551812172,0.747340642628972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37035,0.00104212196985139,0.00325666536037197,-0.00534094213647767,0.00742518607618045,0.748975952622313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37052,0.00268524633060175,0.00842094084665112,-0.0138197977288344,0.0191902903900379,0.74982465647879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37039,-0.00247020958827932,0.00777142898947354,-0.0177022104076475,0.0127617912310888,0.750597814400298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,39775,0.00083627604186207,0.00264034764884122,-0.00433880534986671,0.00601135743359085,0.751453002120174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,39583,-0.000892975541116224,0.00282458672170128,-0.00642916551565072,0.00464321443341828,0.751897569601321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39790,0.000987044681612356,0.00312447630681084,-0.0051369288797369,0.00711101824296161,0.752077056287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37017,0.00189411538059904,0.00608977422743,-0.0100418421051638,0.0138300728663618,0.755781131990143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,36987,0.00269797710320356,0.00871949621153236,-0.0143922354713999,0.019788189677807,0.75700779083187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39854,0.000778097340311298,0.00255146600895643,-0.00422277603724331,0.00577897071786591,0.760399909093586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,39784,0.00261603488832203,0.00860292810368541,-0.0142457041949014,0.0194777739715454,0.7610659125029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,36958,-0.0021867327114799,0.00720557581811893,-0.016309661314993,0.0119361958920332,0.761530539592922
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37433,0.00136193652336475,0.00451614604748369,-0.00748970972970329,0.0102135827764328,0.762984101981237
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39485,0.00176231916628664,0.00585747820252156,-0.00971833811065562,0.0132429764432289,0.763520273599466
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37035,-0.00125747225444788,0.00429338323808319,-0.00967250340109093,0.00715755889219518,0.769613829523191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36971,0.000907831037490058,0.00312297681657422,-0.00521320352299542,0.00702886559797554,0.771289857135413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,39904,-0.00149911146082787,0.00516797443414077,-0.0116283413517438,0.00863011843008805,0.771760940540927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37017,0.00142351263873004,0.00491398460482767,-0.0082078971867322,0.0110549224641923,0.772061017756955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36987,-0.000785406801451256,0.00272267899868537,-0.00612185763887458,0.00455104403597207,0.772992785564032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39784,-0.00113380444368257,0.00395861026281288,-0.00889268055879581,0.00662507167143067,0.774564190374736
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37378,0.00147611951140966,0.00518472314847027,-0.00868593785959208,0.0116381768824114,0.775874091222668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,39864,0.000880653081314703,0.00319849187844253,-0.00538839100043265,0.00714969716306206,0.78306331547701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37017,0.000909493738042249,0.00331201474418034,-0.00558205516055122,0.00740104263663572,0.783624516395181
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37384,0.00152832485523113,0.00560271079570914,-0.00945298830435878,0.012509638014821,0.785024111237602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,39583,0.00099240105465707,0.00365732016342519,-0.00617594646565629,0.00816074857497043,0.78612810187134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39473,-0.00295837250317729,0.0109028147669105,-0.0243278894463218,0.0184111444399672,0.786132938186633
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39864,-0.000431537072280708,0.00159310789141701,-0.00355402853945804,0.00269095439489662,0.786488749117765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,39716,-0.00126492936598157,0.00467498489520819,-0.0104278997605896,0.00789804102862649,0.786722216357522
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37378,0.00616727823661408,0.0229735467861819,-0.0388608734643025,0.0511954299375307,0.788356061619706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37165,0.00106302953912276,0.00397170261375379,-0.00672150758383466,0.00884756666208018,0.788972242602803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37321,-0.000650476111230901,0.00243345464812205,-0.00542004722155012,0.00411909499908831,0.789237952656741
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40048,0.00129998241367892,0.00492068080084728,-0.00834455195598175,0.0109445167833396,0.791638797112866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39581,0.00201464764045704,0.00763252753981546,-0.0129451063375813,0.0169744016184953,0.791817666840119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39473,-0.000725698371156798,0.00276067438925964,-0.00613662017410569,0.00468522343179209,0.792654277858863
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36987,-0.00139773158455055,0.00532736890966234,-0.0118393746474887,0.00904391147838763,0.793041791748213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36987,-0.00163964880463164,0.00647196647262234,-0.0143247030909714,0.0110454054817081,0.800004582574371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,39554,0.000971579102712278,0.00383745949727923,-0.00654984151195501,0.00849299971737957,0.800130200467351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37017,-0.000951684188895126,0.00376281703465526,-0.00832680557681944,0.00642343719902918,0.800335524680685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37165,-0.00133205853818375,0.00534644747002771,-0.0118110955794381,0.00914697850307057,0.803249880301625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37039,-0.000908623331505341,0.00368219012471705,-0.00812571597595076,0.00630846931294008,0.805096530738779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37017,-0.00143781045005995,0.00583810904224417,-0.0128805041728585,0.0100048832727386,0.80546920622314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40004,-0.00128744286980357,0.00528877945728623,-0.0116534506060846,0.00907856486647743,0.807676089276404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37120,0.00163685599269426,0.00680974142898127,-0.011710237208109,0.0149839491934976,0.810047325880266
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37017,0.00085425909804913,0.00359907447165319,-0.00619992686639112,0.00790844506248938,0.812384925253041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37017,-0.00102083498017718,0.00430865643800372,-0.00946580159866448,0.00742413163831012,0.812717483469837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36958,0.001935777523358,0.00827427819042232,-0.0142818077298697,0.0181533627765857,0.815026500642956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37165,0.000607076567996446,0.00263010288892768,-0.0045479250943018,0.0057620782302947,0.817459308809733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36958,0.000956658612442433,0.00418167729694117,-0.00723942888956226,0.00915274611444713,0.819048227367385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36958,-0.00104365221144171,0.00459524135160593,-0.0100503252605893,0.00796302083770592,0.820337192939306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,36958,0.001472931022664,0.00654652100146135,-0.0113582501402003,0.0143041121855283,0.821987086246644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37384,0.00073293065638027,0.00326874475059282,-0.00567380905478165,0.00713967036754219,0.822586484012168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39581,0.000674041426537318,0.0030135976481976,-0.00523260996392998,0.00658069281700462,0.823019569077578
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36958,0.000648417391906019,0.00291436070458858,-0.0050637295890876,0.00636056437289964,0.82393558460961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37017,-0.00115563946819316,0.00522257401175351,-0.01139188453123,0.00908060559484371,0.824879601188784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37035,0.00092729945283377,0.00419655444133618,-0.00729794725218514,0.00915254615785268,0.825121662125144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37364,0.000808704616034052,0.00382221186114147,-0.00668283063180323,0.00830023986387133,0.832437696340649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,39711,0.00138926313109055,0.00659542436806897,-0.0115377686303246,0.0143162948925057,0.833170556485341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36958,-0.000747734223013698,0.00357399085916997,-0.00775275630698684,0.00625728786095944,0.834283279974655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36987,-0.00220379570737633,0.0105648937609928,-0.0229109874789222,0.0185033960641695,0.83476678646473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37384,-0.000517930166484799,0.00253257593484931,-0.00548177899878945,0.00444591866581985,0.837960196275359
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,37364,-0.000921306644613309,0.00451518720349168,-0.00977107356345699,0.00792846027423038,0.838320496079388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37165,-0.00105750537272193,0.00519357666085277,-0.0112369156279933,0.00912190488254949,0.838655187965325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37035,0.000670317038740796,0.00331626462268171,-0.00582956162171536,0.00717019569919695,0.839818105220064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37035,-0.00115239050279438,0.00570698346896938,-0.0123380781019744,0.0100332970963856,0.839977397540875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37017,0.000724577173741083,0.00365222279892915,-0.00643377951216005,0.00788293385964222,0.842740287173112
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,36987,0.000631793380472437,0.00318514699726686,-0.00561109473417061,0.00687468149511548,0.842769522889821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37165,0.00117734429962338,0.00594389212033371,-0.0104726842562307,0.0128273728554774,0.842988374903436
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37052,-0.00101547189087934,0.00519571991708016,-0.0111990829283565,0.00916813914659777,0.845048442886313
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37052,-0.000937876917409387,0.00491627809348068,-0.0105737819806315,0.00869802814581274,0.848708960924841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40005,-0.000790552687470674,0.00420620777911586,-0.00903471993453776,0.00745361455959641,0.850918966327012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37052,-0.000644363524901462,0.00345334557853793,-0.00741292085883581,0.00612419380903289,0.851984120293516
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37165,0.00072906634313088,0.00390744972714934,-0.00692953512208183,0.00838766780834359,0.85198990948666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37145,0.000904343874874445,0.00492464262602222,-0.0087479556721291,0.010556643421878,0.854301471258382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37165,0.000846176287570484,0.00461840804467078,-0.00820590347998424,0.00989825605512521,0.854629626912255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37039,-0.00425746678533645,0.023304954429082,-0.0499351774663373,0.0414202438956644,0.855047956044893
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39485,0.00115399005174103,0.00635023818948326,-0.0112924767996462,0.0136004569031282,0.855801765787973
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37035,0.000553495018165125,0.00305744219036882,-0.00543909167495777,0.00654608171128802,0.856345206390503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37165,-0.00137863687660298,0.00777087219635194,-0.0166095463814528,0.0138522726282468,0.859188402739431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37165,0.000699052878225138,0.00394607582798967,-0.00703525574463461,0.00843336150108488,0.859392161399128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37052,0.00145438137756772,0.00822750548366773,-0.014671529370421,0.0175802921255565,0.859691268461289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,36987,-0.000988253617374748,0.00561865186489598,-0.0120008112725709,0.0100243040378214,0.860384621149316
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36987,0.000987504255436845,0.00568260333324213,-0.0101503982777177,0.0121254067885914,0.862043608274385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36987,0.000859282162480398,0.0049602073822497,-0.00886272430672902,0.0105812886316898,0.8624692836087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37165,0.00111653081842756,0.00658988681029316,-0.011799647329747,0.0140327089666021,0.865460252362505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37017,-0.00071175081222057,0.00432950068113351,-0.00919757214724224,0.0077740705228011,0.869422261578372
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40054,-0.000509449213277328,0.00311025426482078,-0.00660554757232606,0.00558664914577141,0.869893277100978
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,36958,-0.000452756127427426,0.00280972540415168,-0.00595981791956472,0.00505430566470986,0.871986469378321
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,39583,-0.000678349511799753,0.00427977990125697,-0.00906671811826342,0.00771001909466391,0.874064046680126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39927,-0.000382375038400679,0.00254207481058705,-0.0053648416671513,0.00460009159034994,0.880436347504393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37035,0.000551404605682938,0.00368723735140756,-0.00667558060307588,0.00777838981444175,0.881126599690268
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39485,-0.000441848637586355,0.00295994620973115,-0.00624334320865941,0.0053596459334867,0.881337856898924
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,39750,0.000690855933919731,0.00467769845844753,-0.00847743304463744,0.0098591449124769,0.882588176052131
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,39862,-0.000768707400926868,0.00522435649527047,-0.011008446131657,0.00947103132980325,0.883024038526484
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37408,-0.000316689584377232,0.00216221706086788,-0.00455463502367828,0.00392125585492382,0.883556328195676
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39485,0.000510551660777441,0.00354137948033754,-0.00643055212068414,0.00745165544223903,0.885370100218681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37017,-0.000601421145098002,0.00419750182457059,-0.00882852472125636,0.00762568243106036,0.886070664554945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37408,0.000657176704440456,0.00474977751873366,-0.00865238723227752,0.00996674064115843,0.889958382720356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36671,-0.000605222109579658,0.00442344467832533,-0.00927517367909731,0.008064729459938,0.891174079381015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37039,-0.000496439704507795,0.00372670642649144,-0.00780078430043103,0.00680790489141544,0.894028245279566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37039,-0.000440880809828309,0.00335895098040104,-0.00702442473141434,0.00614266311175773,0.895575191939123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37035,-0.000508177584851572,0.00389145751925113,-0.0081354343225838,0.00711907915288065,0.896103243949264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37364,-0.000699886461014341,0.00538558498647649,-0.0112556330345083,0.00985586011247959,0.896603559014325
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36927,-0.00102779303047177,0.00795107685875951,-0.0166119036736404,0.0145563176126969,0.897150245058471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,39583,0.000506585053911221,0.00393145817356513,-0.00719907296627643,0.00821224307409888,0.897474634247842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37035,0.000423645696823259,0.00334015202417773,-0.00612305227056509,0.00697034366421161,0.899073517860292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39485,-0.000620636646305156,0.00489336038787874,-0.0102116230065475,0.00897034971393717,0.899074682649949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37035,0.000497556932196224,0.00394174752470325,-0.00722826821622215,0.0082233820806146,0.899553770436443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,39581,0.000310477065182603,0.00247962647855417,-0.00454959083278357,0.00517054496314878,0.900357933111353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40007,-0.000346146489363838,0.0027879947895273,-0.00581061627683735,0.00511832329810967,0.901193245804397
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39473,-0.000489177465582757,0.00394089560084321,-0.00821333284323544,0.00723497791206993,0.901215129643694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39581,0.000358248994253212,0.00303798537245235,-0.0055962023357534,0.00631270032425982,0.906130007275037
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37035,-0.000514765481767337,0.0043956834809465,-0.00913030510442247,0.0081007741408878,0.906777015946572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37035,0.000801433659104239,0.00725292479648873,-0.0134142989420137,0.0150171662602222,0.912016121724156
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39485,0.00046739331488775,0.00424908541369197,-0.00786081409594851,0.00879560072572401,0.912411922500322
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36958,0.000256707748556683,0.00237596569406277,-0.00440018501180634,0.00491360050891971,0.913962807971896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37165,0.000376483886095625,0.00356945141868861,-0.00661964089453404,0.00737260866672529,0.916001386097982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39854,-0.000260880310097781,0.00273611485151081,-0.00562366541905898,0.00510190479886342,0.92404041603889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37364,-0.000402225551696668,0.00434471530310512,-0.00891786754578271,0.00811341644238937,0.926240104304963
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39583,-0.000501424788320617,0.00548789127086134,-0.0112576916792089,0.0102548421025676,0.927200318061341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,36958,0.00043462015321144,0.00487138599730761,-0.00911329640151147,0.00998253670793435,0.928909235426249
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,36958,-0.000434858461945376,0.00492630805453679,-0.0100904222488375,0.00922070532494672,0.929661294228109
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37017,0.000261121859524017,0.00303194700395798,-0.00568149426823361,0.00620373798728165,0.931369560648505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37165,0.000523197830020826,0.00616887595008959,-0.0115677990321548,0.0126141946921964,0.932411726885549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39784,0.000260656810229507,0.00311934436370785,-0.00585325814263787,0.00637457176309688,0.933406201082961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,36958,-0.000855912842965624,0.010464992011604,-0.0213672971857094,0.0196554714997782,0.934816390635067
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39581,0.000375635937110784,0.0047889669185411,-0.00901073922322978,0.00976201109745134,0.937480819684948
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37017,-0.000442188831778012,0.00612163577428123,-0.0124405949493692,0.0115562172858132,0.942416968583251
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37378,-0.000713432082699816,0.00999516030516163,-0.0203039462808166,0.018877082115417,0.943098170945936
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,39784,9.40438929924892e-05,0.00136439085561939,-0.00258016218402152,0.0027682499700065,0.945048286195503
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37165,0.000268826612506345,0.00406390375510199,-0.00769642474749355,0.00823407797250624,0.947259519269945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40026,0.000198893208958037,0.00303478514188069,-0.00574928566912811,0.00614707208704418,0.947746603704964
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39340,-0.00045202388306749,0.00693744994230353,-0.0140494257699824,0.0131453780038474,0.948049786264926
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37165,0.000161528783307988,0.00250877861746613,-0.00475567730692563,0.00507873487354161,0.948664300537403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37052,-0.000249132313132501,0.00390631122376897,-0.00790550231171968,0.00740723768545468,0.949148860068239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,36958,-0.000248468775227312,0.00413444499369452,-0.00835198096286857,0.00785504341241395,0.952079096896847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39473,-0.000737850008188275,0.012479636208253,-0.0251979369763641,0.0237222369599876,0.952853844419293
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,39784,0.000407378229795476,0.00713711763339084,-0.0135813723316506,0.0143961287912415,0.954483126812577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37035,0.000187926189928339,0.003300166684082,-0.00628040051087238,0.00665625289072906,0.954590306104077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40048,0.000133903220671849,0.0024131373778342,-0.00459584603988319,0.00486365248122689,0.955749366449534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37017,0.000173586411550794,0.00318117155604301,-0.0060615098382935,0.00640868266139509,0.956484402697758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37120,0.000165985867357774,0.0030478245790867,-0.00580775030765215,0.0061397220423677,0.95656914662163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37035,0.000181329451557358,0.00334925125956641,-0.00638320301719282,0.00674586192030753,0.956824209342915
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37017,0.000302557940534197,0.00585563966778912,-0.0111744958083325,0.0117796116894009,0.958792829155947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36987,-0.000182600500277795,0.00361018712005865,-0.00725856725559275,0.00689336625503716,0.959661579805257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36987,0.000183090671672635,0.00369177148987087,-0.00705278144847428,0.00741896279181955,0.960446476134378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37408,-9.09303771862197e-05,0.00195592863389789,-0.00392455049962609,0.00374268974525365,0.962920693108299
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39837,-0.000408703588767938,0.00883066883071143,-0.0177168144969623,0.0168994073194265,0.963085831979454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37052,-0.000187280204145175,0.00430530853710563,-0.0086256849368722,0.00825112452858185,0.965303755680374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,36987,0.000302284452021178,0.00701807135223492,-0.0134531353983593,0.0140577043024016,0.965644557878973
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39909,-0.000157148840494546,0.00370290621377074,-0.00741484501948519,0.0071005473384961,0.966149007649009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37384,0.000211667790164613,0.00513916239014803,-0.00986109049452552,0.0102844260748548,0.967147253371231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37035,0.000117631754392848,0.00288836835929151,-0.00554357022981851,0.0057788337386042,0.967514933057849
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37035,0.000276062735893654,0.00710652989568761,-0.0136527358596541,0.0142048613314414,0.969013480637362
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37035,-0.000216305447843047,0.00584092233145688,-0.0116645132174985,0.0112319023218124,0.970459449695172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37035,0.000211444546253495,0.00586189959296826,-0.0112778786559643,0.0117007677484713,0.971226297010375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37039,9.08407193107595e-05,0.00264877961726081,-0.00510076733052042,0.00528244876914194,0.97264218376113
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,37035,0.000109203926065313,0.00353470788561068,-0.00681882352973161,0.00703723138186224,0.975353942618694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39485,0.000172275395378445,0.00720743784740221,-0.0139543027855299,0.0142988535762868,0.980930728284003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37384,0.000128863911423104,0.0054178584895832,-0.01049013872816,0.0107478665510062,0.981024434163985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37035,0.000100427332496091,0.00544724622946284,-0.0105761752772511,0.0107770299422433,0.985291034241231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,39784,-2.98515414154377e-05,0.00171039369175889,-0.00338222317726286,0.00332252009443199,0.986075427547949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40026,4.46291109065568e-05,0.00401292949269931,-0.00782071269478408,0.00790997091659719,0.99112678309285
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37035,-5.17671059762923e-05,0.00466865509527421,-0.00920233109271374,0.00909879688076115,0.991153224300235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36987,-4.00770984567856e-05,0.0038832538817083,-0.00765125470660505,0.00757110050969148,0.99176574017335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37364,-1.80771810684851e-05,0.00408401851567099,-0.00802275347178363,0.00798659910964666,0.996468382917242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37165,1.16797372679567e-05,0.00533165609779848,-0.0104383662144171,0.010461725688953,0.998252156682242
